e10vk
    UNITED STATES SECURITIES AND
    EXCHANGE COMMISSION
    Washington, D.C.
    20549
    Form 10-K
 
    |   | 	
      | 	
      | 	
| 
    (Mark One)
    
 | 
 
 | 
 
 | 
| 
 
    þ
 
 | 
 
 | 
    ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)  OF THE
    SECURITIES EXCHANGE ACT OF 1934 
 | 
| 
 
 | 
 
 | 
    For the fiscal year ended
    December 31,
    2010
    
 | 
| 
 
    or
 
 | 
| 
 
    o
 
 | 
 
 | 
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934
 | 
| 
 
 | 
 
 | 
    For the transition period
    from          to          
 | 
 
    Commission file number 0-26946
    INTEVAC, INC.
    (Exact name of registrant as
    specified in its charter)
 
    |   | 	
      | 	
      | 	
| 
 
    Delaware
 
 | 
 
 | 
    94-3125814
 | 
| 
 
    (State or other jurisdiction of
    incorporation or organization)
 
 | 
 
 | 
    (I.R.S. Employer Identification
    No.)
    
 | 
 
    3560 Bassett Street
    Santa Clara, California 95054
    (Address of principal executive
    office, including Zip Code)
 
    Registrants telephone number, including area code:
    (408) 986-9888
 
    Securities registered pursuant to Section 12(b) of the
    Act:
 
    |   | 	
      | 	
      | 	
| 
 
    Title of Each Class
 
 | 
 
 | 
 
    Name of Each Exchange on Which Registered
 
 | 
|  
 | 
| 
 
    Common Stock ($0.001 par value)
 
 | 
 
 | 
    The Nasdaq Stock Market LLC (NASDAQ Global Select)
 | 
 
    Securities registered pursuant to Section 12(g) of the
    Act:
    None.
 
 
    Indicate by check mark if the registrant is a well-known
    seasoned issuer, as defined in Rule 405 of the Securities
    Act.  o Yes     þ No
 
    Indicate by check mark if the registrant is not required to file
    reports pursuant to Section 13 or Section 15(d) of the
    Act.  o Yes     þ No
 
    Indicate by check mark whether the registrant (1) has filed
    all reports required to be filed by Section 13 or 15(d) of
    the Securities Exchange Act of 1934 during the preceding
    12 months (or for such shorter period that the registrant
    was required to file such reports), and (2) has been
    subject to such filing requirements for the past
    90 days.  þ Yes     o No
 
    Indicate by check mark whether the registrant has submitted
    electronically and posted on its corporate Web site, if any,
    every Interactive Data File required to be submitted and posted
    pursuant to Rule 405 of
    Regulation S-T
    (§ 232.405 of this chapter) during the preceding
    12 months (or for such shorter period that the registrant
    was required to submit and post such
    files).  Yes o     No o
    
 
    Indicate by a check mark if disclosure of delinquent filers
    pursuant to Item 405 of
    Regulation S-K
    is not contained herein, and will not be contained, to the best
    of registrants knowledge, in definitive proxy or
    information statements incorporated by reference in
    Part III of this
    Form 10-K
    or any amendment to this
    Form 10-K.
 
    Indicate by check mark whether the registrant is a large
    accelerated filer, an accelerated filer, a non-accelerated
    filer, or a smaller reporting company. See the definitions of
    large accelerated filer, accelerated
    filer and smaller reporting company in
    Rule 12b-2
    of the Exchange Act. (Check one):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Large accelerated
    filer o
    
 
 | 
 
 | 
         Accelerated
    filer þ
    
 | 
 
 | 
    Non-accelerated
    filer o
    
 | 
 
 | 
    Smaller reporting
    company o
    
 | 
| 
 
 | 
 
 | 
    (Do not check if a smaller reporting
    company)     
 | 
 
    Indicate by check mark whether the registrant is a shell company
    (as defined in
    Rule 12b-2
    of the
    Act).  o Yes     þ No
 
    The aggregate market value of voting stock held by
    non-affiliates of the Registrant, as of July 3, 2010 was
    approximately $146,965,844 (based on the closing price for
    shares of the Registrants Common Stock as reported by the
    Nasdaq Stock Market for the last trading day prior to that
    date). Shares of Common Stock held by each executive officer,
    director, and holder of 5% or more of the outstanding Common
    Stock have been excluded in that such persons may be deemed to
    be affiliates. This determination of affiliate status is not
    necessarily a conclusive determination for other purposes.
 
    On February 24, 2011, 22,761,223 shares of the
    Registrants Common Stock, $0.001 par value, were
    outstanding.
 
    DOCUMENTS INCORPORATED BY REFERENCE.
 
    Portions of the Registrants Proxy Statement for the 2011
    Annual Meeting of Stockholders are incorporated by reference
    into Part III. Such proxy statement will be filed within
    120 days after the end of the fiscal year covered by this
    Annual Report on
    Form 10-K.
 
 
TABLE OF CONTENTS
 
    CAUTIONARY
    NOTE REGARDING FORWARD-LOOKING STATEMENTS
 
    Certain information in this Annual Report on
    Form 10-K
    (report or
    Form 10-K)
    of Intevac, Inc. and its subsidiaries (Intevac or
    the Company), including Managements
    Discussion and Analysis of Financial Condition and Results of
    Operations in Item 7, is forward-looking in nature.
    All statements in this report, including those made by the
    management of Intevac, other than statements of historical fact,
    are forward-looking statements. Examples of forward-looking
    statements include statements regarding Intevacs future
    financial results, operating results, cash flows and cash
    deployment strategies, business strategies, costs, products,
    working capital, competitive positions, managements plans
    and objectives for future operations, research and development,
    acquisitions and joint ventures, growth opportunities, customer
    contracts, investments, liquidity, declaration of dividends, and
    legal proceedings, as well as market conditions and industry
    trends. These forward-looking statements are based on
    managements estimates, projections and assumptions as of
    the date hereof and include the assumptions that underlie such
    statements. Forward-looking statements may contain words such as
    may, will, should,
    could, would, expect,
    plan, anticipate, believe,
    estimate, predict, potential
    and continue, the negative of these terms, or other
    comparable terminology. Any expectations based on these
    forward-looking statements are subject to risks and
    uncertainties and other important factors, including those
    discussed in Item 1A, Risk Factors, below and
    elsewhere in this report. Other risks and uncertainties may be
    disclosed in Intevacs prior Securities and Exchange
    Commission (SEC) filings. These and many other
    factors could affect Intevacs future financial condition
    and operating results and could cause actual results to differ
    materially from expectations based on forward-looking statements
    made in this report or elsewhere by Intevac or on its behalf.
    Intevac undertakes no obligation to revise or update any
    forward-looking statements.
 
    The following information should be read in conjunction with the
    Consolidated Financial Statements and the accompanying Notes to
    Consolidated Financial Statements included in this report.
 
    PART I
 
 
    Overview
 
    Intevacs business consists of two reportable segments:
 
    Equipment:  Intevac is a leader in the design,
    development and marketing of high-productivity process
    manufacturing equipment solutions to the hard disk drive
    industry. Intevac also offers high-productivity process
    manufacturing equipment and inspection solutions for the solar
    photovoltaic (PV) industry and wafer handling
    platforms for the semiconductor industry.
 
    Intevac Photonics:  Intevac is a leader in the
    development and manufacture of leading edge, high-sensitivity
    imaging products and vision systems, as well as table-top and
    handheld Raman instruments. Markets addressed include military,
    law enforcement, industrial, medical and scientific.
 
    Intevac was incorporated in October 1990 in California and
    completed a leveraged buyout of a number of divisions of Varian
    Associates in February 1991. Intevac was reincorporated in
    Delaware in 2007.
 
    Equipment
    Segment
 
    Hard
    Disk Drive Equipment Market
 
    Intevac designs, manufactures, markets and services complex
    capital equipment used to deposit thin films onto magnetic disks
    that are used in hard disk drives, and also equipment to
    lubricate these disks. Disk and disk drive manufacturers produce
    magnetic disks in a sophisticated manufacturing process
    involving many steps, including plating, annealing, polishing,
    texturing, sputtering, etching, stripping and lubrication.
    Intevac believes its systems represent approximately 60% of the
    installed capacity of disk sputtering systems worldwide.
    Intevacs systems are used by manufacturers such as Fuji
    Electric, Hitachi Global Storage Technologies, Seagate
    Technology, Showa Denko and Western Digital.
    
    2
 
    Hard disk drives are a primary storage medium for digital data
    and are used in products and applications such as personal
    computers, enterprise data storage, personal audio and video
    players and video game platforms. Intevac believes that hard
    disk drive shipments will continue to grow over time, driven by
    growth in digital storage, by new and emerging applications, and
    by the proliferation of personal computers into emerging
    economies. Continued growth in hard disk drive shipments is a
    key factor in determining demand for magnetic disks used in hard
    disk drives.
 
    Demand for Intevacs disk manufacturing products is driven
    by a number of factors, including unit demand for hard disk
    drives, market share, the average number of magnetic disks used
    in each hard drive, utilization and productivity of disk
    manufacturers installed base of magnetic disk
    manufacturing equipment and obsolescence of the installed base
    as a result of new technologies such as perpendicular recording.
    The introduction of perpendicular recording technology by disk
    manufacturers had a significant impact on the equipment market,
    and increased demand both for new equipment, such as
    Intevacs 200
    Lean®
    disk sputtering system, and for technology upgrades to the
    installed base of Intevacs legacy MDP-250 systems from
    2005 through 2007.
 
    Intevac expects that hard disk drive manufacturers will extend
    planar perpendicular media for the next several years with the
    introduction of thermal assisted magnetic recording
    (TAMR) followed by patterned media, the next major
    media technology for the hard drive industry. Intevac believes
    that the transition to TAMR will require that disk manufacturers
    upgrade their installed base of equipment and will result in
    increased demand for equipment technology upgrades to be
    performed by Intevac. The transition to patterned media by disk
    manufacturers, which introduces new processes and requires new
    equipment, will result in increased demand for Intevacs
    equipment. Although Intevac does not expect the transition to
    patterned media to occur for several years, Intevac introduced
    the 200 Lean Gen II etch and deposition system in 2009
    which is being used by the industry for patterned media
    application development.
 
    Hard
    Disk Drive Equipment Products
 
    Disk
    Sputtering Systems
 
    Disk sputtering is the process of depositing a thin film of
    various materials on a substrate. Intevac equipment deposits
    magnetic films, non-magnetic films and protective carbon-based
    overcoats on disks that are to be used in hard disk drives using
    sputtering or chemical vapor deposition (CVD)
    technologies.
 
    Intevacs 200 Lean systems began shipping in 2003 with the
    installed base reaching over 140 systems by the end of 2010.
    Intevac estimates that approximately 90% of these systems are
    used in production with the balance used for research and
    development.
 
    In 2008, Intevac shipped the first 200 Lean Gen II system,
    which is designed to deliver 25% higher throughput than the
    original 200 Lean systems. This increase in throughput enables
    Intevac customers to manufacture more magnetic disks per square
    foot of factory floor space, further reducing overall cost per
    disk.
 
    In 2009, Intevac shipped the first 200 Lean Gen II etch and
    deposition system to be used for patterned media. Intevac
    provides a cost-effective solution for high-volume manufacturing
    by providing new etch and associated process modules on the
    high-productivity 200 Lean Gen II platform.
 
    From 1994 through 2005, Intevac shipped approximately 110
    MDP-250s. As of the end of 2010, Intevac believes that
    approximately 65% of these systems are still being used for
    production. The balance of these systems is being used by
    customers for research and development, is in storage or has
    been retired from service.
 
    Disk
    Lubrication Systems
 
    Disk lubrication is the manufacturing step that follows
    deposition of thin films. During lubrication, a microscopic
    layer of lubricant is applied to the disks surface to
    improve durability and reduce surface friction between the disk
    and the read/write head assembly.
 
    The Intevac DLS-100 disk lubrication system provides
    Intevacs customers with a lubrication process by dipping
    disks into a lubricant/solvent mixture. Intevac has been
    manufacturing dip lubrication systems similar to the DLS-100
    since 1996.
    
    3
 
    The Intevac
    AccuLubertm
    lubricates disks by depositing a thin film of lubricant on the
    disk while it is under vacuum. This eliminates the use of
    solvents during the lubrication process, which are
    environmentally hazardous and are expensive to procure, store
    and dispose.
 
    Deposition
    System
 
    The Intevac
    LithoPrimetm
    is a process-critical production tool for
    nano-imprint-lithography. It enables patterning on hard disks by
    coating a thin adhesion layer between the disk and the resist.
    This is a crucial step of the imprint process for patterned
    media. Nano-imprinting is vital for the next generation
    technology transition to patterned media.
 
    Non-Systems
    Business
 
    Intevac also provides installation, maintenance and repair
    services, technology upgrades, spare parts and consumables to
    Intevacs system customers. Non-system business as a
    percentage of Equipment revenues was 45% in 2008, 51% in 2009
    and 27% in 2010.
 
    Semiconductor
    Equipment Market
 
    Intevac designs, manufactures and markets vacuum wafer-handling
    automation equipment to the semiconductor manufacturing
    industry. Semiconductor manufacturers fabricate chips and
    devices which are used in a variety of products including
    computers, telecommunications equipment, automotive, consumer
    electronics and wireless communications devices. Intevac
    believes that demand for semiconductor chips will continue to
    grow over time both in terms of unit volumes and device
    complexity.
 
    Semiconductor device fabrication is the process used to create
    the integrated circuits (silicon chips). It is a multiple-step
    sequence of photographic and chemical processing steps during
    which electronic circuits are gradually created on a silicon
    wafer. Semiconductor manufacturers fabricate semiconductor chips
    in a sophisticated manufacturing process using a wide range of
    manufacturing equipment and process steps. The requirement for
    efficient, high throughput and extremely clean manufacturing for
    semiconductor wafer fabs has created a substantial market for
    vacuum wafer handling automation equipment. Wafer handling
    equipment moves wafers between process chambers on semiconductor
    systems.
 
    Wafer
    Handling System
 
    In 2010 Intevac introduced
    Continuumtm,
    a high-productivity vacuum wafer handling system. Intevacs
    platform solution offers customers a cost-effective, flexible
    alternative to the current cluster platform designs.
    Continuums linear motion architecture and dual robot
    transport system enables faster wafer transport, and offers
    advantages over alternative wafer transfer design as well as
    traditional cluster mainframes. To date Intevac has not
    recognized revenue from its semiconductor wafer handling product.
 
    Solar
    Market
 
    Intevac designs, manufactures and markets capital equipment to
    the photovoltaic (PV) solar manufacturing industry.
    Today, fossil fuels are used to generate most of the
    worlds electricity supply. Volatile prices, increasing
    demand, growing environmental concerns and the desire for energy
    security are all driving the growth of renewable energy sources
    such as solar. As a result there is growing global demand for
    renewable energy sources such as PV solar electricity.
 
    The cost of electricity generated from solar PV energy is higher
    than that of electricity generated by traditional energy
    sources. To offset the higher costs associated with solar energy
    and to encourage the adoption of alternative energy supplies,
    governments around the world have implemented various tax
    credits and other financial incentives. If solar power is to
    become an effective competitor to traditional energy sources, a
    more efficient solar manufacturing process must be implemented
    to lower the cost per watt of electricity from solar PVs. New
    process technologies and integrated processing steps will become
    increasingly important as companies search for lower cost
    manufacturing solutions. Leading solar market research analysts
    are forecasting that the global PV energy market
    
    4
 
    demand will double between 2011 and 2014 to 33.95 GigaWatts. In
    2010 the capital equipment spending amount in crystalline
    silicon (c-Si) cell alone was $3.47 billion. At
    the same time solar cell manufacturers are forecasted to
    increase capacities on average by 35% per year.
 
    A solar cell (also called photovoltaic or PV cell) is a solid
    state device that converts the energy of sunlight directly into
    electricity. Solar cells, photovoltaic modules and photovoltaic
    arrays are assembled components. Assemblies of cells are used to
    make solar modules, also known as solar panels. Solar panels
    have broad-based end market applications for solar farms,
    integrated building PV arrays, rooftop grids and portable
    devices.
 
    Currently, there are two prevailing processes for manufacturing
    PV material: wafer-based c-Si and thin film solar cell
    manufacturing processes. Crystalline silicon uses silicon wafers
    and is similar to traditional semiconductor manufacturing
    processes. Thin film coating involves applying a deposition
    process and thin-film coating process onto glass or metal
    substrates. Intevac offers products for both manufacturing
    processes.
 
    While the manufacturing of thin film photovoltaic cells is
    expected to be an important and growing low cost cell segment of
    the market, the majority of the market is served by c-Si cell
    manufacturers. Intevac believes that the c-Si solar market will
    continue to be a large and growing market with multiple cell
    technologies. Intevac believes that both thin film and c-Si
    solar technologies can benefit in lower cost manufacturing
    solutions from the integrated processing solutions that Intevac
    specializes in.
 
    In c-Si solar processing there are three vacuum process
    applications: deposition, etching and doping by ion implant.
    With Intevacs acquisition of Solar Implant Technologies,
    Inc. in November 2010, Intevac believes that it now has the
    required expertise to develop a complete set of vacuum process
    modules to support c-Si cell manufacturers technology and
    cost reduction roadmaps.
 
    Solar
    Manufacturing Products
 
    Solar
    Cell Processing System
 
    Intevac offers integrated, multi-step manufacturing solutions
    for c-Si and Copper indium gallium (di)selenide
    (CIGS) thin film applications. Integrating multiple
    steps onto one platform can significantly lower solar cell
    manufacturing costs. This unique manufacturing solution, LEAN
    SOLARtm,
    was leveraged from our leading hard disk drive system design.
    LEAN SOLAR is a high-productivity solar process equipment
    solution enabling low-cost solar cell manufacturing and high
    cell efficiency for both CIGS (thin film) and c-Si solar. LEAN
    SOLAR performs single substrate processing for precise process
    control, and as a small footprint solar cell processing system,
    offers low-cost, high-productivity manufacturing to the
    photovoltaic industry. Intevac believes that LEAN SOLAR has the
    flexibility to accommodate Intevacs customers
    specific system configurations and the ability to run multiple
    applications. These applications include CIGS on glass or
    stainless steel substrates, and c-Si based applications.
 
    In 2009 Intevac began offering processing equipment to PV cell
    manufacturers for CIGS thin film applications and in 2010 began
    offering processing equipment for wafer-based crystalline
    silicon (c-Si) applications. To date Intevac has not
    recognized revenue from its PV manufacturing products.
 
    Inspection
    System
 
    Intevacs
    NanoVistatm
    Photoluminescence Inspection System is used in photovoltaic cell
    inspection. With high throughput material handling capability
    and a proprietary, high sensitivity, high resolution camera,
    NanoVista captures solar cell images in milliseconds with
    greater accuracy than other imaging systems. The NanoVista
    system benefits from the use of Intevacs leadership in
    low-light imaging technology and uses the proven proprietary
    Electron Bombarded Active Pixel Sensor
    (EBAPS®)
    technology developed at Intevacs Photonics division. This
    sensor technology enables higher sensitivity and higher speed
    photoluminescence inspection. The NanoVista photoluminescence
    inspection system can be used in multiple spots along the
    crystalline silicon wafering and cell manufacturing lines as
    well as in CIGS manufacturing.
 
    In 2010 Intevac began offering inspection equipment to PV cell
    manufacturers. To date Intevac has not recognized revenue from
    its PV inspection products.
    
    5
 
    Intevac
    Photonics Segment
 
    Intevac
    Photonics Market
 
    Intevac develops, manufactures and sells compact,
    cost-effective, high-sensitivity digital-optical products for
    the capture and display of low-light images based on
    Intevacs core
    EBAPS®
    technology. Intevac provides sensors, cameras, near-eye displays
    and systems for military applications such as night vision,
    long-range target identification and simulation training.
    Intevac also provides commercial products that include compact
    Raman instruments and cameras for commercial applications in the
    inspection, medical, and scientific markets, and for government
    applications in law enforcement and in the chemical, biological
    and explosives threat-detection markets. Historically, the
    majority of Intevacs Photonics revenue has been derived
    from contracts related to the development of low-light
    electro-optical sensors, systems and cameras, funded by the
    U.S. government, its agencies and contractors. However, the
    percentage of Intevac Photonics revenue derived from product
    sales continues to increase and grew from 37% in 2008 to 40% in
    2009 and 47% in 2010.
 
    Military
    Products
 
    Digital
    Enhanced Night Vision Goggle
 
    The U.S. military is funding development of a compact,
    head-mounted digital imaging system, or Digital Enhanced Night
    Vision Goggle (ENVG-D). ENVG-D integrates a visible
    light imager, a thermal imager and a video display. This
    approach allows low-light level and thermal imagery to be viewed
    individually, or to be overlaid (digitally fused),
    and enables connectivity to a wireless network for distribution
    of the imagery and other information. The U.S. Army
    continues to further develop and evaluate this system.
 
    Night
    Port
 
    Night
    Porttm
    is an integrated digital night vision viewer utilizing
    Intevacs EBAPS and display technology. Night Port combines
    digital sensor and near-eye display technology to create a
    compact, monocular system that provides full digital night
    vision viewing and recording capabilities. The Night Port system
    is designed to replace legacy night vision goggles for military
    and commercial applications for ground and avionics night
    vision. Derivatives of Night Port are currently being evaluated
    by the U.S. Special Operations for ground applications.
 
    LIVAR
 
    Intevac Photonics Laser Illuminated Viewing and Ranging
    (LIVAR®)
    camera enables the development of long range military nighttime
    surveillance systems which can identify targets at distances of
    up to twenty kilometers. Presently, Intevac Photonics
    LIVAR camera is being incorporated into multiple
    U.S. military programs for long-range target identification
    in land-based and airborne applications.
 
    Intensified
    Photodiodes
 
    Intevac continues to develop, under a number of research and
    development contracts, intensified photodiode technology that
    enables single photon detection at extremely high data rates,
    which is designed for use in target identification and other
    military applications.
 
    Near-Eye
    Display Systems
 
    Near-eye display systems are high-performance, micro-display
    products for near-eye, portable viewing of video in military and
    commercial markets. Intevacs eyeglass and helmet-mounted
    display systems provide high definition and a wide
    field-of-view
    in miniaturized light-weight and portable designs. Intevac
    I-Porttm
    helmet-mounted display provides solutions for such diverse
    markets as medical, industrial, commercial and military,
    including training and simulation.
    
    6
 
    Commercial
    Products
 
    Raman spectrometer systems are used to identify the chemical
    composition of solid materials, powders and liquids by
    illuminating the sample with a laser and measuring the
    characteristic spectrum of light scattered from the tested
    sample. Raman spectroscopy is used in forensics, homeland
    security, geology, gemology, medical, pharmaceutical and
    industrial quality assurance applications. Intevac provides
    bench-top and handheld Raman instruments, designed by
    DeltaNu®,
    that perform non-destructive identification of liquids and
    solids in the field and in the laboratory. Intevac is developing
    handheld Raman instruments to incorporate Intevacs core
    near infrared (NIR) sensors to enable the detection
    of critical materials in the growing chemical, biological and
    explosives threat detection market.
 
    Handheld
    Raman Materials Identification Instruments
 
    ReporteRtm
    is a palm-sized spectrometer that identifies materials for the
    first responder, homeland security and law enforcement
    industries. ReporteR identifies substances by comparing unique
    molecular fingerprints to reference materials stored in its
    library.
    RAPID-IDtm
    is a palm-sized, lightweight materials identification tool
    designed to analyze and identify industrial plastics for use in
    the automotive, consumer products and medical device industries.
    Observertm
    is a stand-off materials identification tool that operates at
    distances from three meters to over twenty meters which is used
    by defense contractors for detecting explosives and hazardous
    materials.
    PHARMA-IDtm
    is a palm-sized materials identification tool used by
    pharmaceutical manufacturers in inspection of incoming raw
    materials.
 
    Laboratory
    Instruments
 
    Intevacs Advantage product line of low-cost,
    high-performance bench-top spectrometers are available at
    532 nm, 633 nm, 785 nm or 1064 nm excitation wavelengths
    for education and research use.
    ExamineRtm
    is a modular Raman microscopy system designed for applications
    that require precise spectral characterization at 532 nm,
    785 nm, or 1064 nm wavelengths.
 
    Low-Light
    Cameras
 
    Intevac Photonics
    MicroVista®
    product line of commercial low-light Complementary
    Metal  Oxide  Semiconductor
    (CMOS) cameras provides high sensitivity in the
    ultraviolet, visible or NIR regions of the spectrum by using
    proprietary fabrication technology in back-thinning CMOS
    sensors. MicroVistas compact and lightweight camera design
    is used in industrial inspection, bio-medical and scientific
    applications. These cameras are primarily sold through
    distribution channels and to original equipment manufacturers.
 
    Backlog
 
    Intevacs backlog of orders at December 31, 2010 was
    $46.7 million, as compared to $73.8 million at
    December 31, 2009. Backlog at December 31, 2010
    consisted of $27.3 million of Equipment backlog and
    $19.4 million of Intevac Photonics backlog. Backlog at
    December 31, 2009 consisted of $57.5 million of
    Equipment backlog and $16.3 million of Intevac Photonics
    backlog. The decrease in Equipment backlog was primarily the
    result of decreased orders for 200 Lean disk sputtering systems.
    Backlog at December 31, 2010 included two 200 Lean systems
    and two LEAN SOLAR systems, as compared to ten 200 Lean systems
    in backlog at December 31, 2009. Backlog includes only
    customer orders with scheduled delivery dates.
 
    Customer
    Concentration
 
    Historically, a significant portion of Intevacs revenue in
    any particular period has been attributable to sales to a
    limited number of customers. In 2010 sales to Seagate, Hitachi
    Global Storage Technologies, and Fuji Electric each accounted
    for more than 10% of Intevacs revenues. In 2009 and 2008
    sales to Seagate and Hitachi Global Storage Technologies each
    accounted for more than 10% of Intevacs revenues. In the
    aggregate, sales to these three customers accounted for 78%, 58%
    and 80% of revenues in 2010, 2009 and 2008 respectively. Intevac
    expects that sales of Intevacs products to relatively few
    customers will continue to account for a high percentage of
    Intevacs revenues in the foreseeable future.
    
    7
 
    Foreign sales accounted for 77% of revenue in 2010, 50% of
    revenue in 2009, and 69% of revenue in 2008. The majority of
    Intevacs foreign sales are to companies in Asia or to
    U.S. companies for use in their Asian manufacturing or
    development operations. Intevac anticipates that sales to these
    international customers will continue to be a significant
    portion of Intevacs Equipment revenues. Intevacs
    disk sputtering equipment customers include magnetic disk
    manufacturers, such as Fuji Electric and Showa Denko, and
    vertically integrated hard disk drive manufacturers, such as
    Hitachi Global Storage Technology, Seagate, and Western Digital.
    Intevacs customers manufacturing facilities are
    primarily located in California, China, Taiwan, Japan, Malaysia
    and Singapore.
 
    Competition
 
    The principal competitive factors affecting the markets for
    Intevac Equipment products include price, product performance
    and functionality, ease of integration, customer support and
    service, reputation and reliability. Intevac has only one major
    competitor, Canon Anelva, in the hard disk drive equipment
    market and has historically experienced intense worldwide
    competition for magnetic disk sputtering equipment. Intevac is
    entering the semiconductor wafer-handling equipment market, and
    Intevac faces competition from large established competitors
    including Brooks Automation and Genmark Automation as well as
    competition from internally developed products at Applied
    Materials and Tokyo Electron. Intevac is entering the PV
    equipment market, and faces competition from large established
    global competitors including Veeco Instruments, Centrotherm
    Photovoltaics, Roth & Rau, and Von Ardenne as well as
    smaller regional competitors and cell module manufacturers that
    are internally developing manufacturing equipment that may be
    sold externally in the future. These competitors all have
    substantially greater financial, technical, marketing,
    manufacturing and other resources as compared to Intevac.
    Furthermore, any of Intevacs competitors may develop
    enhancements to, or future generations of, competitive products
    that offer superior price or performance features. In addition,
    new competitors with enhanced products may enter the markets
    that Intevac currently serves.
 
    The principal competitive factors affecting Intevac Photonics
    products include price, extreme low-light level detection
    performance, power consumption, resolution, size, ease of
    integration, reliability, reputation and customer support and
    service. Intevac faces substantial competition for Intevac
    Photonics products And many competitors have substantially
    greater resources and brand recognition. In the military market,
    ITT Industries, is a large and well-established defense
    contractor and is a primary U.S. manufacturer of image
    intensifier tubes used in Generation-III night vision devices
    and their derivative products. Intevacs digital night
    vision sensors, cameras and systems are intended to displace
    Generation-III night vision based products. Intevac expects that
    ITT, Fairchild Imaging (which is being acquired by BAE Systems)
    and other companies will develop digital night vision products
    and aggressively promote their sales. Furthermore,
    Intevacs LIVAR target identification sensors and cameras
    face competition from CMC Electronics, DRS, FLIR Systems,
    Goodrich and Raytheon, established companies that manufacture
    infrared sensors and cameras which are presently used in
    long-range target identification systems. Within the near-eye
    display market, Intevac also faces competition from
    Rockwell-Collins, Vuzix and BAE, all of which can offer
    cost-competitive products. In the commercial markets, companies
    such as Andor, Dalsa, E2V, Hamamatsu, Texas Instruments and
    Roper offer competitive sensor and camera products, and
    companies such as Ahura, B&W Tek, GE Security,
    Horiba  Jobin Yvon, Ocean Optics, Renishaw, Thermo
    Scientific and Smiths Detection offer competitive Raman
    spectrometer products.
 
    Marketing
    and Sales
 
    Equipment sales are made through Intevacs direct sales
    force, except in Japan where Intevac sells its products through
    a distributor, Matsubo. The selling process for Intevacs
    Equipment products is multi-level and long-term, involving
    individuals from marketing, engineering, operations, customer
    service and senior management.
 
    Installing and integrating new equipment requires a substantial
    investment by a customer. Sales of Intevacs systems
    depend, in significant part, upon the decision of a prospective
    customer to replace obsolete equipment or to increase
    manufacturing capacity by upgrading or expanding existing
    manufacturing facilities or by constructing new manufacturing
    facilities, all of which typically involve a significant capital
    commitment. After making a decision to select Intevacs
    equipment, Intevacs customers typically purchase one or
    more engineering systems to develop and qualify their production
    process prior to ordering and taking delivery of multiple
    production systems.
    
    8
 
    Accordingly, Intevacs systems have a lengthy sales cycle,
    during which Intevac may expend substantial funds and management
    time and effort with no assurance that a sale will result.
 
    The production of large complex systems requires Intevac to make
    significant investments in inventory both to fulfill customer
    orders and to maintain adequate supplies of spare parts to
    service previously shipped systems. In some cases Intevac
    manufactures subsystems
    and/or
    complete systems prior to receipt of a customer order to smooth
    Intevacs production flow
    and/or
    reduce lead time.
 
    Intevac maintains inventories of spare parts in the United
    States, Singapore and China to support its customers. Intevac
    often requires its customers to pay for systems in three
    installments, with a portion of the system price billed upon
    receipt of an order, a portion of the price billed upon
    shipment, and the balance of the price and any sales tax due
    upon completion of installation and acceptance of the system at
    the customers factory. All customer product payments are
    recorded as customer advances, which are released into revenue
    in accordance with Intevacs revenue recognition policy.
 
    Intevac provides process and applications support, customer
    training, installation,
    start-up
    assistance and emergency service support to Intevacs
    Equipment customers. Intevac conducts training classes for
    Intevacs customers process engineers, machine
    operators and machine service personnel. Additional training is
    also given to Intevacs customers during equipment
    installation. Intevac has field offices in Singapore, China, and
    Malaysia to support Intevacs customers in Asia. Intevac
    generally adds additional support centers as necessary to
    maintain close proximity to Intevacs customers
    factories as they deploy Intevacs systems.
 
    Warranties for Intevacs Equipment typically range between
    12 and 24 months from customer acceptance. During the
    warranty period any necessary non-consumable parts are supplied
    and installed without charge. Intevacs employees provide
    field service support in the United States, Singapore, Malaysia,
    China and Japan. In Japan, field service support is also
    supplemented by Intevacs distributor, Matsubo.
 
    Sales of Intevac Photonics products for military applications
    are primarily made to the end user through Intevacs direct
    sales force. Intevac sells to leading defense contractors such
    as Lockheed Martin Corporation, Northrop Grumman Corporation,
    Raytheon, DRS Technologies, BAE and Sagem.
 
    Intevac is subject to long sales cycles in the Photonics segment
    because many of Intevacs products, such as Intevacs
    night vision systems, typically must be designed into
    Intevacs customers products, which are often complex
    and
    state-of-the-art.
    These development cycles are often multi-year, and
    Intevacs sales are contingent on Intevacs customer
    successfully integrating Intevacs product into its
    product, completing development of its product and then
    obtaining production orders for its product. Sales of these
    products are also often dependent on ongoing funding of defense
    programs by the U.S. government and its allies.
    Additionally, sales to international customers are contingent on
    issuance of export licenses by the U.S. government.
 
    Sales of Intevac Photonics commercial products are made through
    a combination of direct sales, system integrators, distributors
    and value added resellers and can also be subject to long sales
    cycles.
 
    Intevac Photonics generally invoices its research and
    development customers either as costs are incurred, or as
    program milestones are achieved, depending upon the particular
    contract terms. As a government contractor, Intevac invoices
    customers using estimated annual rates approved by the Defense
    Contracts Audit Agency (DCAA).
 
    Research
    and Development and Intellectual Property
 
    Intevacs long-term growth strategy requires continued
    development of new products. Intevac works closely with
    Intevacs global customers to design products that meet
    their planned technical and production requirements. Product
    development and engineering organizations are located primarily
    in the United States and Singapore.
 
    Intevac invested $27.9 million (13.8% of net revenues) in
    fiscal 2010, $28.1 million (36.0% of net revenues) in
    fiscal 2009, and $35.1 million (31.8% of net revenues) in
    fiscal 2008 for product development and engineering programs to
    create new products and to improve existing technologies and
    products. Intevac has spent an average of 18.6% of net revenues
    on product development and engineering over the last five years.
    
    9
 
    Intevacs competitive position significantly depends on
    Intevacs research, development, engineering, manufacturing
    and marketing capabilities, and not just on Intevacs
    patent position. However, protection of Intevacs
    technological assets by obtaining and enforcing intellectual
    property rights, including patents, is important. Therefore,
    Intevacs practice is to file patent applications in the
    United States and other countries for inventions that Intevac
    considers important. Intevac has a substantial number of patents
    in the United States and other countries, and additional
    applications are pending for new inventions. Although Intevac
    does not consider Intevacs business materially dependent
    upon any one patent, the rights of Intevac and the products made
    and sold under Intevacs patents along with other
    intellectual property, including trademarks, know-how, trade
    secrets and copyrights, taken as a whole, are a significant
    element of Intevacs business.
 
    Intevac enters into patent and technology licensing agreements
    with other companies when management determines that it is in
    Intevacs best interest to do so. Intevac pays royalties
    under existing patent license agreements for use of certain
    patented technologies in several of Intevacs products.
    Intevac also receives, from time to time, royalties from
    licenses granted to third parties. Royalties received from or
    paid to third parties have not been material to Intevacs
    consolidated results of operations.
 
    In the normal course of business, Intevac periodically receives
    and makes inquiries regarding possible patent infringements. In
    dealing with such inquiries, it may be necessary or useful for
    us to obtain or grant licenses or other rights. However, there
    can be no assurance that such licenses or rights will be
    available to us on commercially reasonable terms, or at all. If
    Intevac is not able to resolve or settle claims, obtain
    necessary licenses
    and/or
    successfully prosecute or defend Intevacs position,
    Intevacs business, financial condition and results of
    operations could be materially and adversely affected.
 
    Manufacturing
 
    Intevac manufactures its Equipment products at its facilities in
    California and Singapore. Intevacs Equipment manufacturing
    operations include electromechanical assembly, vacuum
    processing, fabrication of sputter sources, and system assembly,
    alignment and testing.
 
    Intevac Photonics products are manufactured at Intevacs
    facilities in California and Wyoming. Intevac Photonics
    manufactures sensors, cameras, integrated camera systems,
    compact Raman spectrometry instruments and near-eye display
    systems using advanced manufacturing techniques and equipment.
    Intevacs operations include vacuum processing, and
    electromechanical and optical system assembly.
 
    Employees
 
    At December 31, 2010, Intevac had 445 employees,
    including 45 contract employees.
 
    Compliance
    with Environmental Regulations
 
    Intevac is subject to a variety of governmental regulations
    relating to the use, storage, discharge, handling, emission,
    generation, manufacture, treatment and disposal of toxic or
    otherwise hazardous substances, chemicals, materials or waste.
    Intevac treats the cost of complying with government regulations
    and operating a safe workplace as a normal cost of business and
    allocates the cost of these activities to all functions, except
    where the cost can be isolated and charged to a specific
    function. The environmental standards and regulations
    promulgated by government agencies in California, Wyoming and
    Singapore are rigorous and set a high standard of compliance.
    Intevac believes its costs of compliance with these regulations
    and standards are comparable to other companies operating
    similar facilities in these jurisdictions.
    
    10
 
    Executive
    Officers of the Registrant
 
    Certain information about our executive officers as of
    February 25, 2011 is listed below:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Name
 
 | 
 
 | 
 
    Age
 
 | 
 
 | 
 
    Position
 
 | 
|  
 | 
| 
 
    Executive Officers:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Norman H. Pond
 
 | 
 
 | 
 
 | 
    72
 | 
 
 | 
 
 | 
    Chairman of the Board
 | 
| 
 
    Kevin Fairbairn
 
 | 
 
 | 
 
 | 
    57
 | 
 
 | 
 
 | 
    President and Chief Executive Officer
 | 
| 
 
    Jeffrey Andreson
 
 | 
 
 | 
 
 | 
    49
 | 
 
 | 
 
 | 
    Executive Vice President, Finance and Administration, Chief
    Financial Officer, Treasurer and Secretary
 | 
| 
 
    Michael Russak
 
 | 
 
 | 
 
 | 
    64
 | 
 
 | 
 
 | 
    Executive Vice President and General Manager, Hard Disk
    Equipment Products
 | 
| 
 
    Luke Marusiak
 
 | 
 
 | 
 
 | 
    48
 | 
 
 | 
 
 | 
    Executive Vice President, Chief Operating Officer
 | 
| 
 
    Christopher Smith
 
 | 
 
 | 
 
 | 
    51
 | 
 
 | 
 
 | 
    Executive Vice President, Emerging Markets
 | 
| 
 
    Kimberly Burk
 
 | 
 
 | 
 
 | 
    45
 | 
 
 | 
 
 | 
    Vice President, Human Resources
 | 
| 
 
    Joseph Pietras
 
 | 
 
 | 
 
 | 
    56
 | 
 
 | 
 
 | 
    Executive Vice President and General Manager, Intevac Photonics
 | 
| 
 
    Other Key Officers:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Babak Adibi
 
 | 
 
 | 
 
 | 
    56
 | 
 
 | 
 
 | 
    Vice President and General Manager, Solar Implant
 | 
| 
 
    Verle Aebi
 
 | 
 
 | 
 
 | 
    56
 | 
 
 | 
 
 | 
    Chief Technology Officer, Intevac Photonics
 | 
| 
 
    James Birt
 
 | 
 
 | 
 
 | 
    46
 | 
 
 | 
 
 | 
    Vice President, Manufacturing and Customer Support, Equipment
    Products
 | 
| 
 
    Terry Bluck
 
 | 
 
 | 
 
 | 
    51
 | 
 
 | 
 
 | 
    Vice President, Technology, Equipment Products
 | 
| 
 
    Jerry Carollo
 
 | 
 
 | 
 
 | 
    57
 | 
 
 | 
 
 | 
    Vice President, Strategic Business Development, Intevac Photonics
 | 
| 
 
    Timothy Justyn
 
 | 
 
 | 
 
 | 
    48
 | 
 
 | 
 
 | 
    Vice President of Manufacturing, Intevac Photonics
 | 
| 
 
    Dave Kelly
 
 | 
 
 | 
 
 | 
    48
 | 
 
 | 
 
 | 
    Vice President, Engineering, Intevac Vision Systems
 | 
| 
 
    Edward Murrer
 
 | 
 
 | 
 
 | 
    61
 | 
 
 | 
 
 | 
    Vice President, Business Development, Solar Implant
 | 
 
    Mr. Pond is a founder of Intevac and has served as
    Chairman of the Board since February 1991. Mr. Pond served
    as President and Chief Executive Officer from February 1991
    until July 2000 and again from September 2001 through January
    2002. Mr. Pond holds a BS in physics from the University of
    Missouri at Rolla and an MS in physics from the University of
    California at Los Angeles.
 
    Mr. Fairbairn joined Intevac as President and Chief
    Executive Officer in January 2002 and was appointed a director
    in February 2002. Before joining Intevac, Mr. Fairbairn was
    employed by Applied Materials from July 1985 to January 2002,
    most recently as Vice President and General Manager of the
    Conductor Etch Organization with responsibility for the Silicon
    and Metal Etch Divisions. From 1996 to 1999, Mr. Fairbairn
    was General Manager of Applied Materials Plasma Enhanced
    Chemical Vapor Deposition Business Unit and from 1993 to 1996,
    he was General Manager of Applied Materials Plasma Silane
    CVD Product Business Unit. Mr. Fairbairn holds an MA in
    engineering sciences from Cambridge University.
 
    Mr. Andreson joined Intevac in June 2007 and has
    served as Executive Vice President, Finance and Administration,
    Chief Financial Officer, Treasurer and Secretary since August
    2007. Before joining Intevac Mr. Andreson served as
    Managing Director and Controller of Applied Materials
    Global Services product group. Since joining Applied Materials
    in 1995, Mr. Andreson held a number of senior financial
    positions, including Managing Director, Global Financial
    Planning and Analysis; Controller, Metron Subsidiary;
    Controller, North American Sales and Service; and Controller,
    Volume Manufacturing. From 1989 through 1995, Mr. Andreson
    held various roles at Measurex Corporation. Mr. Andreson
    holds an MBA from Santa Clara University and a BS in
    finance from San Jose State University.
 
    Dr. Russak joined Intevac in July 2008 and currently
    serves as Executive Vice President and General Manager, Hard
    Disk Equipment Products. Before joining Intevac Dr. Russak
    served as President and Chief Technical Officer
    
    11
 
    of Komag from 2000 to 2007. From 1993 to 2000, Dr. Russak
    served as Vice President of Research and Development at HMT
    Technology. Previously, Dr. Russak held management
    positions in the Research Division of IBM Corporation. Prior to
    IBM, Dr. Russak worked for Grumman Aerospace Corporation as
    a contributing scientist. Dr. Russak holds a BS in ceramic
    engineering and a PhD in materials science from Rutgers
    University.
 
    Mr. Marusiak rejoined Intevac in January 2010 and
    currently serves as Executive Vice President, Chief Operating
    Officer. Mr. Marusiak had previously served as
    Intevacs Chief Operating Officer from 2004 through 2008.
    From October 2008 through December 2009, Mr. Marusiak
    served as the Chief Executive Officer of MDC Vacuum Products,
    LLC. Before joining Intevac, Mr. Marusiak was employed by
    Applied Materials from July 1991 to April 2004, most recently as
    Senior Director of North American Operations. From 1984 to 1991,
    Mr. Marusiak served as a signal officer in the
    U.S. Army. Mr. Marusiak holds a BS in electrical
    engineering from Gannon University and an MS in teleprocessing
    science from the University of Southern Mississippi.
 
    Mr. Smith joined Intevac in August 2010 as Executive
    Vice President, Emerging Markets. Mr. Smith has over
    25 years of executive-level experience in the semiconductor
    and solar capital equipment markets. Prior to joining Intevac,
    Mr. Smith served as Senior Vice President Sales and
    Customer Support at Oerlikon Solar, from November 2007 to August
    2010. From 2006 to 2007 he served as Senior Vice President of
    Sales and Service with Cymer. Previously, Mr. Smith was
    employed by Applied Materials from 1994 to 2006. While at
    Applied Materials he held a variety of executive-level customer
    support and operations positions. He also served as product
    business group general manager for Chemical Mechanical Polishing
    and was managing director of Global Business Development for the
    Dielectric and Physical Vapor Deposition Product Business
    Groups. Mr. Smith earned his BS in Business
    Administration / Material Management from
    San Jose State University.
 
    Ms. Burk joined Intevac in May 2000 and currently
    serves as Vice President of Human Resources. Prior to joining
    Intevac, Ms. Burk served as Human Resources Manager of
    Moen, Inc. from 1999 to 2000 and as Human Resources Manager of
    Lawson Mardon from 1994 to 1999. Ms. Burk holds a BS in
    sociology from Northern Illinois University.
 
    Dr. Pietras joined Intevac as Executive Vice
    President and General Manager of the Intevac Photonics Business
    in August 2006. Before joining Intevac, Dr. Pietras was
    employed by the Sarnoff Corporation from March 2005 to July 2006
    as General Manager of Sarnoff Imaging Systems. From September
    1998 to March 2005, he was employed by Roper Scientific as Vice
    President, Operations. Dr. Pietras holds a BS in physics
    from the Stevens Institute of Technology and a MA and PhD in
    physics from Columbia University.
 
    Dr. Adibi joined Intevac in November 2010 as Vice
    President and General Manager, Solar Implant. Prior to joining
    Intevac, Dr. Adibi was President, Chief Technology Officer
    and Co-Founder of Solar Implant Technologies, Inc. Prior to
    founding Solar Implant Technologies, Inc., Dr. Adibi worked
    for Silicon Genesis Corporation from 2006 to 2008 as the General
    Manager of the Solar Equipment Division. From 2003 to 2006 he
    served as Vice President in the Laser Annealing Product Division
    of Ultratech, Inc. Previously, Dr. Adibi was employed by
    Applied Materials from 1985 to 2003. While at Applied Materials
    he held a variety of executive-level engineering positions.
    Dr. Adibi holds numerous patents in the area of ion
    implantation, a PhD in ion implantation and semiconductors and a
    MS in nuclear power from Surrey University in England and a BS
    in physics from the Imperial College of London.
 
    Mr. Aebi has served as Chief Technology Officer of
    the Intevac Photonics business since August 2006. Previously,
    Mr. Aebi served as President of the Photonics Division from
    July 2000 to July 2006 and as General Manager of the Photonics
    Division since May 1995. Mr. Aebi was elected as a Vice
    President of the Company in September 1995. From 1988 through
    1994, Mr. Aebi was the Engineering Manager of the night
    vision business Intevac acquired from Varian Associates in 1991,
    where he was responsible for new product development in the
    areas of advanced photocathodes and image intensifiers.
    Mr. Aebi holds a BS in physics and an MS in electrical
    engineering from Stanford University.
 
    Mr. Birt joined Intevac in September 2004 and
    currently serves as Vice President, Manufacturing and Customer
    Support of the Equipment Products Division. Before joining
    Intevac, Mr. Birt was employed by Applied Materials from
    July 1992 to September 2004, most recently as Director, Field
    Operations/Quality North America. Mr. Birt holds a BS in
    electrical engineering from Texas A&M University.
    
    12
 
    Mr. Bluck rejoined Intevac as Vice President,
    Technology of the Equipment Products Division in August 2004.
    Mr. Bluck had previously worked at Intevac from December
    1996 to November 2002 in various engineering positions. The
    business unit Mr. Bluck worked for was sold to Photon
    Dynamics in November 2002, and he was employed there as Vice
    President, Rapid Thermal Process Product Engineering until
    August 2004. Mr. Bluck holds a BS in physics from
    San Jose State University.
 
    Mr. Carollo joined Intevac in November 2007 as Vice
    President and General Manager of Intevacs Creative Display
    Systems subsidiary and currently serves as Vice President of
    Strategic Business Development, Intevac Photonics. Prior to
    joining Intevac, Mr. Carollo was founder, President and
    Chief Executive Officer of Creative Display Systems. Prior to
    founding Creative Display Systems Mr. Carollo worked for
    Rockwell-Collins Optronics Electro-Optics from 1993 to 2006
    where his most recent position was General Manager.
    Mr. Carollo holds numerous patents in the area of optics,
    display systems and optical communications, a MS in optics from
    the University of Rochester and a BS in physics from the State
    University of New York.
 
    Mr. Justyn  currently serves as Vice President of
    Manufacturing, Intevac Photonics. Mr. Justyn  served as
    Vice President of Operations, Intevac Photonics from October
    2008 to September 2010. Mr. Justyn served as Vice
    President, Equipment Manufacturing from April 1997 to October
    2008. Mr. Justyn joined Intevac in February 1991 and has
    served in various roles in our Equipment Products Division and
    our former night vision business. Mr. Justyn holds a BS in
    chemical engineering from the University of California,
    Santa Barbara.
 
    Mr. Kelly joined Intevac in December 2006 and
    currently serves as Vice President, Engineering, Intevac Vision
    Systems. Before joining Intevac, Mr. Kelly was employed by
    Redlake MASD LLC, a division of Roper Industries from January
    2004 to December 2006, most recently as Vice President,
    Engineering and Custom Service. From November 2000 to December
    2003, he was employed by Fast Technology AG as Vice President,
    Engineering. Mr. Kelly holds a BS and a MS in mechanical
    engineering from the University of Michigan.
 
    Mr. Murrer joined Intevac in November 2010 as Vice
    President, Business Development, Solar Implant. Mr. Murrer
    has over 25 years of executive-level experience in the
    solar capital equipment and software markets. Prior to joining
    Intevac, Mr. Murrer was Chairman, Chief Executive Officer
    and Co-Founder of Solar Implant Technologies, Inc. Prior to
    founding Solar Implant Technologies, Inc., Mr. Murrer
    worked for Silicon Genesis Corporation from 2006 to 2008 as Vice
    President of Marketing and Business Development. From 2003 to
    2006 he served as Senior Vice President of Sales and Marketing
    with Kyberpass, Inc. Previously, Mr. Murrer was employed by
    Persistence Software from 2001 to 2003. Mr. Murrer holds a
    BS and a MS in mechanical engineering from the Purdue University.
 
    Available
    Information
 
    Intevacs website is
    http://www.intevac.com.
    Intevac makes available free of charge, on or through its
    website, its annual, quarterly and current reports, and any
    amendments to those reports, as soon as reasonably practicable
    after electronically filing such reports with, or furnishing
    them to, the SEC. This website address is intended to be an
    inactive textual reference only and none of the information
    contained on Intevacs website is part of this report or is
    incorporated by reference herein.
 
    Trade
    Marks
 
    200 Lean®,
    AccuLubertm,
    Continuumtm,
    DeltaNu®,
    EBAPS®,
    ExaminerRtm,
    I-Porttm,
    LEAN
    SOLARtm,
    LithoPrimetm,
    LIVAR®,
    MicroVista®,
    NanoVistatm,
    NightVista®,
    Night
    Porttm,
    PHARMA-IDtm,
    and
    RAPID-IDtm
    among others, are our trademarks.
 
 
    The following factors could materially affect Intevacs
    business, financial condition or results of operations and
    should be carefully considered in evaluating the Company and its
    business, in addition to other information presented elsewhere
    in this report.
    
    13
 
    The
    industries we serve are cyclical, volatile and
    unpredictable.
 
    The majority of our revenue is derived from the sale of
    equipment used to manufacture commodity technology products such
    as disk drives. We have also entered markets to sell equipment
    used to manufacture commodity technology products such as
    semiconductor devices and photovoltaic (PV) solar
    cells. This subjects us to business cycles, the timing, length
    and volatility of which can be difficult to predict. When demand
    for commodity technology products exceeds production capacity,
    then demand for new capital equipment such as ours tends to be
    amplified. Conversely, when supply of commodity technology
    products exceeds demand, then demand for new capital equipment
    such as ours tends to be depressed. For example, sales of
    systems for magnetic disk production were severely depressed
    from mid-1998 until mid-2003 and grew rapidly from 2004 through
    2006, followed by a downturn in the cycle in late 2007 which
    continued through 2009. The number of new systems delivered
    declined sequentially in 2007, 2008 and 2009. The number of new
    systems delivered increased in 2010 as customers increased their
    production capacity in response to increased demand for digital
    storage. We cannot predict with any certainty when these cycles
    will begin or end.
 
    Our equipment represents only a portion of the capital
    expenditure that our customers incur when they upgrade or add
    production capacity. Accordingly, our customers generally commit
    to making large capital expenditures, far in excess of the cost
    of our systems alone, when they decide to purchase our systems.
    The magnitude of these capital expenditures requires our
    customers to have access to large amounts of capital. The
    magnetic disk, semiconductor and solar cell manufacturing
    industries have from time to time made significant additions to
    their production capacity. Our customers generally reduce their
    level of capital investment during downturns in the overall
    economy, or during a downturn in their industries.
 
    We must effectively manage our resources and production capacity
    to meet rapidly changing demand. Our business experiences rapid
    growth and contraction, which stresses our infrastructure,
    internal systems and managerial resources. During periods of
    increasing demand for our products, we must have sufficient
    manufacturing capacity and inventory to meet customer demand;
    attract, retain and motivate a sufficient number of qualified
    individuals; and effectively manage our supply chain. During
    periods of decreasing demand for our products, we must be able
    to align our cost structure with prevailing market conditions;
    motivate and retain key employees and effectively manage our
    supply chain.
 
    Sales
    of our equipment are primarily dependent on our customers
    upgrade and capacity expansion plans and whether our customers
    select our equipment.
 
    We have no control over our customers upgrade and capacity
    expansion plans, and we cannot be sure they will select, or
    continue to select, our equipment when they upgrade or expand
    their capacity. The sales cycle for our equipment systems can be
    a year or longer, involving individuals from many different
    areas of Intevac and numerous product presentations and
    demonstrations for our prospective customers. Our sales process
    also commonly includes production of samples, customization of
    our products, and installation of evaluation systems in the
    factories of our prospective customers. We do not enter into
    long-term contracts with our customers, and until an order is
    actually submitted by a customer there is no binding commitment
    to purchase our systems.
 
    Intevac Photonics business is also subject to long sales
    cycles because many of its products, such as our military
    imaging products, often must be designed into the
    customers end products, which are often complex
    state-of-the-art
    products. These development cycles are often multi-year, and our
    sales are contingent on our customers successfully integrating
    our product into their product, completing development of their
    product and then obtaining production orders for their product
    from the U.S. government or its allies.
 
    Sales of new manufacturing systems are also dependent on
    obsolescence and replacement of the installed base of our
    customers existing equipment with newer, more capable
    equipment. If upgrades are developed that extend the useful life
    of the installed base of systems, then we tend to sell more
    upgrade products and fewer new systems, which can significantly
    reduce total revenue. For example, some of our 200 Lean
    customers continue to use legacy systems for the production of
    perpendicular media, which delayed the replacement of such
    systems with new 200 Lean systems.
    
    14
 
    Our 200 Lean customers also experience competition from
    companies that produce alternative storage technologies like
    flash memory, which offer smaller size, lower power consumption
    and more rugged designs. If alternative technologies, such as
    flash memory, replace hard disk drives as a significant method
    of digital storage, then demand for our hard disk manufacturing
    products would decrease.
 
    We
    operate in an intensely competitive marketplace, and our
    competitors have greater resources than we do.
 
    In the market for our disk sputtering systems, we experience
    competition from Canon Anelva, which has sold a substantial
    number of systems worldwide. In the market for semiconductor
    wafer handling equipment we are attempting to enter a market
    with several large established competitors including Brooks
    Automation and Genmark Automation as well as competition from
    internally developed products at Applied Materials and Tokyo
    Electron. Intevac is attempting to enter the PV equipment
    market, and faces competition from large established competitors
    including Veeco Instruments, Centrotherm Photovoltaics,
    Roth & Rau, Von Ardenne and cell module manufacturers
    that are internally developing manufacturing equipment that may
    be sold externally in the future. In the market for our military
    imaging products we experience competition from companies such
    as ITT Industries and Fairchild Imaging (which is being acquired
    by BAE Systems). In the markets for our commercial imaging
    products we compete with companies such as Andor, Dalsa, E2V,
    Hamamatsu, Texas Instruments and Roper Industries for sensor and
    camera products, and with companies such as Ahura, B&W Tek,
    GE Security, Horiba  Jobin Yvon, Ocean Optics,
    Renishaw, Thermo Scientific and Smiths Detection for Raman
    spectrometer products. Our competitors have substantially
    greater financial, technical, marketing, manufacturing and other
    resources than we do, especially in the semiconductor and
    photovoltaic equipment markets where we have not previously
    offered products. We cannot ensure that our competitors will not
    develop enhancements to, or future generations of, competitive
    products that offer superior price or performance features.
    Likewise, we cannot ensure that new competitors will not enter
    our markets and develop such enhanced products. Moreover,
    competition for our customers is intense, and our competitors
    have historically offered substantial pricing concessions and
    incentives to attract our customers or retain their existing
    customers.
 
    We are
    exposed to risks associated with a highly concentrated customer
    base and industry consolidation.
 
    Historically, a significant portion of our revenue in any
    particular period has been attributable to sales of our disk
    sputtering systems to a limited number of customers. This
    concentration of customers can lead to extreme variability in
    revenue and financial results from period to period.
 
    Industry consolidation can limit the number of potential
    customers for our products. For example, Seagate acquired Maxtor
    in 2006 and Western Digital acquired Komag in 2007 and
    Hoyas magnetic media operations in 2010. The concentration
    of our customer base may enable our customers to demand pricing
    and other terms unfavorable to Intevac, and makes us more
    vulnerable to changes in demand by a given customer. Orders from
    a relatively limited number of manufacturers have accounted for,
    and will likely continue to account for, a substantial portion
    of our revenues. The loss of one of these large customers, or
    delays in purchasing by them, could have a material and adverse
    effect on our revenues.
 
    Our
    growth depends on development of technically advanced new
    products and processes.
 
    We have invested heavily, and continue to invest, in the
    development of new products, such as our 200 Lean Gen II
    system, our Continuum wafer handling product, LEAN SOLAR systems
    for PV applications, our digital night-vision products, our
    Raman system products and our near-eye display products. Our
    success in developing and selling new products depends upon a
    variety of factors, including our ability to: predict future
    customer requirements, make technological advances, achieve a
    low total cost of ownership for our products, introduce new
    products on schedule, manufacture products cost-effectively
    including transitioning production to volume manufacturing;
    commercialize and attain customer acceptance of our products;
    and achieve acceptable and reliable performance of our new
    products in the field. Our new product decisions and development
    commitments must anticipate continuously evolving industry
    requirements significantly in advance of sales. In addition, we
    are attempting to expand into new or related markets, including
    the semiconductor market for wafer fabrication equipment and the
    PV market. Our expansion into the PV market is dependent upon
    the success of our customers
    
    15
 
    development plans, some of which are
    start-ups
    and in their preliminary stages of development, as well as their
    ability to raise capital to fund their future development and
    capacity expansion. To date Intevac has not recognized revenue
    from our semiconductor wafer handling or PV manufacturing
    products. Failure to correctly assess the size of the markets,
    to successfully develop cost effective products to address the
    markets or to establish effective sales and support of the new
    products would have a material adverse effect on future revenues
    and profits.
 
    Rapid technological change in our served markets requires us to
    rapidly develop new technically advanced products. Our future
    success depends in part on our ability to develop and offer new
    products with improved capabilities and to continue to enhance
    our existing products. If new products have reliability or
    quality problems, our performance may be impacted by reduced
    orders, higher manufacturing costs, delays in acceptance and
    payment for new products and additional service and warranty
    expenses.
 
    Our
    operating results fluctuate significantly from quarter to
    quarter, which can lead to volatility in the price of our common
    stock.
 
    Our quarterly revenues and common stock price have fluctuated
    significantly. We anticipate that our revenues, operating
    margins and common stock price will continue to fluctuate for a
    variety of reasons, including: (1) changes in the demand,
    due to seasonality, cyclicality and other factors in the markets
    for computer systems, storage subsystems and consumer
    electronics containing disks our customers produce with our
    systems; (2) delays or problems in the introduction and
    acceptance of our new products, or delivery of existing
    products; (3) timing of orders, acceptance of new systems
    by our customers or cancellation of those orders; (4) new
    products, services or technological innovations by our
    competitors or us; (5) changes in our manufacturing costs
    and operating expense; (6) changes in general economic,
    political, stock market and industry conditions; and
    (7) any failure of our operating results to meet the
    expectations of investment research analysts or investors.
 
    Any of these, or other factors, could lead to volatility
    and/or a
    rapid change in the trading price of our common shares. In the
    past, securities class action litigation has been instituted
    against companies following periods of volatility in the market
    price of their securities. Any such litigation, if instituted
    against Intevac, could result in substantial costs and diversion
    of management time and attention.
 
    Adverse
    economic conditions and volatility and disruption of the capital
    and credit markets may negatively impact our revenues and our
    ability to access financing.
 
    Economic conditions worldwide have contributed to decreased
    spending by our customers and a slowdown in the hard disk drive
    industry. These factors have adversely impacted our operating
    results in prior periods, including most recently during fiscal
    2009, and have caused us to be cautious about our future
    outlook. Although macroeconomic and global market conditions
    improved in the latter half of 2009 and during fiscal 2010, our
    customers continue to remain cautious as it relates to the
    sustainability of the recovery. Negative macroeconomic and
    global recessionary factors, further volatility or disruption in
    the capital and credit markets or further uncertainty or
    weakening in key markets could negatively impact spending for
    our products and may materially adversely affect our business,
    operating results and financial condition.
 
    In addition, while we intend to finance operations with existing
    cash and cash flow from operations, if necessary, we may require
    financing to support our continued operations. Due to the
    existing uncertainty in the capital and credit markets, our
    access to capital may not be available on terms acceptable to us
    or at all.
 
    We may
    not be able to obtain export licenses from the U.S. government
    permitting delivery of our products to international
    customers.
 
    Many of our products, especially Intevac Photonics
    products, require export licenses from U.S. government
    agencies under the Export Administration Act, the Trading with
    the Enemy Act of 1917, the Arms Export Act of 1976 or the
    International Traffic in Arms Regulations. These regulations
    limit the potential market for some of our products. We can give
    no assurance that we will be successful in obtaining all the
    licenses necessary to export our products. Heightened government
    scrutiny of export licenses for defense related products has
    resulted in lengthened review periods for our license
    applications. Exports to countries that are not considered by
    the U.S. government to be allies are likely to be
    prohibited, and even sales to U.S. allies may be limited.
    Failure to comply with export
    
    16
 
    control laws, including identification and reporting of all
    exports and re-exports of controlled technology or exports made
    without correct license approval or improper license use could
    result in severe penalties and revocation of licenses. Failure
    to obtain export licenses, delays in obtaining licenses, or
    revocation of previously issued licenses would prevent us from
    selling the affected products outside the United States and
    could negatively impact our results of operations.
 
    The
    Intevac Photonics business is dependent on U.S. government
    contracts, which are subject to fixed pricing, immediate
    termination and a number of procurement rules and
    regulations.
 
    We sell many of our imaging products and services directly to
    the U.S. government, as well as to prime contractors for
    various U.S. government programs. Funding of multi-year
    government programs is subject to congressional appropriations,
    and there is no guarantee that the U.S. government will
    make further appropriations, particularly given the
    U.S. governments recent focus on spending in other
    areas. Sales to the U.S. government and its prime
    contractors may also be affected by changes in procurement
    policies, budget considerations and political developments in
    the United States or abroad. For example, if the
    U.S. government is less focused on defense spending or
    there is a decrease in hostilities, demand for our products
    could decrease. The loss of funding for a government program
    would result in a loss of future revenues attributable to that
    program. The influence of any of these factors, which are beyond
    our control, could negatively impact our results of operations.
 
    A significant portion of our U.S. government revenue is
    derived from fixed-price development and production contracts.
    Under fixed-price contracts, unexpected increases in the cost to
    develop or manufacture a product, whether due to inaccurate
    estimates in the bidding process, unanticipated increases in
    material costs, reduced production volumes, inefficiencies or
    other factors, are borne by us. We have experienced cost
    overruns in the past that have resulted in losses on certain
    contracts, and may experience additional cost overruns in the
    future. We are required to recognize the total estimated impact
    of cost overruns in the period in which they are first
    identified. Such cost overruns could have a material adverse
    effect on our results of operations.
 
    Generally, government contracts contain provisions permitting
    termination, in whole or in part, without prior notice at the
    governments convenience upon the payment of compensation
    only for work done and commitments made at the time of
    termination. We cannot ensure that one or more of the government
    contracts under which we, or our customers, operate will not be
    terminated under these circumstances. Also, we cannot ensure
    that we, or our customers, would be able to procure new
    government contracts to offset the revenues lost as a result of
    any termination of existing contracts, nor can we ensure that
    we, or our customers, will continue to remain in good standing
    as federal contractors.
 
    As a U.S. government contractor we must comply with
    specific government rules and regulations and are subject to
    routine audits and investigations by U.S. government
    agencies. If we fail to comply with these rules and regulations,
    the results could include: (1) reductions in the value of
    our contracts; (2) reductions in amounts previously billed
    and recognized as revenue; (3) contract modifications or
    termination; (4) the assessment of penalties and fines; and
    (5) suspension or debarment from government contracting or
    subcontracting for a period of time or permanently.
 
    Changes
    to our effective tax rate affect our results of
    operations.
 
    As a global company, we are subject to taxation in the United
    States and various other countries. Significant judgment is
    required to determine and estimate worldwide tax liabilities.
    Our future effective tax rate could be affected by:
    (1) changes in tax laws; (2) the allocation of
    earnings to countries with differing tax rates; (3) changes
    in worldwide projected annual earnings in current and future
    years: (4) accounting pronouncements; or (5) changes
    in the valuation of our deferred tax assets and liabilities.
    Although we believe our tax estimates are reasonable, there can
    be no assurance that any final determination will not be
    different from the treatment reflected in our historical income
    tax provisions and accruals, which could result in additional
    payments by Intevac.
 
    We booked a significant tax benefit in both 2009 and 2008 based
    on managements belief that we could both carryback losses
    to years Intevac paid income taxes and carryforward tax credits
    to future years where we would generate taxable income. Intevac
    will need to generate approximately $52 million of taxable
    income in order to
    
    17
 
    realize the Federal deferred tax assets recorded as of
    December 31, 2010. If our expectations of future income are
    incorrect, we could be required to establish a valuation
    allowance against some or all of the deferred tax assets.
 
    Our
    success depends on international sales and the management of
    global operations.
 
    The majority of our revenues come from regions outside the
    United States. Most of our international sales are to customers
    in Asia, which includes products shipped to overseas operations
    of U.S. companies. We currently have manufacturing
    facilities in California, Wyoming and Singapore and
    international customer support offices in Singapore, China, and
    Malaysia. We expect that international sales will continue to
    account for a significant portion of our total revenue in future
    years. Certain of our suppliers are also located outside the
    United States.
 
    Managing our global operations presents challenges including,
    but not limited to, those arising from: (1) global trade
    issues; (2) variations in protection of intellectual
    property and other legal rights in different countries;
    (3) concerns of U.S. governmental agencies regarding
    possible national commercial
    and/or
    security issues posed by growing manufacturing business in Asia;
    (4) fluctuation of interest rates, raw material costs,
    labor and operating costs, and exchange rates, including the
    weakening relative position of the U.S. dollar;
    (5) variations in the ability to develop relationships with
    suppliers and other local businesses; (6) changes in the
    laws and regulations of the United States, including export
    restrictions, and other countries, as well as their
    interpretation and application; (7) the need to provide
    technical and spares support in different locations;
    (8) political and economic instability; (9) cultural
    differences; (10) varying government incentives to promote
    development; (11) shipping costs and delays;
    (12) adverse conditions in credit markets;
    (13) variations in tariffs, quotas, tax codes and other
    market barriers; and (14) barriers to movement of cash.
 
    We must regularly assess the size, capability and location of
    our global infrastructure and make appropriate changes to
    address these issues.
 
    We may
    be subject to additional impairment charges due to potential
    declines in the fair value of our assets.
 
    As a result of our acquisitions, we have significant goodwill
    and intangible assets on our balance sheet. We test goodwill and
    intangible assets for impairment on a periodic basis as
    required, and whenever events or changes in circumstances
    indicate that the carrying value may not be recoverable. The
    events or changes that could require us to test our goodwill and
    intangible assets for impairment include: a significant
    reduction in our stock price, and as a result market
    capitalization, changes in our estimated future cash flows, as
    well as changes in rates of growth in our industry or in any of
    our reporting units. In the fourth quarter of 2008, we recorded
    an impairment charge of $10.5 million for goodwill due to a
    decline in our market capitalization and certain purchased
    technology intangible assets due to lower revenue expectations.
    We will continue to evaluate the carrying value of our remaining
    goodwill and intangible assets and if we determine in the future
    that there is a potential further impairment in any of our
    reporting units, we may be required to record additional charges
    to earnings which could materially adversely affect our
    financial results and could also materially adversely affect our
    business. See Note 6 Goodwill and Purchased
    Intangible Assets, Net in the Notes to the Consolidated
    Financial Statements for additional information related to
    impairment of goodwill and intangible assets.
 
    The
    liquidity of our auction rate securities is impaired, which
    could impact our ability to meet cash requirements and require
    additional financing.
 
    At December 31, 2010, we held auction rate securities
    (ARS) with a par value of $10.9 million. The
    market for these securities had historically been highly liquid,
    even though the ARS that we hold have underlying maturities
    ranging from 21 to 35 years. The liquidity was achieved
    through auctions, which occurred every 7 or 28 days
    depending on the security, in which the interest paid on each
    security was reset to current market rates. We never intended to
    hold these securities to maturity, but rather to use the auction
    feature to sell the securities as needed to provide liquidity.
    Since February 2008, all of these ARS auctions have failed. The
    ARS will continue to be illiquid until a successful auction
    process is reinstated, they are restructured into a more liquid
    security, or a buyer is found outside of the auction process. We
    do not know when, or if, this will occur. All of the ARS held by
    us are student loan structured issues, originated under the
    U.S. Department of Educations Federal Family
    Education Loan Program with principal and interest
    97%  98% reinsured by the U.S. Department of
    Education. As of December 31, 2010, all of these securities
    are currently rated
    
    18
 
    investment grade but there is no assurance that these ARS will
    continue to be similarly rated in the future. As of
    December 31, 2010, securities with a par value of
    $8.5 million are rated AAA/Aaa, and a security with a par
    value of $2.4 million is rated AAA/A3. These securities are
    classified as long-term investments and we recorded a temporary
    impairment charge of $627,000. If: (1) the issuers of the
    ARS are unable to successfully resume auctions; or (2) the
    issuers do not redeem the ARS; or (3) a liquid market for
    the ARS does not develop; or (4) the U.S. Department
    of Education fails to support its guaranty of the obligations;
    or (5) these or any other valuation metrics or processes
    change, then Intevac may be required to further adjust the
    carrying value of the ARS
    and/or
    record an
    other-than-temporary
    impairment charge. In addition, Intevac could, in such a
    situation require additional financing which might not be
    available on favorable terms, if at all.
 
    Our
    success is dependent on recruiting and retaining a highly
    talented work force.
 
    Our employees are vital to our success, and our key management,
    engineering and other employees are difficult to replace. We
    generally do not have employment contracts with our key
    employees. Further, we do not maintain key person life insurance
    on any of our employees. The expansion of high technology
    companies worldwide has increased demand and competition for
    qualified personnel, and has made companies increasingly
    protective of prior employees. It may be difficult for us to
    locate employees who are not subject to non-competition
    agreements and other restrictions.
 
    The majority of our U.S. operations are located in
    California where the cost of living and of recruiting employees
    is high. Additionally, our operating results depend, in large
    part, upon our ability to retain and attract qualified
    management, engineering, marketing, manufacturing, customer
    support, sales and administrative personnel. Furthermore, we
    compete with industries such as the hard disk drive,
    semiconductor, and solar industries for skilled employees.
    Failure to retain existing key personnel, or to attract,
    assimilate or retain additional highly qualified employees to
    meet our needs in the future, could have a material and adverse
    effect on our business, financial condition and results of
    operations.
 
    We are
    dependent on certain suppliers for parts used in our
    products.
 
    We are a manufacturing business. Purchased parts constitute the
    largest component of our product cost. Our ability to
    manufacture depends on the timely delivery of parts, components
    and subassemblies from suppliers. We obtain some of the key
    components and subassemblies used in our products from a single
    supplier or a limited group of suppliers. If any of our
    suppliers fail to deliver quality parts on a timely basis, we
    may experience delays in manufacturing, which could result in
    delayed product deliveries, increased costs to expedite
    deliveries or develop alternative suppliers, or require redesign
    of our products to accommodate alternative suppliers. Some of
    our suppliers are thinly capitalized and may be vulnerable to
    failure given recent economic conditions.
 
    Our
    business depends on the integrity of our intellectual property
    rights.
 
    The success of our business depends upon the integrity of our
    intellectual property rights, and we cannot ensure that:
    (1) any of our pending or future patent applications will
    be allowed or that any of the allowed applications will be
    issued as patents or will issue with claims of the scope we
    sought; (2) any of our patents will not be invalidated,
    deemed unenforceable, circumvented or challenged; (3) the
    rights granted under our patents will provide competitive
    advantages to us; (4) other parties will not develop
    similar products, duplicate our products or design around our
    patents; or (5) our patent rights, intellectual property
    laws or our agreements will adequately protect our intellectual
    property or competitive position.
 
    From time to time, we have received claims that we are
    infringing third parties intellectual property rights or
    seeking to invalidate our rights. We cannot ensure that third
    parties will not in the future claim that we have infringed
    current or future patents, trademarks or other proprietary
    rights relating to our products. Any claims, with or without
    merit, could be time-consuming, result in costly litigation,
    cause product shipment delays or require us to enter into
    royalty or licensing agreements. Such royalty or licensing
    agreements, if required, may not be available on terms
    acceptable to us.
    
    19
 
 
    We
    could be involved in litigation.
 
    From time to time we may be involved in litigation of various
    types, including litigation alleging infringement of
    intellectual property rights and other claims. Litigation is
    expensive, subjects us to the risk of significant damages and
    requires significant management time and attention and could
    have a material and adverse effect on our business, financial
    condition and results of operations.
 
    Difficulties
    in integrating past or future acquisitions could adversely
    affect our business.
 
    We have completed a number of acquisitions during our operating
    history. For example, in 2007, we acquired certain assets of
    DeltaNu, LLC and certain assets of Creative Display Systems,
    LLC, in 2008 we acquired certain assets of OC Oerlikon Balzers
    Ltd. and in 2010 we acquired the outstanding shares of Solar
    Implant Technologies, Inc. We have spent and may continue to
    spend significant resources identifying and pursuing future
    acquisition opportunities. Acquisitions involve numerous risks
    including: (1) difficulties in integrating the operations,
    technologies and products of the acquired companies;
    (2) the diversion of our managements attention from
    other business concerns; and (3) the potential loss of key
    employees of the acquired companies. Failure to achieve the
    anticipated benefits of the prior and any future acquisitions or
    to successfully integrate the operations of the companies we
    acquire could have a material and adverse effect on our
    business, financial condition and results of operations. Any
    future acquisitions could also result in potentially dilutive
    issuance of equity securities, acquisition- or
    divestiture-related write-offs or the assumption of debt and
    contingent liabilities.
 
    We use
    hazardous materials and are subject to risks of non-compliance
    with environmental and safety regulations.
 
    We are subject to a variety of governmental regulations relating
    to the use, storage, discharge, handling, emission, generation,
    manufacture, treatment and disposal of toxic or otherwise
    hazardous substances, chemicals, materials or waste. If we fail
    to comply with current or future regulations, such failure could
    result in suspension of our operations, alteration of our
    manufacturing process, or substantial civil penalties or
    criminal fines against us or our officers, directors or
    employees. Additionally, these regulations could require us to
    acquire expensive remediation or abatement equipment or to incur
    substantial expenses to comply with them.
 
    Business
    interruptions could adversely affect our
    operations.
 
    Our operations are vulnerable to interruption by fire,
    earthquake or other natural disaster, quarantines or other
    disruptions associated with infectious diseases, national
    catastrophe, terrorist activities, war, disruptions in our
    computing and communications infrastructure due to power loss,
    telecommunications failure, human error, physical or electronic
    security breaches and computer viruses, and other events beyond
    our control. We do not have a detailed disaster recovery plan.
    Despite our implementation of network security measures, our
    tools and servers may be vulnerable to computer viruses,
    break-ins and similar disruptions from unauthorized tampering
    with our computer systems and tools located at customer sites.
    Political instability could cause us to incur increased costs in
    transportation, make such transportation unreliable, increase
    our insurance costs or cause international currency markets to
    fluctuate. This same instability could have the same effects on
    our suppliers and their ability to timely deliver their
    products. In addition, we do not carry sufficient business
    interruption insurance to compensate us for all losses that may
    occur, and any losses or damages incurred by us could have a
    material adverse effect on our business and results of
    operations. For example, we self-insure earthquake risks because
    we believe this is the prudent financial decision based on the
    high cost of the limited coverage available in the earthquake
    insurance market. An earthquake could significantly disrupt our
    operations, most of which are conducted in California. It could
    also significantly delay our research and engineering effort on
    new products, most of which is also conducted in California. We
    take steps to minimize the damage that would be caused by
    business interruptions, but there is no certainty that our
    efforts will prove successful.
 
    We are
    required to evaluate our internal control over financial
    reporting under Section 404 of the Sarbanes-Oxley Act of
    2002, and any adverse results from such evaluation could result
    in a loss of investor confidence in our financial reports and
    have an adverse effect on our stock price.
 
    Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002,
    our management must perform evaluations of our internal control
    over financial reporting. Beginning in 2004, our
    Form 10-K
    has included a report by management of
    
    20
 
    their assessment of the adequacy of such internal control.
    Additionally, our independent registered public accounting firm
    must publicly attest to the effectiveness of our internal
    control over financial reporting.
 
    We have completed the evaluation of our internal controls over
    financial reporting as required by Section 404 of the
    Sarbanes-Oxley Act. Although our assessment, testing, and
    evaluation resulted in our conclusion that as of
    December 31, 2010, our internal controls over financial
    reporting were effective, we cannot predict the outcome of our
    testing in future periods. Ongoing compliance with this
    requirement is complex, costly and time-consuming. If Intevac
    fails to maintain effective internal control over financial
    reporting; our management does not timely assess the adequacy of
    such internal control; or our independent registered public
    accounting firm does not deliver an unqualified opinion as to
    the effectiveness of our internal control over financial
    reporting, then we could be subject to restatement of previously
    reported financial results, regulatory sanctions and a decline
    in the publics perception of Intevac, which could have a
    material and adverse effect on our business, financial condition
    and results of operations.
 
     | 
     | 
    | 
    Item 1B.  
 | 
    
    Unresolved
    Staff Comments
 | 
 
    None.
 
 
    Intevac maintains its corporate headquarters in
    Santa Clara, California. The location, approximate size and
    type of facility of the principal properties are listed below.
    Intevac leases all of its properties and does not own any real
    estate.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Location
 
 | 
 
 | 
    Square Footage
 | 
 
 | 
 
 | 
 
    Principal Use
 
 | 
|  
 | 
| 
 
    Santa Clara, CA
 
 | 
 
 | 
 
 | 
    169,583
 | 
 
 | 
 
 | 
    Corporate Headquarters; Equipment and Intevac Photonics
    Marketing, Manufacturing, Engineering and Customer Support
 | 
| 
 
    Fremont, CA
 
 | 
 
 | 
 
 | 
    9,505
 | 
 
 | 
 
 | 
    Intevac Photonics Sensor Fabrication
 | 
| 
 
    Laramie, WY
 
 | 
 
 | 
 
 | 
    12,000
 | 
 
 | 
 
 | 
    Intevac Photonics Raman Spectrometer Manufacturing
 | 
| 
 
    Carlsbad, CA
 
 | 
 
 | 
 
 | 
    10,360
 | 
 
 | 
 
 | 
    Intevac Photonics Micro Display Product Manufacturing
 | 
| 
 
    Singapore
 
 | 
 
 | 
 
 | 
    31,947
 | 
 
 | 
 
 | 
    Equipment Manufacturing and Customer Support
 | 
| 
 
    Malaysia
 
 | 
 
 | 
 
 | 
    1,291
 | 
 
 | 
 
 | 
    Equipment Customer Support
 | 
| 
 
    Shenzhen, China
 
 | 
 
 | 
 
 | 
    2,568
 | 
 
 | 
 
 | 
    Equipment Customer Support
 | 
 
    Intevac considers these properties adequate to meet its current
    and future requirements. Intevac regularly assesses the size,
    capability and location of its global infrastructure and
    periodically makes adjustments based on these assessments.
 
     | 
     | 
    | 
    Item 3.  
 | 
    
    Legal
    Proceedings
 | 
 
    From time to time, Intevac is involved in claims and legal
    proceedings that arise in the ordinary course of business.
    Intevac expects that the number and significance of these
    matters will increase as Intevacs business expands. Any
    claims or proceedings against us, whether meritorious or not,
    could be time consuming, result in costly litigation, require
    significant amounts of management time, result in the diversion
    of significant operational resources, or require us to enter
    into royalty or licensing agreements which, if required, may not
    be available on terms favorable to us or at all. Intevac is not
    presently a party to any lawsuit or proceeding that, in
    Intevacs opinion, is likely to seriously harm
    Intevacs business.
 
     | 
     | 
    | 
    Item 4.  
 | 
    
    (Removed
    and Reserved)
 | 
    
    21
 
 
    PART II
 
     | 
     | 
    | 
    Item 5.  
 | 
    
    Market
    for Registrants Common Equity, Related Stockholder Matters
    and Issuer Purchases of Equity Securities
 | 
 
    Price
    Range of Common Stock
 
    Intevac common stock is traded on The Nasdaq Stock Market
    (NASDAQ Global Select) under the symbol IVAC. As of
    February 25, 2011, there were 111 holders of record. In
    fiscal years 2010 and 2009 Intevac did not declare or pay cash
    dividends to its stockholders. Intevac currently has no plans to
    declare or pay cash dividends.
 
    The following table sets forth the high and low closing sale
    prices per share as reported on The Nasdaq Stock Market for the
    periods indicated.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    High
 | 
 
 | 
    Low
 | 
|  
 | 
| 
 
    Fiscal 2010:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    First Quarter
 
 | 
 
 | 
    $
 | 
    16.82
 | 
 
 | 
 
 | 
    $
 | 
    13.63
 | 
 
 | 
| 
 
    Second Quarter
 
 | 
 
 | 
 
 | 
    15.48
 | 
 
 | 
 
 | 
 
 | 
    10.48
 | 
 
 | 
| 
 
    Third Quarter
 
 | 
 
 | 
 
 | 
    11.57
 | 
 
 | 
 
 | 
 
 | 
    9.04
 | 
 
 | 
| 
 
    Fourth Quarter
 
 | 
 
 | 
 
 | 
    15.25
 | 
 
 | 
 
 | 
 
 | 
    9.73
 | 
 
 | 
| 
 
    Fiscal 2009:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    First Quarter
 
 | 
 
 | 
    $
 | 
    5.73
 | 
 
 | 
 
 | 
    $
 | 
    3.43
 | 
 
 | 
| 
 
    Second Quarter
 
 | 
 
 | 
 
 | 
    8.65
 | 
 
 | 
 
 | 
 
 | 
    5.02
 | 
 
 | 
| 
 
    Third Quarter
 
 | 
 
 | 
 
 | 
    13.14
 | 
 
 | 
 
 | 
 
 | 
    7.45
 | 
 
 | 
| 
 
    Fourth Quarter
 
 | 
 
 | 
 
 | 
    13.45
 | 
 
 | 
 
 | 
 
 | 
    10.00
 | 
 
 | 
 
    Recent
    Sales of Unregistered Securities
 
    None.
 
    Purchases
    of Equity Securities by the Issuer and Affiliated
    Purchasers
 
    None.
 
    Performance
    Graph
 
    The following graph compares the cumulative total stockholder
    return on Intevacs Common Stock with that of the NASDAQ
    Stock Market Total Return Index, a broad market index published
    by the Center for Research in Security Prices
    (CRSP), and the NASDAQ Computer Manufacturers Stock
    Total Return Index compiled by CRSP. The comparison for each of
    the periods assumes that $100 was invested on December 31,
    2005 in Intevacs Common Stock, the stocks included in the
    NASDAQ Stock Market Total Return Index and the stocks included
    in the NASDAQ Computer Manufacturers Stock Total Return Index.
    These indices, which reflect formulas for dividend reinvestment
    and weighting of individual stocks, do not necessarily reflect
    returns that could be achieved by individual investors.
    
    22
 
    COMPARISON
    OF CUMULATIVE TOTAL RETURN SINCE DECEMBER 31, 2005
    AMONG INTEVAC, NASDAQ STOCK MARKET TOTAL RETURN INDEX AND
    NASDAQ COMPUTER MANUFACTURERS TOTAL RETURN INDEX
 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
 
 | 
    12/31/05
 | 
 
 | 
 
 | 
    12/30/06
 | 
 
 | 
 
 | 
    12/29/07
 | 
 
 | 
 
 | 
    12/31/08
 | 
 
 | 
 
 | 
    12/31/09
 | 
 
 | 
 
 | 
    12/31/10
 | 
| 
 
    Intevac, Inc. 
 
 | 
 
 | 
 
 | 
    $
 | 
    100
 | 
 
 | 
 
 | 
 
 | 
    $
 | 
    197
 | 
 
 | 
 
 | 
 
 | 
    $
 | 
    110
 | 
 
 | 
 
 | 
 
 | 
    $
 | 
    38
 | 
 
 | 
 
 | 
 
 | 
    $
 | 
    87
 | 
 
 | 
 
 | 
 
 | 
    $
 | 
    106
 | 
 
 | 
| 
 
    Nasdaq Stock Market Total Return Index
 
 | 
 
 | 
 
 | 
 
 | 
    100
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    110
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    119
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    57
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    83
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    98
 | 
 
 | 
| 
 
    Nasdaq Computer Manufacturers Total Return Index
 
 | 
 
 | 
 
 | 
 
 | 
    100
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    102
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    149
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    63
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    138
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    197
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
     | 
     | 
    | 
    Item 6.  
 | 
    
    Selected
    Financial Data
 | 
 
    The following selected financial information has been derived
    from Intevacs historical audited consolidated financial
    statements and should be read in conjunction with the
    consolidated financial statements, the accompanying notes and
    Managements Discussion and Analysis of Financial Condition
    and Results of Operations for the corresponding fiscal years.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Year Ended December 31,
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
    2009
 | 
 
 | 
    2008
 | 
 
 | 
    2007
 | 
 
 | 
    2006
 | 
| 
 
 | 
 
 | 
    (In thousands, except per share data)
 | 
|  
 | 
| 
 
    Net revenues
 
 | 
 
 | 
    $
 | 
    202,526
 | 
 
 | 
 
 | 
    $
 | 
    77,981
 | 
 
 | 
 
 | 
    $
 | 
    110,307
 | 
 
 | 
 
 | 
    $
 | 
    215,834
 | 
 
 | 
 
 | 
    $
 | 
    259,875
 | 
 
 | 
| 
 
    Gross profit
 
 | 
 
 | 
    $
 | 
    87,672
 | 
 
 | 
 
 | 
    $
 | 
    32,720
 | 
 
 | 
 
 | 
    $
 | 
    43,339
 | 
 
 | 
 
 | 
    $
 | 
    96,043
 | 
 
 | 
 
 | 
    $
 | 
    100,959
 | 
 
 | 
| 
 
    Operating income (loss)
 
 | 
 
 | 
    $
 | 
    31,238
 | 
 
 | 
 
 | 
    $
 | 
    (17,347
 | 
    )
 | 
 
 | 
    $
 | 
    (30,471
 | 
    )
 | 
 
 | 
    $
 | 
    27,436
 | 
 
 | 
 
 | 
    $
 | 
    47,999
 | 
 
 | 
| 
 
    Net income (loss)
 
 | 
 
 | 
    $
 | 
    28,049
 | 
 
 | 
 
 | 
    $
 | 
    (10,077
 | 
    )
 | 
 
 | 
    $
 | 
    (15,345
 | 
    )
 | 
 
 | 
    $
 | 
    27,345
 | 
 
 | 
 
 | 
    $
 | 
    46,698
 | 
 
 | 
| 
 
    Earnings (loss) per share:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Basic
 
 | 
 
 | 
    $
 | 
    1.26
 | 
 
 | 
 
 | 
    $
 | 
    (0.46
 | 
    )
 | 
 
 | 
    $
 | 
    (0.71
 | 
    )
 | 
 
 | 
    $
 | 
    1.28
 | 
 
 | 
 
 | 
    $
 | 
    2.22
 | 
 
 | 
| 
 
    Diluted
 
 | 
 
 | 
    $
 | 
    1.22
 | 
 
 | 
 
 | 
    $
 | 
    (0.46
 | 
    )
 | 
 
 | 
    $
 | 
    (0.71
 | 
    )
 | 
 
 | 
    $
 | 
    1.23
 | 
 
 | 
 
 | 
    $
 | 
    2.13
 | 
 
 | 
| 
 
    At year end:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total assets
 
 | 
 
 | 
    $
 | 
    251,771
 | 
 
 | 
 
 | 
    $
 | 
    203,378
 | 
 
 | 
 
 | 
    $
 | 
    189,169
 | 
 
 | 
 
 | 
    $
 | 
    215,413
 | 
 
 | 
 
 | 
    $
 | 
    206,003
 | 
 
 | 
| 
 
    Long-term debt
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    1,898
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
    
    23
 
 
     | 
     | 
    | 
    Item 7.  
 | 
    
    Managements
    Discussion and Analysis of Financial Condition and Results of
    Operations
 | 
 
    Managements Discussion and Analysis (MD&A) is
    intended to facilitate an understanding of Intevacs
    business and results of operations. This MD&A should be
    read in conjunction with Intevacs Consolidated Financial
    Statements and the accompanying Notes to Consolidated Financial
    Statements included elsewhere in this
    Form 10-K.
    The following discussion contains forward-looking statements and
    should also be read in conjunction with the cautionary statement
    set forth at the beginning of this
    Form 10-K.
    MD&A includes the following sections:
 
     | 
     | 
     | 
    |   | 
         
 | 
    
    Overview: a summary of Intevacs business,
    measurements and opportunities.
 | 
|   | 
    |   | 
         
 | 
    
    Results of Operations: a discussion of operating results.
 | 
|   | 
    |   | 
         
 | 
    
    Liquidity and Capital Resources: an analysis of cash
    flows, sources and uses of cash, contractual obligations and
    financial position.
 | 
|   | 
    |   | 
         
 | 
    
    Critical Accounting Policies: a discussion of critical
    accounting policies that require the exercise of judgments and
    estimates.
 | 
 
    Overview
 
    Intevac provides process manufacturing equipment solutions to
    the hard disk drive industry, high-productivity process
    manufacturing equipment and inspection solutions to the
    photovoltaic (PV) industry and wafer handling
    platforms to the semiconductor industry. In 2009, Intevac
    announced a high-productivity thin-film solar cell manufacturing
    system for PV applications, LEAN
    SOLARtm,
    and began offering equipment to thin-film PV cell manufacturers.
    Intevac shipped the first LEAN SOLAR system to a customer in the
    second quarter of 2010. In 2010 Intevac also began offering LEAN
    SOLAR to support wafer-based crystalline silicon
    (c-Si) applications and inspection equipment to PV
    cell manufacturers. In the semiconductor capital equipment
    market, Intevac stopped offering its Lean Etch product and
    refocused its efforts on a linear wafer handling platform
    solution and in the second quarter of 2010 introduced
    Continuumtm,
    a high-productivity vacuum wafer handling system. To date,
    Intevac has not yet recognized any revenue from shipments of its
    semiconductor wafer handling and PV products. Intevac also
    provides sensors, cameras and systems for government
    applications such as night vision and long-range target
    identification and for commercial applications in the
    inspection, medical, scientific and security industries.
    Intevacs customers and potential customers include
    manufacturers of hard disk drives, semiconductor equipment, and
    PV cells as well as medical, scientific and security companies,
    law enforcement and the U.S. government and its agencies
    and contractors. Intevac reports two segments: Equipment and
    Intevac Photonics. During the fourth quarter of 2010, Intevac
    completed the acquisition of the outstanding shares of Solar
    Implant Technologies, Inc. (SIT), a privately-owned,
    development stage company, creating a manufacturing module for
    PV applications. During the third quarter of 2008, Intevac
    completed the acquisition of certain assets and liabilities of
    the magnetic media equipment business of OC Oerlikon Balzers
    Ltd. (Oerlikon).
 
    Product development and manufacturing activities occur in North
    America and Asia. Intevac has field offices in Asia to support
    its equipment customers. Intevacs equipment and service
    products are highly technical and, with the exception of Japan,
    are sold primarily through a direct sales force. In Japan, sales
    are typically made by Intevacs Japanese distributor,
    Matsubo.
 
    Intevacs results are driven primarily by worldwide demand
    for hard drive disks, which in turn depends on end-user demand
    for personal computers, enterprise data storage, personal audio
    and video players and video game platforms. Intevac continues to
    execute its equipment diversification strategy into new markets
    by introducing products for PV solar cell and semiconductor
    equipment manufacturing. Intevac believes that expansion into
    these new markets which are significantly larger than the hard
    disk drive market will result in incremental equipment revenues
    for Intevac and decrease Intevacs dependence on the hard
    drive industry. Intevacs business is subject to cyclical
    industry conditions, as demand for manufacturing equipment and
    services can change depending on supply
    
    24
 
    and demand for hard drive disks, semiconductor wafer handling
    equipment, and PV cells, as well as other factors, such as
    global economic conditions and technological advances in
    fabrication processes.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
    % Change 
    
 | 
| 
 
    Fiscal Year
 
 | 
 
 | 
    2010
 | 
 
 | 
    2009
 | 
 
 | 
    2008
 | 
 
 | 
    2010 vs. 2009
 | 
 
 | 
    2009 vs. 2008
 | 
| 
 
 | 
 
 | 
    (In thousands, except percentages and per share amounts)
 | 
|  
 | 
| 
 
    Net revenues
 
 | 
 
 | 
    $
 | 
    202,526
 | 
 
 | 
 
 | 
    $
 | 
    77,981
 | 
 
 | 
 
 | 
    $
 | 
    110,307
 | 
 
 | 
 
 | 
 
 | 
    159.7
 | 
    %
 | 
 
 | 
 
 | 
    (29.3
 | 
    ) %
 | 
| 
 
    Gross profit
 
 | 
 
 | 
 
 | 
    87,672
 | 
 
 | 
 
 | 
 
 | 
    32,720
 | 
 
 | 
 
 | 
 
 | 
    43,339
 | 
 
 | 
 
 | 
 
 | 
    167.9
 | 
    %
 | 
 
 | 
 
 | 
    (24.5
 | 
    ) %
 | 
| 
 
    Gross margin percent
 
 | 
 
 | 
 
 | 
    43.3
 | 
    %
 | 
 
 | 
 
 | 
    42.0
 | 
    %
 | 
 
 | 
 
 | 
    39.3
 | 
    %
 | 
 
 | 
 
 | 
    1.3 points
 | 
 
 | 
 
 | 
 
 | 
    2.7 points
 | 
 
 | 
| 
 
    Net income (loss)
 
 | 
 
 | 
 
 | 
    28,049
 | 
 
 | 
 
 | 
 
 | 
    (10,077
 | 
    )
 | 
 
 | 
 
 | 
    (15,345
 | 
    )
 | 
 
 | 
 
 | 
    378.3
 | 
    %
 | 
 
 | 
 
 | 
    34.3
 | 
    %
 | 
| 
 
    Earnings (loss) per diluted share
 
 | 
 
 | 
    $
 | 
    1.22
 | 
 
 | 
 
 | 
    $
 | 
    (0.46
 | 
    )
 | 
 
 | 
    $
 | 
    (0.71
 | 
    )
 | 
 
 | 
 
 | 
    365.2
 | 
    %
 | 
 
 | 
 
 | 
    35.2
 | 
    %
 | 
 
    Fiscal 2008 financial results reflected a difficult environment
    as Intevacs customers reduced or delayed capital
    expenditures as a result of industry consolidation, lower growth
    and global economic conditions. In this period, Intevac focused
    on lowering costs, improving efficiencies, and bringing new
    products to market. In 2008, Intevac acquired certain assets and
    liabilities of Oerlikons magnetic media equipment
    business. In the fourth quarter of fiscal 2008, in response to
    the deteriorating economic conditions, Intevac announced and
    executed a global cost reduction plan that reduced its cost
    structure and its cash burn, while still enabling Intevac to
    invest in products to drive future growth. Also during the
    fourth quarter of fiscal 2008, Intevacs market
    capitalization and financial outlook were adversely impacted by
    the prevailing macroeconomic business environment. This
    triggered Intevacs performing interim impairment tests on
    its goodwill and intangible assets; and as a result Intevac
    recorded non-cash goodwill and intangible impairment charges of
    $10.5 million.
 
    Fiscal 2009 financial results reflected a challenging
    environment that resulted from the economic slowdown. Demand in
    the hard disk drive industry was flat compared to fiscal 2008
    and Intevacs Equipment customers did not require capacity
    additions. During fiscal 2009, demand for new equipment resulted
    primarily from the retirement of some legacy systems and
    customer research and development activities, including in
    patterned media. At the end of 2009, however, Intevacs
    hard drive customers began taking delivery of systems for 2010
    capacity needs. In 2009, Intevac Photonics business grew, driven
    by U.S. government spending plus incorporation of Intevac
    products into development, pre-production and some early stage
    production programs.
 
    Fiscal 2010 financial results improved as Intevacs
    Equipment customers took delivery of systems to increase their
    production capacity in response to growing demand for digital
    storage. In fiscal 2010, Intevac acquired SIT to develop PV
    manufacturing products. Net sales during fiscal 2010 reflected
    higher equipment sales to disk manufacturers and increased
    Intevac Photonics technology development contracts and
    product sales. Net income during fiscal 2010 reflected higher
    net sales, partially offset by higher selling, general and
    administrative expenses, and higher income tax expense. The
    increase in selling, general and administrative expenses during
    fiscal 2010 was primarily a result of variable compensation
    expenses, legal expenses associated with the auction rate
    securities (ARS) arbitration and transaction costs
    associated with completing the acquisition of SIT.
 
    Intevac expects to sell fewer 200 Lean systems in fiscal 2011
    compared to fiscal 2010 as the hard drive industry increased
    capacity and retired a significant number of legacy systems in
    2010. Hard drive customers also took delivery of systems in the
    fourth quarter of fiscal 2010 which will meet some of their 2011
    capacity needs. Long-term demand for hard disk drives is
    expected to increase, driven by growth in the demand for digital
    storage, the need for corporations to replace and update
    employee computers, increased information technology spending,
    declining growth rate in areal density improvements and the
    proliferation of personal computers into emerging economies. The
    number of disk manufacturing systems needed to support this
    growth is expected to vary from year to year depending on the
    factors noted above. In fiscal 2011, Intevac expects its hard
    drive customers will add some new systems for capacity
    production as well as invest in systems for technology
    development.
 
    In fiscal 2011, Intevac expects that the Intevac Photonics
    business levels will be flat compared to fiscal 2010. For fiscal
    2011, Intevac expects Photonics product revenue from low-light
    sensors and cameras to increase; however, contract research and
    development revenue will likely be lower as a result of the
    completion of certain development contracts in fiscal 2010 and
    delayed contract funding for several large programs due to
    delays in U.S. government defense budget approvals.
    
    25
 
    Results
    of Operations
 
    Net
    revenues
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
 
 | 
    2010 vs. 2009
 | 
 
 | 
 
 | 
    2009 vs. 2008
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except percentages)
 | 
 
 | 
 
 | 
|  
 | 
| 
 
    Equipment
 
 | 
 
 | 
    $
 | 
    168,252
 | 
 
 | 
 
 | 
    $
 | 
    51,389
 | 
 
 | 
 
 | 
    $
 | 
    87,469
 | 
 
 | 
 
 | 
 
 | 
    227.4
 | 
    %
 | 
 
 | 
 
 | 
    (41.2
 | 
    )
 | 
    %
 | 
| 
 
    Intevac Photonics
 
 | 
 
 | 
 
 | 
    34,274
 | 
 
 | 
 
 | 
 
 | 
    26,592
 | 
 
 | 
 
 | 
 
 | 
    22,838
 | 
 
 | 
 
 | 
 
 | 
    28.9
 | 
    %
 | 
 
 | 
 
 | 
    16.4
 | 
 
 | 
    %
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
| 
 
    Total net revenues
 
 | 
 
 | 
    $
 | 
    202,526
 | 
 
 | 
 
 | 
    $
 | 
    77,981
 | 
 
 | 
 
 | 
    $
 | 
    110,307
 | 
 
 | 
 
 | 
 
 | 
    159.7
 | 
    %
 | 
 
 | 
 
 | 
    (29.3
 | 
    )
 | 
    %
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 | 
 
    Net revenues consist primarily of sales of equipment used to
    manufacture thin-film disks, and, to a lesser extent, related
    equipment and system components; revenue from contract research
    and development related to the development of electro-optical
    sensors, cameras and systems; and sales of low-light imaging
    products and table-top and handheld Raman instruments.
 
    The increase in Equipment revenues in 2010 was due primarily to
    an increase in the number of 200 Lean systems delivered. In
    2010, Intevac delivered twenty-six 200 Lean systems compared to
    four 200 Lean systems in 2009 and eleven 200 Lean systems in
    2008. Revenues from disk equipment technology upgrades and spare
    parts increased in 2010 versus 2009 and 2008. Fiscal 2008 new
    system capacity additions in the hard disk drive market were
    negatively impacted by disk manufacturers upgrading and reusing
    legacy tools previously in storage. The reuse of these systems
    substantially met the incremental capacity requirements of one
    of our largest customers. Equipment revenues in 2011 are
    expected to be lower than 2010 levels due to lower capital
    spending by hard drive customers for capacity additions.
    Nonetheless Intevac expects long-term demand for hard disk
    drives to increase driven by the growth in digital storage, the
    need for corporations to replace and update employee computers,
    increased information technology spending, declining growth rate
    in areal density improvements and the proliferation of personal
    computers into emerging economies. The number of disk
    manufacturing systems needed to support this growth can vary
    from year to year and is dependent on the factors noted above.
 
    Intevac Photonics revenues increased by 28.9% to
    $34.3 million in 2010, which consisted of
    $16.0 million of product revenue and $18.3 million of
    contract research and development revenue. Intevac Photonics
    revenues of $26.6 million in 2009 consisted of
    $10.5 million of product revenue and $16.1 million of
    contract research and development revenue. Intevac Photonics
    2008 revenues of $22.8 million consisted of
    $8.5 million of product revenue and $14.3 million of
    contract research and development revenue. The increase in
    product revenues in both 2010 and 2009 resulted from higher
    sales of low-light sensors and cameras used in military night
    vision and long-range imaging as well as commercial applications
    such as Intevacs table-top and handheld Raman instruments
    and near-eye display products. The increase in contract research
    and development revenue was the result of a higher volume of
    contracts for additional digital night vision applications. In
    2011, Intevac Photonics product revenue is expected to grow due
    to continued expansion of Intevacs low-light camera and
    sensor products in military and commercial applications.
    Contract research and development revenue will likely be lower
    as a result of the completion of certain development contracts
    in 2010 and delayed contract funding for several large programs
    due to delays in U.S. government defense budget approvals.
    Substantial growth in future Intevac Photonics revenues is
    dependent on the proliferation of Intevacs technology into
    major military programs, continued defense spending, the ability
    to obtain export licenses for foreign customers, obtaining
    production subcontracts for these programs, and Intevacs
    development and market acceptance of commercial products.
 
    Intevacs backlog of orders at December 31, 2010 was
    $46.7 million, as compared to $73.8 million at
    December 31, 2009 and $20.2 million at
    December 31, 2008. Equipment backlog at December 31,
    2010 was $27.3 million compared to $57.5 million at
    December 31, 2009 and $11.4 million at
    December 31, 2008. Intevac Photonics backlog at
    December 31, 2010 was $19.4 million compared to
    $16.3 million at December 31, 2009 and
    $8.8 million at December 31, 2008. Equipment backlog
    at December 31, 2010 included two 200 Lean systems and two
    LEAN SOLAR systems, as compared to ten 200 Lean systems at
    December 31, 2009, and one 200 Lean system at
    December 31, 2008.
    
    26
 
    Significant portions of Intevacs revenues in any
    particular period have been attributable to sales to a limited
    number of customers. In 2010 sales to Seagate, Hitachi Global
    Storage Technologies, and Fuji Electric each accounted for more
    than 10% of Intevacs revenues and in the aggregate sales
    to these customers accounted for 78% of revenues. In 2009, sales
    to Seagate and Hitachi Global Storage Technologies each
    accounted for more than 10% of Intevacs revenues and in
    the aggregate sales to these customers accounted for 55% of
    revenues. In 2008, sales to Seagate and Hitachi Global Storage
    Technologies each accounted for more than 10% of Intevacs
    revenues and in the aggregate sales to these customers accounted
    for 69% of revenues. The magnetic disk manufacturing industry
    consists of a small number of large manufacturers. Seagate
    acquired Maxtor in 2006 and Western Digital acquired Komag in
    2007 and Hoyas magnetic media operations in 2010, all of
    which further concentrated the customer base in the industry.
 
    International sales totaled $155.0 million,
    $39.2 million, and $76.5 million in 2010, 2009, and
    2008, respectively, accounting for 77%, 50%, and 69% of net
    revenues. The increase in international sales in 2010 was
    primarily due to increases in net revenues from disk sputtering
    systems. The decrease in international sales in 2009 was
    primarily due to decreases in net revenues from disk sputtering
    systems. Substantially all of Intevacs international sales
    are to customers in Asia, which includes products shipped to
    overseas operations of U.S. companies.
 
    Gross
    margin
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
    % Change 
    
 | 
 
 | 
    % Change 
    
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
    2009
 | 
 
 | 
    2008
 | 
 
 | 
    2010 vs. 2009
 | 
 
 | 
    2009 vs. 2008
 | 
| 
 
 | 
 
 | 
    (In thousands, except percentages)
 | 
|  
 | 
| 
 
    Equipment gross profit
 
 | 
 
 | 
    $
 | 
    79,472
 | 
 
 | 
 
 | 
    $
 | 
    23,266
 | 
 
 | 
 
 | 
    $
 | 
    35,797
 | 
 
 | 
 
 | 
 
 | 
    241.6
 | 
 
 | 
    %
 | 
 
 | 
 
 | 
    (35.0
 | 
    )
 | 
    %
 | 
| 
 
    % of Equipment net revenues
 
 | 
 
 | 
 
 | 
    47.2
 | 
    %
 | 
 
 | 
 
 | 
    45.3
 | 
    %
 | 
 
 | 
 
 | 
    40.9
 | 
    %
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Intevac Photonics gross profit
 
 | 
 
 | 
    $
 | 
    8,200
 | 
 
 | 
 
 | 
    $
 | 
    9,454
 | 
 
 | 
 
 | 
    $
 | 
    7,542
 | 
 
 | 
 
 | 
 
 | 
    (13.3
 | 
    )
 | 
    %
 | 
 
 | 
 
 | 
    25.4
 | 
 
 | 
    %
 | 
| 
 
    % of Intevac Photonics net revenues
 
 | 
 
 | 
 
 | 
    23.9
 | 
    %
 | 
 
 | 
 
 | 
    35.6
 | 
    %
 | 
 
 | 
 
 | 
    33.0
 | 
    %
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total gross profit
 
 | 
 
 | 
    $
 | 
    87,672
 | 
 
 | 
 
 | 
    $
 | 
    32,720
 | 
 
 | 
 
 | 
    $
 | 
    43,339
 | 
 
 | 
 
 | 
 
 | 
    167.9
 | 
 
 | 
    %
 | 
 
 | 
 
 | 
    (24.5
 | 
    )
 | 
    %
 | 
| 
 
    % of net revenues
 
 | 
 
 | 
 
 | 
    43.3
 | 
    %
 | 
 
 | 
 
 | 
    42.0
 | 
    %
 | 
 
 | 
 
 | 
    39.3
 | 
    %
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Cost of net revenues consists primarily of purchased materials
    and costs attributable to contract research and development, and
    also includes fabrication, assembly, test and installation labor
    and overhead, customer-specific engineering costs, warranty
    costs, royalties, provisions for inventory reserves and scrap.
 
    Equipment gross margin was 47.2% in 2010 compared to 45.3% in
    2009 and 40.9% in 2008. Fiscal 2010 gross margins improved
    over fiscal 2009 due to higher revenues and improved factory
    utilization partially offset by the higher mix of system
    shipments which generally have a lower margin than technology
    upgrades and spare parts. Fiscal 2009 gross margins
    improved over fiscal 2008 due to product mix, improved systems
    margins, and savings from cost reduction programs, which were
    partially offset by lower volume and unabsorbed factory
    utilization. Gross margins in the Equipment business will vary
    depending on a number of additional factors, including product
    mix, product cost, system configuration and pricing, factory
    utilization, and provisions for excess and obsolete inventory.
 
    Intevac Photonics gross margin was 23.9% in 2010 compared 35.6%
    in 2009 and 33.0% in 2008. The decrease in gross margin in 2010
    resulted primarily from lower margins associated with Intevac
    Photonics first high volume digital night vision
    production shipments for a NATO customer, lower margins on
    development contracts and increased warranty provisions.
    Although manufacturing costs for the digital night vision
    product decreased in 2010, Intevac expects to make additional
    cost reductions and yield improvement in 2011. The increase in
    gross margin in 2009 resulted primarily from higher technology
    development margins, higher volume and factory utilization,
    partially offset by higher manufacturing costs of new products.
    
    27
 
    Research
    and development
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
    % Change 
    
 | 
 
 | 
    % Change 
    
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
    2009
 | 
 
 | 
    2008
 | 
 
 | 
    2010 vs. 2009
 | 
 
 | 
    2009 vs. 2008
 | 
| 
 
 | 
 
 | 
    (In thousands, except percentages)
 | 
|  
 | 
| 
 
    Research and development expense
 
 | 
 
 | 
    $
 | 
    27,918
 | 
 
 | 
 
 | 
    $
 | 
    28,064
 | 
 
 | 
 
 | 
    $
 | 
    35,083
 | 
 
 | 
 
 | 
 
 | 
    (0.5
 | 
    ) %
 | 
 
 | 
 
 | 
    (20.0
 | 
    ) %
 | 
| 
 
    % of net revenues
 
 | 
 
 | 
 
 | 
    13.8
 | 
    %
 | 
 
 | 
 
 | 
    36.0
 | 
    %
 | 
 
 | 
 
 | 
    31.8
 | 
    %
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Research and development expense consists primarily of prototype
    materials, salaries and related costs of employees engaged in
    ongoing research, design and development activities for disk
    sputtering equipment, semiconductor equipment, PV cell
    manufacturing equipment and Intevac Photonics products.
 
    Research and development spending decreased for Equipment during
    2010 as compared to 2009 and 2008. The decrease in Equipment
    spending during 2010 and 2009 was due primarily to a reduction
    in spending on semiconductor products, offset by investment in
    PV development. Research and development spending decreased for
    Intevac Photonics during 2010 as compared to 2009 primarily
    related to decreased spending for the digital night vision
    camera module for Intevacs military NATO customer as the
    product transitioned into production. Intevac Photonics
    increased research and development spending levels in 2009 for
    sensor yield improvements, sensor development and digital night
    vision goggle development.
 
    Research and development expenses do not include costs of
    $12.9 million, $9.1 million, and $8.5 million, in
    2010, 2009, and 2008, respectively, which are related to
    customer-funded contract research and development programs and
    included in cost of net revenues.
 
    Selling,
    general and administrative
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
    % Change 
    
 | 
 
 | 
    % Change 
    
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
    2009
 | 
 
 | 
    2008
 | 
 
 | 
    2010 vs. 2009
 | 
 
 | 
    2009 vs. 2008
 | 
| 
 
 | 
 
 | 
    (In thousands, except percentages)
 | 
|  
 | 
| 
 
    Selling, general and administrative expense
 
 | 
 
 | 
    $
 | 
    28,516
 | 
 
 | 
 
 | 
    $
 | 
    22,003
 | 
 
 | 
 
 | 
    $
 | 
    28,229
 | 
 
 | 
 
 | 
 
 | 
    29.6
 | 
    %
 | 
 
 | 
 
 | 
    (22.1
 | 
    ) %
 | 
| 
 
    % of net revenues
 
 | 
 
 | 
 
 | 
    14.1
 | 
    %
 | 
 
 | 
 
 | 
    28.2
 | 
    %
 | 
 
 | 
 
 | 
    25.6
 | 
    %
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Selling, general and administrative expense consists primarily
    of selling, marketing, customer support, financial and
    management costs. All domestic sales and international sales of
    disk sputtering products in Asia, with the exception of Japan,
    are typically made by Intevacs direct sales force, whereas
    sales in Japan of disk sputtering products and other products
    are typically made by Intevacs Japanese distributor,
    Matsubo, which provides services such as sales, installation,
    warranty and customer support. Intevac also has subsidiaries in
    Singapore and in Hong Kong, along with field offices in Malaysia
    and Shenzhen, China to support Intevacs equipment
    customers in Asia.
 
    Selling, general and administrative expenses increased in 2010
    over the amount spent in 2009 due primarily to the result of
    variable compensation, legal expenses associated with the
    auction rate securities (ARS) arbitration and
    transaction costs associated with completing the acquisition of
    SIT, offset in part by lower equity-based compensation expense.
    Selling, general and administrative expenses decreased in 2009
    over the amount spent in 2008 due primarily to the global cost
    reduction plan implemented in the fourth quarter of 2008,
    decreased costs related to customer service and support for the
    Equipment business, partially offset by business development
    expenses in the Intevac Photonics business.
 
    Global
    cost reduction plan
 
    During the fourth quarter of fiscal 2008, Intevac announced a
    global cost reduction plan (the Plan) to reduce the
    global workforce by fifteen percent. Implementation of the Plan
    was completed in the fourth quarter. The total cost of
    implementing the Plan was $386,000 and was reported under cost
    of products sold and operating expenses. Substantially all cash
    outlays in connection with the Plan occurred in the fourth
    quarter of fiscal 2008. Implementation of the Plan reduced
    expenses by approximately $15 million on an annual basis.
    
    28
 
    Impairment
    of goodwill and intangibles
 
    Goodwill and Intevacs indefinite life intangible assets
    are tested for impairment on an annual basis or more frequently
    upon the occurrence of circumstances that indicate that goodwill
    and the indefinite life intangible assets may be impaired. In
    the fourth quarter of 2010, Intevac performed its 2010 annual
    assessment of impairment which did not result in an impairment
    of goodwill or Intevacs indefinite life intangible assets.
    Intevacs reporting units for goodwill impairment testing
    purposes are consistent with the reportable segments: Equipment
    and Intevac Photonics. Intevac tested goodwill for possible
    impairment by first determining the fair value of the related
    reporting unit and then comparing this value to the recorded net
    assets of the reporting unit. At December 31, 2010, Intevac
    had a total of $18.4 million of goodwill and
    $4.1 million of indefinite-life intangible assets. Goodwill
    in the amount of $10.5 million is attributed to the
    Equipment segment. Goodwill in the amount of $7.9 million
    is attributed to the Intevac Photonics segment.
 
    The process of evaluating the potential impairment of goodwill
    is highly subjective and requires significant judgment. Intevac
    used two valuation methodologies to determine the fair value for
    its reporting units, with each approach given equal weighting:
    the income approach and the market approach. Using the income
    approach, the fair value of each reporting unit was calculated
    based on the present value of estimated future cash flows, which
    were formed by evaluating historical trends, current budgets,
    operating plans and industry data. Estimates of the future cash
    flows associated with the businesses are critical to these
    assessments. The assumptions used in the fair value calculation
    included revenue growth rates, operating margins, risk adjusted
    discount rates and future economic and market conditions.
    Changes in these assumptions based on changed economic
    conditions or business strategies could result in material
    impairment charges in future periods. The market approach looked
    at the valuations of comparable public companies which Intevac
    selected based upon similar industries and products. Intevac
    then evaluated the reasonableness of the fair value calculations
    of the reporting units by reconciling the total of the fair
    values of the two reporting units to Intevacs total market
    capitalization, taking into account an appropriate control
    premium. Intevac compared the carrying value of the reporting
    units to the fair value calculations.
 
    The results of the test for goodwill impairment, as of
    October 2, 2010, showed that the estimated fair values of
    the Equipment and Intevac Photonics reporting units exceeded
    their carrying values by more than $75 million and
    $25 million, respectively. There was no impairment of
    goodwill recorded during the years ended December 31, 2010
    and 2009.
 
    Intevac also performed the annual impairment review of a
    tradename, an indefinite life intangible asset during the fourth
    quarter of 2010 using a discounted cash flow model and the
    relief-from-royalty method. Based on the discounted cash flow
    model Intevac determined the fair value of the tradename
    exceeded its carrying value.
 
    In the fourth quarter of fiscal 2008, Intevac experienced a
    significant decline in its stock price and as a result of the
    decline in its stock price, Intevacs market capitalization
    fell significantly below the recorded value of its consolidated
    net assets. Based on the results of its assessment of goodwill
    for impairment, Intevac determined that the fair value of its
    Equipment reporting unit was less than the carrying value and
    that an impairment existed. Therefore, Intevac performed the
    second step of the impairment test to determine the implied fair
    value of goodwill. The analysis indicated that there was no
    remaining implied value attributable to goodwill in the
    Equipment reporting unit and accordingly, during fiscal 2008,
    Intevac wrote off all $9.7 million of goodwill in its
    Equipment reporting unit. The goodwill associated with the
    Intevac Photonics reporting unit was not impaired. As a result
    of the intangible assets impairment test, in fiscal 2008,
    Intevac recorded an $808,000 impairment charge related to the
    write-down to fair value of the net carrying value of certain
    purchased technology intangible assets in the Equipment and
    Intevac Photonics segments due to lower revenue expectations and
    future operating expectations.
 
    Intevac will continue to evaluate the carrying value of goodwill
    and intangible assets and if it is determined that there is a
    potential impairment, Intevac may record additional charges
    which would adversely affect its financial results. For further
    details, see Note 6 of Notes to Consolidated Financial
    Statements.
    
    29
 
    Interest
    income and other, net
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
 
 | 
    2010 vs. 2009
 | 
 
 | 
 
 | 
    2009 vs. 2008
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except percentages)
 | 
 
 | 
|  
 | 
| 
 
    Interest income and other, net
 
 | 
 
 | 
    $
 | 
    773
 | 
 
 | 
 
 | 
    $
 | 
    1,254
 | 
 
 | 
 
 | 
    $
 | 
    3,932
 | 
 
 | 
 
 | 
 
 | 
    (38.4
 | 
    ) %
 | 
 
 | 
 
 | 
    (68.1
 | 
    ) %
 | 
 
    Interest income and other, net in 2010 included $899,000 of
    interest income on investments, a gain of $481,000 related to
    the remeasurement of Intevacs pre-acquisition equity
    interest in SIT at the acquisition-date fair value, partially
    offset by $520,000 of foreign currency losses and $87,000 in net
    other expense. Interest income and other, net in 2009 included
    $1.4 million of interest income on investments and $134,000
    in net other income, partially offset by $226,000 of foreign
    currency losses and $16,000 in interest expense. Interest income
    and other, net in 2008 included $4.0 million of interest
    income on investments, and $84,000 in net other income,
    partially offset by $120,000 in interest expense. The decrease
    in interest income in 2010 was driven by lower interest rates on
    Intevacs investments. The decrease in interest income in
    2009 was driven by lower interest rates on Intevacs
    investments and lower average invested balances.
 
    Provision
    for (benefit from) income taxes
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
 
 | 
    2010 vs. 2009
 | 
 
 | 
 
 | 
    2009 vs. 2008
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except percentages)
 | 
 
 | 
|  
 | 
| 
 
    Provision for (benefit from) income taxes
 
 | 
 
 | 
    $
 | 
    3,962
 | 
 
 | 
 
 | 
    $
 | 
    (6,016
 | 
    )
 | 
 
 | 
    $
 | 
    (11,194
 | 
    )
 | 
 
 | 
 
 | 
    165.9
 | 
    %
 | 
 
 | 
 
 | 
    46.3
 | 
    %
 | 
 
    Intevacs effective income tax provision rate was 12.4% for
    fiscal 2010, 37.4% for fiscal 2009, and 42.2% for fiscal 2008.
    Intevacs tax rate differs from the applicable statutory
    rates due primarily to the utilization of deferred and current
    credits and the effect of permanent differences and adjustments
    of prior permanent differences. Intevacs future effective
    income tax rate depends on various factors including, the level
    of Intevacs projected earnings, the geographic composition
    of worldwide earnings, tax regulations governing each region,
    net operating loss carryforwards, availability of tax credits
    and the effectiveness of Intevacs tax planning strategies.
    Management carefully monitors these factors and timely adjusts
    the effective income tax rate accordingly. Management believes
    that the valuation allowances for Intevacs deferred tax
    assets are adequate based on several factors including:
    (1) degree to which Intevacs 2009 and 2008 losses
    were attributable to unusual items or charges; (2) long
    duration of Intevacs deferred tax assets; and
    (3) expectation of improved earnings in the long term.
 
    Intevac enjoys a tax holiday in Singapore through the tax years
    ending in 2015. The tax holiday provides a lower income tax rate
    on certain classes of income and the agreement requires that
    certain thresholds of business investment and employment levels
    be met in Singapore in order to maintain this holiday.
 
    During 2009, Intevac established an additional valuation
    allowance to fully reserve its California state deferred tax
    assets due to the impact of California tax legislation that was
    enacted in February 2009. This additional valuation allowance
    decreased the income tax benefit by $1.0 million. Intevac
    recognized the effect of the change in valuation allowance as a
    discrete item.
 
    Business
    Combinations
 
    On November 19, 2010, Intevac acquired the outstanding
    shares of Solar Implant Technologies, Inc. (SIT), a
    privately-owned, development stage company, creating an ion
    implant module to be used in the manufacturing of photovoltaic
    cells. Intevacs primary reasons for this acquisition were
    to complement its existing product offerings and to provide
    opportunities for future growth. The preliminary aggregate
    purchase price was $12.4 million, which consisted of an
    initial cash payment totaling $2.7 million and contingent
    consideration obligations with a fair value of $9.7 million
    payable in cash based on the achievement of certain product
    development milestones achieved over a specified period and
    revenue earnout on Intevacs net revenue from commercial
    sales of certain products achieved over a specified period.
    
    30
 
    On July 14, 2008, Intevac acquired certain assets and
    liabilities of OC Oerlikon Balzers Ltd.
    (Oerlikon)s magnetic media equipment business
    for a purchase price of $15.1 million in cash, net of cash
    acquired. In addition Intevac agreed to pay contingent
    consideration to Oerlikon in the form of a royalty on
    Intevacs net revenue from commercial sales of certain
    products. This agreement terminates on July 13, 2011.
    Intevac has made no payments to Oerlikon under this agreement
    through December 31, 2010. As part of the acquisition,
    Intevac also entered into a settlement agreement with Oerlikon
    related to a patent infringement lawsuit filed by Intevac
    against Unaxis USA, Inc., a wholly owned subsidiary of Oerlikon,
    and all claims in the litigation were dismissed.
 
    For further details, see Note 7 of Notes to Consolidated
    Financial Statements.
 
    Recent
    Accounting Pronouncements
 
    In January 2009, the Securities and Exchange Commission
    (SEC) issued Release
    No. 33-9002,
    Interactive Data to Improve Financial Reporting. The
    final rule requires companies to provide their financial
    statements and financial statement schedules to the SEC and on
    their corporate websites in interactive data format using the
    eXtensible Business Reporting Language (XBRL). The
    rule was adopted by the SEC to improve the ability of financial
    statement users to access and analyze financial data. The SEC
    adopted a phase-in schedule indicating when registrants must
    furnish interactive data. Under this schedule, Intevac will be
    required to submit filings with financial statement information
    using XBRL commencing with its July 2, 2011 quarterly
    report on
    Form 10-Q.
    Intevac is currently evaluating the impact of XBRL reporting on
    its financial reporting process.
 
    In December 2010, the Financial Accounting Standards Board
    (FASB) issued Accounting Standards Update
    (ASU)
    2010-29,
    Business Combinations (Topic 805): Disclosure of
    Supplementary Pro Forma Information for Business
    Combinations. For business combinations that are material
    on an individual or aggregate basis the amendment requires that
    comparative financial statements be presented and revenue and
    earnings of the combined entity be disclosed as though the
    business combination(s) that occurred during the current year
    had occurred as of the beginning of the comparable prior annual
    reporting period. The amendment also expands the supplemental
    pro forma disclosures to include a description of the nature and
    amount of material, nonrecurring pro forma adjustments directly
    attributable to the business combination included in the
    reported pro forma revenue and earnings. The amendment is
    effective prospectively for business combinations for which the
    acquisition date is on or after the beginning of the first
    annual reporting period beginning on or after December 15,
    2010. The adoption of the
    ASU 2010-29
    will not have material impact to the financial statements of the
    Company.
 
    Liquidity
    and Capital Resources
 
    At December 31, 2010, Intevac had $137.4 million in
    cash, cash equivalents, and investments compared to
    $89.8 million at December 31, 2009. During fiscal
    2010, cash, cash equivalents and investments increased by
    $47.5 million due primarily to cash provided by operating
    activities and cash received from the sale of Intevac common
    stock to employees through employee benefit plans, partially
    offset by purchases of fixed assets and cash used in the
    acquisition of SIT.
 
    Cash, cash equivalents and investments consist of the following:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31, 
    
 | 
 
 | 
 
 | 
    December 31, 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Cash and cash equivalents
 
 | 
 
 | 
    $
 | 
    109,520
 | 
 
 | 
 
 | 
    $
 | 
    17,592
 | 
 
 | 
| 
 
    Short-term investments
 
 | 
 
 | 
 
 | 
    4,994
 | 
 
 | 
 
 | 
 
 | 
    6,000
 | 
 
 | 
| 
 
    Long-term investments
 
 | 
 
 | 
 
 | 
    22,866
 | 
 
 | 
 
 | 
 
 | 
    66,249
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total cash, cash-equivalents and investments
 
 | 
 
 | 
    $
 | 
    137,380
 | 
 
 | 
 
 | 
    $
 | 
    89,841
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Cash generated by operating activities totaled
    $51.3 million in 2010. Cash used by operating activities
    totaled $16.6 million in 2009 and $8.2 million in
    2008. Higher operating cash flow was a result of net income
    adjusted to exclude the effect of non-cash charges including,
    depreciation, amortization and equity-based compensation. This
    increase in cash from operating activities was also affected by
    changes in working capital. Intevac continues to carefully
    manage working capital.
    
    31
 
    Accounts receivable totaled $25.9 million at
    December 31, 2010 compared to $44.8 million at
    December 31, 2009. The number of days outstanding for
    Intevacs accounts receivable was 62 at December 31,
    2010 compared to 136 at December 31, 2009. The decrease in
    the receivable balance and days outstanding was due primarily to
    collection of customer deposit invoices which were outstanding
    at the end of the prior year and collection of systems
    receivables. Net inventories increased by $1.6 million
    during 2010 primarily as a result of increased business levels.
    Inventory turns were 5.8 in fiscal 2010 compared to 2.5 in
    fiscal 2009. Accounts payable totaled $5.6 million at
    December 31, 2010 compared to $4.7 million at
    December 31, 2009. The increase of $861,000 relates to the
    increase in inventory purchases as a result of increased
    business levels. Accrued payroll and related liabilities
    increased by $8.6 million during 2010 to $11.4 million
    primarily related to bonus and profit sharing accruals. Customer
    advances decreased from $13.2 million at December 31,
    2009 to $4.9 million at December 31, 2010, as
    liquidations related to revenue recognition were higher than new
    advances received from customers.
 
    Investing activities generated cash of $37.7 million in
    2010, used cash of $4.1 million in 2009, and generated cash
    of $19.6 million in 2008. In 2010, proceeds from sales and
    maturities of investments, net of purchases, totaled
    $47.4 million. In 2009, purchases of investments, net of
    proceeds from sales and maturities, totaled $1.5 million.
    In 2008, proceeds from maturities of investments, net of
    purchases, totaled $38.9 million. During 2010, Intevac
    acquired the outstanding shares of SIT for a preliminary
    aggregate purchase price of $12.4 million, which consisted
    of an initial cash payment totaling $2.7 million and a
    contingent consideration obligation with a fair value of
    $9.7 million payable in cash. During 2008, Intevac invested
    $15.1 million in the acquisition of certain assets from
    Oerlikon. Capital expenditures totaled $7.1 million in 2010
    compared to $2.6 million in 2009 and $4.2 million in
    2008.
 
    Financing activities generated cash of $2.9 million in
    2010, used cash of $809,000 in 2009 and generated cash of
    $165,000 in 2008. The sale of Intevac common stock to
    Intevacs employees through Intevacs employee benefit
    plans provided $2.8 million in 2010, $1.1 million in
    2009, and $1.8 million in 2008. Subsequent to the
    SIT acquisition, Intevac paid in full $177,000 in notes
    payable to certain selling shareholders assumed upon the
    acquisition. In 2009 and 2008, Intevac made scheduled payments
    of $2.0 million each to the former owners of DeltaNu.
 
    As of December 31, 2010, Intevacs
    available-for-sale
    securities included $10.9 million par value of ARS, less a
    temporary valuation adjustment of $627,000 to reflect their
    current lack of liquidity. Management believes that the
    impairment of the ARS investments is temporary. Due to market
    conditions, these investments have experienced failed auctions
    beginning in mid-February 2008. These failed auctions result in
    a lack of liquidity in the securities, but do not affect the
    underlying collateral of the securities. Intevac does not
    anticipate that any potential lack of liquidity in these ARS
    will affect its ability to finance its operations and planned
    capital expenditures. Intevac continues to monitor efforts by
    the financial markets to find alternative means for restoring
    the liquidity of these investments. These investments are
    classified as non-current assets until Intevac has better
    visibility as to when their liquidity will be restored. The
    classification and valuation of these securities will continue
    to be reviewed quarterly. During 2010, including the Citigroup
    repurchase of securities discussed below, $59.1 million of
    ARS were redeemed at par.
 
    As described in Note 8 of Notes to Consolidated Financial
    Statements, at December 31, 2010, the fair value of the ARS
    was estimated at $10.3 million based on a valuation by
    Houlihan Capital Advisors, LLC, using discounted cash flow
    models and applying managements internal analysis to the
    valuation. The estimates of future cash flows are based on
    certain key assumptions, such as discount rates appropriate for
    the type of asset and risk, which are significant unobservable
    inputs. As of December 31, 2010, there was insufficient
    observable market information for the ARS held by Intevac to
    determine the fair value. Therefore Level 3 fair values
    were estimated for these securities by incorporating assumptions
    that market participants would use in their estimates of fair
    value. Some of these assumptions included credit quality,
    collateralization, final stated maturity, estimates of the
    probability of being called or becoming liquid prior to final
    maturity, redemptions of similar ARS, previous market activity
    for the same investment security, impact due to extended periods
    of maximum auction rates and valuation models.
 
    On March 19, 2009, Intevac filed a statement of claim under
    the Financial Industry Regulatory Authority dispute resolution
    process against Citigroup Inc. and Citigroup Global Markets,
    Inc. (collectively, Citigroup) with respect to
    alleged fraud and market manipulation by Citigroup related to
    ARS held at that time. The statement of
    
    32
 
    claim requested that Citigroup accept Intevacs tender of
    its ARS at par value and that Intevac receive compensatory,
    consequential and punitive damages and costs and expenses.
    Citigroup responded denying Intevacs claims. The
    arbitration proceedings were completed on June 10, 2010. On
    June 29, 2010, Intevac received a favorable ruling from the
    arbitration panel whereby Citigroup was ordered to rescind the
    sale of the $54.8 million par value in outstanding ARS
    investments. On July 27, 2010, Intevac received
    $54.8 million from the repurchase of the securities by
    Citigroup at par including interest and recognized the reversal
    of a $3.3 million temporary impairment charge in other
    comprehensive income.
 
    Intevac believes that Intevacs existing cash, cash
    equivalents and investments will be sufficient to meet
    Intevacs cash requirements for the next 12 months.
    Intevac intends to undertake approximately $5 
    $6 million in capital expenditures during the next
    12 months.
 
    Contractual
    Obligations
 
    The following table summarizes Intevacs contractual
    obligations as of December 31, 2010:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Payments Due by Period
 | 
 
 | 
| 
 
 | 
 
 | 
    Total
 | 
 
 | 
 
 | 
    < 1 Year
 | 
 
 | 
 
 | 
    1-3 Years
 | 
 
 | 
 
 | 
    3-5 Years
 | 
 
 | 
 
 | 
    > 5 Years
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Operating lease obligations
 
 | 
 
 | 
    $
 | 
    11,699
 | 
 
 | 
 
 | 
    $
 | 
    2,596
 | 
 
 | 
 
 | 
    $
 | 
    4,017
 | 
 
 | 
 
 | 
    $
 | 
    3,094
 | 
 
 | 
 
 | 
    $
 | 
    1,992
 | 
 
 | 
| 
 
    Purchase obligations and commitments(1)
 
 | 
 
 | 
 
 | 
    9,664
 | 
 
 | 
 
 | 
 
 | 
    9,664
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Other long-term liabilities(2, 4)
 
 | 
 
 | 
 
 | 
    1,909
 | 
 
 | 
 
 | 
 
 | 
    1,909
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total(3, 4)
 
 | 
 
 | 
    $
 | 
    23,272
 | 
 
 | 
 
 | 
    $
 | 
    14,169
 | 
 
 | 
 
 | 
    $
 | 
    4,017
 | 
 
 | 
 
 | 
    $
 | 
    3,094
 | 
 
 | 
 
 | 
    $
 | 
    1,992
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 
     | 
     | 
     | 
    | 
    (1)  | 
     | 
    
    Purchase obligations include agreements to purchase goods or
    services that are enforceable and legally binding on Intevac and
    that specify all significant terms, including fixed or minimum
    quantities to be purchased; fixed, minimum or variable price
    provisions; and the approximate timing of the transaction.
    Purchase obligations exclude agreements that are cancelable
    without penalty. These purchase obligations are related
    principally to inventory and other items. | 
|   | 
    | 
    (2)  | 
     | 
    
    Intevac is unable to reliably estimate the timing of future
    payments related to uncertain tax positions; therefore,
    $4.5 million of unrecognized tax benefits has been excluded
    from the table above. | 
|   | 
    | 
    (3)  | 
     | 
    
    Total excludes contractual obligations already recorded on the
    consolidated balance sheet as current liabilities (except other
    long-term liabilities) and certain purchase obligations. | 
|   | 
    | 
    (4)  | 
     | 
    
    Total excludes contingent consideration that may be paid
    pursuant to asset purchases or business combinations. | 
 
    Off-Balance
    Sheet Arrangements
 
    As of December 31, 2010, Intevac did not have any material
    off-balance sheet arrangements (as defined in
    Item 303(a)(4)(ii) of
    Regulation S-K).
 
    Critical
    Accounting Policies
 
    The preparation of consolidated financial statements and related
    disclosures in conformity with accounting principles generally
    accepted in the United States of America requires management to
    make judgments, assumptions and estimates that affect the
    amounts reported. Note 1 of Notes to Consolidated Financial
    Statements describes the significant accounting policies used in
    the preparation of the consolidated financial statements.
    Certain of these significant accounting policies are considered
    to be critical accounting policies.
 
    A critical accounting policy is defined as one that is both
    material to the presentation of Intevacs consolidated
    financial statements and requires management to make difficult,
    subjective or complex judgments that could have a material
    effect on Intevacs financial condition or results of
    operations. Specifically, these policies have the following
    attributes: (1) Intevac is required to make assumptions
    about matters that are highly uncertain at the time of the
    estimate; and (2) different estimates Intevac could
    reasonably have used, or changes in the estimate that are
    reasonably likely to occur, would have a material effect on
    Intevacs financial condition or results of operations.
    
    33
 
    Estimates and assumptions about future events and their effects
    cannot be determined with certainty. Intevac bases its estimates
    on historical experience and on various other assumptions
    believed to be applicable and reasonable under the
    circumstances. These estimates may change as new events occur,
    as additional information is obtained and as Intevacs
    operating environment changes. These changes have historically
    been minor and have been included in the consolidated financial
    statements as soon as they became known. In addition, management
    is periodically faced with uncertainties, the outcomes of which
    are not within its control and will not be known for prolonged
    periods of time. These uncertainties are discussed in the
    section above entitled Risk Factors. Based on a
    critical assessment of its accounting policies and the
    underlying judgments and uncertainties affecting the application
    of those policies, management believes that Intevacs
    consolidated financial statements are fairly stated in
    accordance with accounting principles generally accepted in the
    United States of America, and provide a meaningful presentation
    of Intevacs financial condition and results of operations.
 
    Management believes that the following are critical accounting
    policies:
 
    Revenue
    Recognition
 
    Intevac recognizes revenue when persuasive evidence of an
    arrangement exists, delivery has occurred and title and risk of
    loss have passed to Intevacs customer or services have
    been rendered, the price is fixed or determinable, and
    collectibility is reasonably assured. Intevacs shipping
    terms are customarily FOB shipping point or equivalent terms.
    Intevacs revenue recognition policy generally results in
    revenue recognition at the following points: (1) for all
    transactions where legal title passes to the customer upon
    shipment, Intevac recognizes revenue upon shipment for all
    products that have been demonstrated to meet product
    specifications prior to shipment; the portion of revenue
    associated with certain installation-related tasks is deferred,
    and that revenue is recognized upon completion of the
    installation-related tasks; (2) for products that have not
    been demonstrated to meet product specifications prior to
    shipment, revenue is recognized at customer acceptance; and
    (3) for arrangements containing multiple elements, the
    revenue relating to the undelivered elements is deferred until
    delivery of the deferred elements. When a sales arrangement
    contains multiple elements, Intevac allocates revenue to each
    element based on a selling price hierarchy. The selling price
    for a deliverable is based on its vendor specific evidence
    (VSOE) if available, third party evidence
    (TPE) if VSOE is not available, or best estimate of
    selling price (ESP) if neither VSOE nor TPE is
    available. Intevac generally utilizes the ESP due to the nature
    of its products. In certain cases, technology upgrade sales are
    accounted for as multiple-element arrangements, usually split
    between delivery of the parts and installation on the
    customers systems. In these cases, Intevac recognizes
    revenue for the relative sales price of the parts upon shipment
    and transfer of title, and recognizes revenue for the relative
    sales price of installation services when those services are
    completed. Revenue related to sales of spare parts is generally
    recognized upon shipment. Revenue related to services is
    generally recognized upon completion of the services. In
    addition, Intevac uses the installment method to record revenue
    based on cash receipts in situations where the account
    receivable is collected over an extended period of time and in
    managements judgment the degree of collectibility is
    uncertain.
 
    Intevac performs research and development work under various
    government-sponsored research contracts. Revenue on
    cost-plus-fee contracts is recognized to the extent of costs
    actually incurred plus a proportionate amount of the fee earned.
    Intevac considers fixed fees under cost-plus-fee contracts to be
    earned in proportion to the allowable costs actually incurred in
    performance of the contract. Revenue on fixed-price contracts is
    recognized on a milestone method or
    percentage-of-completion
    method of contract accounting. For contracts structured as
    milestone agreements, revenue is recognized when a specified
    milestone is achieved, provided that (1) the milestone
    event is substantive in nature and there is substantial
    uncertainty about the achievement of the milestone at the
    inception of the agreement, (2) the milestone payment is
    non-refundable, and (3) there is no continuing performance
    obligations associated with the milestone payment. Any milestone
    payments received prior to satisfying these revenue recognition
    criteria are deferred. Intevac generally determines the
    percentage completed based on the percentage of costs incurred
    to date in relation to total estimated costs expected through
    completion of the contract. When estimates of total costs to be
    incurred on a contract exceed estimates of total revenue to be
    earned, a provision for the entire loss on the contract is
    recorded in the period the loss is determined.
    
    34
 
    Inventories
 
    Inventories are valued using average actual costs and are stated
    at the lower of cost or market. The carrying value of inventory
    is reduced for estimated obsolescence by the difference between
    its cost and the estimated market value based upon assumptions
    about future demand. Intevac evaluates the inventory carrying
    value for potential excess and obsolete inventory exposures by
    analyzing historical and anticipated demand. In addition,
    inventories are evaluated for potential obsolescence due to the
    effect of known and anticipated engineering change orders and
    new products. If actual demand were to be substantially lower
    than estimated, additional inventory adjustments for excess or
    obsolete inventory might be required, which could have a
    material adverse effect on Intevacs business, financial
    condition and results of operations.
 
    Warranty
 
    Intevac estimates the costs that may be incurred under the
    warranty it provides and records a liability in the amount of
    such costs at the time the related revenue is recognized.
    Estimated warranty costs are determined by analyzing specific
    product and historical configuration statistics and regional
    warranty support costs. Intevacs warranty obligation is
    affected by product failure rates, material usage, and labor
    costs incurred in correcting product failures during the
    warranty period. As Intevacs customer service engineers
    and process support engineers are highly trained and deployed
    globally, labor availability is a significant factor in
    determining labor costs. The quantity and availability of
    critical replacement parts is another significant factor in
    estimating warranty costs. Unforeseen component failures or
    exceptional component performance can also result in changes to
    warranty costs. If actual warranty costs differ substantially
    from our estimates, revisions to the estimated warranty
    liability would be required.
 
    Income
    Taxes
 
    Intevac accounts for income taxes by recognizing deferred tax
    assets and liabilities using statutory tax rates for the effect
    of temporary differences between the book and tax bases of
    recorded assets and liabilities, net operating losses and tax
    credit carryforwards. Deferred tax assets are also reduced by a
    valuation allowance if it is more likely than not that a portion
    of the deferred tax asset will not be realized. Management has
    determined that it is more likely than not that its future
    taxable income will be sufficient to realize its deferred tax
    assets.
 
    The effective tax rate is highly dependent upon the geographic
    composition of worldwide earnings, tax regulations governing
    each region, non-tax deductible expenses and availability of tax
    credits. Management carefully monitors the changes in many
    factors and adjusts the effective income tax rate as required.
    If actual results differ from these estimates, Intevac could be
    required to record a valuation allowance on deferred tax assets
    or adjust its effective income tax rate, which could have a
    material adverse effect on Intevacs business, financial
    condition and results of operations.
 
    The calculation of tax liabilities involves significant judgment
    in estimating the impact of uncertainties in the application of
    complex tax laws. Resolution of these uncertainties in a manner
    inconsistent with Intevacs expectations could have a
    material impact on Intevacs results of operations and
    financial condition.
 
    Valuation
    of IPR&D, Contingent Consideration, Goodwill and Other
    Intangible Assets
 
    The purchase price of an acquired business is allocated, as
    applicable, between in-process research and development
    (IPR&D), other identifiable intangible assets,
    net tangible assets and goodwill. IPR&D is defined as the
    value assigned to those projects for which the related products
    have no alternative future use. Determining the portion of the
    purchase price allocated to IPR&D and other intangible
    assets requires the Company to make significant estimates. The
    amount of the purchase price allocated to IPR&D and other
    intangible assets is determined by estimating the future cash
    flows of each project or technology and discounting the net cash
    flows back to their present values. The discount rate used is
    determined at the time of the acquisition in accordance with
    accepted valuation methods. For IPR&D, these valuation
    methodologies include consideration of the risk of the project
    not achieving commercial feasibility.
    
    35
 
    Contingent consideration is recorded at the acquisition date at
    the estimated fair value of the contingent payments. The
    acquisition date fair value is measured based on the
    consideration expected to be transferred (probability-weighted),
    discounted back to present value. The discount rate used is
    determined at the time of the acquisition in accordance with
    accepted valuation methods. The fair value of the contingent
    consideration is remeasured at the estimated fair value at each
    reporting period with the change in fair value recognized as
    income or expense in the consolidated statements of operations.
 
    Goodwill represents the excess of the aggregate purchase price
    over the fair value of net assets, including IPR&D, of
    acquired businesses. Intevacs methodology for allocating
    the purchase price relating to purchase acquisitions is
    determined through established and generally accepted valuation
    techniques. Goodwill is measured as the excess of the cost of
    the acquisition over the sum of the amounts assigned to tangible
    and identifiable intangible assets acquired less liabilities
    assumed. Intevac assigns assets acquired (including goodwill)
    and liabilities assumed to a reporting unit as of the date of
    acquisition.
 
    Goodwill and purchased intangible assets with indefinite useful
    lives are not amortized, but are reviewed for impairment
    annually during the fourth quarter of each fiscal year and
    whenever events or changes in circumstances indicate that the
    carrying value of an asset may not be recoverable. For goodwill,
    Intevac performs a two-step impairment test. In the first step,
    Intevac compares the fair value of each reporting unit to its
    carrying value. Intevacs reporting units are consistent
    with the reportable segments identified in Note 12, based
    on the manner in which Intevac operates its business and the
    nature of those operations. Depending on the facts and
    circumstances Intevac determines the fair value of each of its
    reporting units based upon the most appropriate valuation
    technique using the income approach, the market approach or a
    combination thereof. The income and market approaches were
    selected as management believes these approaches generally
    provide the most reliable indications of fair value when the
    value of the operations is more dependent on the ability to
    generate earnings than on the value of the assets used in the
    production process. Under the income approach Intevac calculates
    the fair value of the reporting units based on the present value
    of estimated future cash flows. Under the market approach
    Intevac estimates the fair value based on market multiples of
    revenue or earnings for comparable companies. Each valuation
    technique has advantages and drawbacks, which must be considered
    when applying those techniques. The income approach closely
    correlates to managements expectations of future results
    but requires significant assumptions which can be highly
    sensitive. The market approach is relatively straightforward to
    measure, but it may be difficult to find directly comparable
    companies in the marketplace. If the fair value of the reporting
    unit exceeds the carrying value of the net assets assigned to
    that unit, goodwill is not impaired and no further testing is
    performed. If the carrying value of the net assets assigned to
    the reporting unit exceeds the fair value of the reporting unit,
    then Intevac would perform the second step of the impairment
    test in order to determine the implied fair value of the
    reporting units goodwill. If the carrying value of a
    reporting units goodwill exceeds its implied fair value,
    Intevac would record an impairment loss equal to the difference.
    In the fourth quarter of 2008, Intevac recorded an impairment
    charge of $10.5 million for goodwill and purchased
    technology intangible assets due to a decline in market value
    and lower revenue expectations in light of current operating
    performance and future operating expectations. No impairment
    charges were recognized in fiscal 2009 and 2010.
 
    Equity-Based
    Compensation
 
    Intevac records compensation expense for equity-based awards
    under Accounting Standards Codification (ASC) 718,
    Compensation-Stock Compensation, using the
    Black-Scholes option pricing model. This model requires Intevac
    to estimate the expected volatility of the price of
    Intevacs common stock and the expected life of the
    equity-based awards. ASC 718 also requires forfeiture
    estimates of equity-based awards. Estimating volatility,
    expected life and forfeitures requires significant judgment and
    an analysis of historical data. Intevac may have to increase or
    decrease compensation expense for equity-based awards if actual
    results differ significantly from Intevacs estimates.
    
    36
 
 
     | 
     | 
    | 
    Item 7A.  
 | 
    
    Quantitative
    and Qualitative Disclosures About Market Risk
 | 
 
    Interest rate risk.  Intevacs exposure to
    market risk for changes in interest rates relates primarily to
    Intevacs investment portfolio. Intevac does not use
    derivative financial instruments in Intevacs investment
    portfolio. Intevac places investments with high quality credit
    issuers and, by policy, limits the amount of credit exposure to
    any one issuer. Investments typically consist of commercial
    paper, obligations of the U.S. government and its agencies,
    corporate debt securities and ARS.
 
    The table below presents principal amounts and related
    weighted-average interest rates by year of maturity for
    Intevacs investment portfolio at December 31, 2010.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Fair 
    
 | 
| 
 
 | 
 
 | 
    2011
 | 
 
 | 
    2012
 | 
 
 | 
    2013
 | 
 
 | 
    Beyond
 | 
 
 | 
    Total
 | 
 
 | 
    Value
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
    (In thousands, except percentages)
 | 
|  
 | 
| 
 
    Cash equivalents
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Fixed rate amounts
 
 | 
 
 | 
    $
 | 
    4,258
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    4,258
 | 
 
 | 
 
 | 
    $
 | 
    4,257
 | 
 
 | 
| 
 
    Weighted-average rate
 
 | 
 
 | 
 
 | 
    1.81
 | 
    %
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Variable rate amounts
 
 | 
 
 | 
    $
 | 
    82,376
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    82,376
 | 
 
 | 
 
 | 
    $
 | 
    82,376
 | 
 
 | 
| 
 
    Weighted-average rate
 
 | 
 
 | 
 
 | 
    0.12
 | 
    %
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Short-term investments
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Fixed rate amounts
 
 | 
 
 | 
    $
 | 
    4,994
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    4,994
 | 
 
 | 
 
 | 
    $
 | 
    4,994
 | 
 
 | 
| 
 
    Weighted-average rate
 
 | 
 
 | 
 
 | 
    0.33
 | 
    %
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Long-term investments
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Fixed rate amounts
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    12,593
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    10,900
 | 
 
 | 
 
 | 
    $
 | 
    23,493
 | 
 
 | 
 
 | 
    $
 | 
    22,866
 | 
 
 | 
| 
 
    Weighted-average rate
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    3.31
 | 
    %
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    1.64
 | 
    %
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total investment portfolio
 
 | 
 
 | 
    $
 | 
    91,628
 | 
 
 | 
 
 | 
    $
 | 
    12,593
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    10,900
 | 
 
 | 
 
 | 
    $
 | 
    115,121
 | 
 
 | 
 
 | 
    $
 | 
    114,493
 | 
 
 | 
 
    At December 31, 2010, Intevac held investments in ARS. With
    the liquidity issues experienced in global credit and capital
    markets, Intevacs ARS have experienced multiple failed
    auctions. Intevac continues to earn interest at the maximum
    contractual rate for each security. The estimated values of the
    ARS held by Intevac are no longer at par. As of
    December 31, 2010, Intevac had $10.3 million in ARS in
    the consolidated balance sheet, which is net of a temporary
    unrealized loss of $627,000. Management believes that the
    impairment of the ARS investments is temporary, primarily due to
    the government guarantee of the underlying securities and
    Intevacs ability to hold the ARS for the foreseeable
    future. Management believes that it is more likely than not that
    it would not be required to sell these securities before the
    recovery of their par amounts. The unrealized loss is included
    in other comprehensive income (loss).
 
    Intevac continues to monitor the market for ARS and consider its
    impact (if any) on the fair market value of its investments. If
    the current market conditions continue, or the anticipated
    recovery in market values does not occur, Intevac may be
    required to record additional unrealized losses or record an
    other-than-temporary
    impairment charge in 2011.
 
    Based on Intevacs ability to access its cash, its expected
    operating cash flows, and other sources of cash, Intevac does
    not anticipate that the lack of liquidity of these investments
    will affect Intevacs ability to operate its business in
    the ordinary course.
 
    Foreign exchange risk.  From time to time,
    Intevac enters into foreign currency forward exchange contracts
    to economically hedge certain of Intevacs anticipated
    foreign currency transaction, translation and re-measurement
    exposures. The objective of these contracts is to minimize the
    impact of foreign currency exchange rate movements on
    Intevacs operating results. Intevac had no foreign
    currency forward exchange contracts during any of the years
    ended December 31, 2010, 2009 and 2008.
    
    37
 
 
     | 
     | 
    | 
    Item 8.  
 | 
    
    Financial
    Statements and Supplementary Data
 | 
 
    INTEVAC,
    INC.
    
 
    CONSOLIDATED
    FINANCIAL STATEMENTS
 
    Contents
 
    
    38
 
 
    REPORT OF
    INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
    Board of Directors and Stockholders
    Intevac, Inc.
 
    We have audited the accompanying consolidated balance sheets of
    Intevac, Inc. (a Delaware corporation) and subsidiaries
    (collectively, the Company) as of December 31,
    2010 and 2009, and the related consolidated statements of
    operations, stockholders equity and comprehensive income
    (loss), and cash flows for each of the three years in the period
    ended December 31, 2010. Our audits of the basic financial
    statements included the financial statement schedule listed in
    the index appearing under Item 15(a)(2). These financial
    statements and financial statement schedule are the
    responsibility of the Companys management. Our
    responsibility is to express an opinion on these financial
    statements and financial statement schedule based on our audits.
 
    We conducted our audits in accordance with the standards of the
    Public Company Accounting Oversight Board (United States). Those
    standards require that we plan and perform the audit to obtain
    reasonable assurance about whether the financial statements are
    free of material misstatement. An audit includes examining, on a
    test basis, evidence supporting the amounts and disclosures in
    the financial statements. An audit also includes assessing the
    accounting principles used and significant estimates made by
    management, as well as evaluating the overall financial
    statement presentation. We believe that our audits provide a
    reasonable basis for our opinion.
 
    In our opinion, the consolidated financial statements referred
    to above present fairly, in all material respects, the financial
    position of Intevac, Inc. and subsidiaries as of
    December 31, 2010 and 2009 and the results of their
    operations and their cash flows for each of the three years in
    the period ended December 31, 2010 in conformity with
    accounting principles generally accepted in the United States of
    America. Also in our opinion, the related financial statement
    schedule, when considered in relation to the basic financial
    statements taken as a whole, presents fairly, in all material
    respects, the information set forth therein.
 
    We also have audited, in accordance with the standards of the
    Public Company Accounting Oversight Board (United States), the
    Companys internal control over financial reporting as of
    December 31, 2010, based on criteria established in
    Internal Control  Integrated Framework issued
    by the Committee of Sponsoring Organizations of the Treadway
    Commission (COSO) and our report dated February 25, 2011
    expressed an unqualified opinion on the effectiveness of the
    Companys internal control over financial reporting.
 
    /s/ GRANT THORNTON LLP
 
    San Jose, California
    February 25, 2011
    
    39
 
    INTEVAC,
    INC.
    
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except par value)
 | 
 
 | 
|  
 | 
| 
 
    ASSETS
 
 | 
| 
 
    Current assets:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Cash and cash equivalents
 
 | 
 
 | 
    $
 | 
    109,520
 | 
 
 | 
 
 | 
    $
 | 
    17,592
 | 
 
 | 
| 
 
    Short-term investments
 
 | 
 
 | 
 
 | 
    4,994
 | 
 
 | 
 
 | 
 
 | 
    6,000
 | 
 
 | 
| 
 
    Trade, notes and other accounts receivable, net of allowances of
    $55 and $133 at December 31, 2010 and 2009, respectively
 
 | 
 
 | 
 
 | 
    25,911
 | 
 
 | 
 
 | 
 
 | 
    44,756
 | 
 
 | 
| 
 
    Inventories
 
 | 
 
 | 
 
 | 
    20,671
 | 
 
 | 
 
 | 
 
 | 
    19,100
 | 
 
 | 
| 
 
    Prepaid expenses and other current assets
 
 | 
 
 | 
 
 | 
    6,630
 | 
 
 | 
 
 | 
 
 | 
    6,687
 | 
 
 | 
| 
 
    Deferred income tax assets
 
 | 
 
 | 
 
 | 
    3,124
 | 
 
 | 
 
 | 
 
 | 
    1,515
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total current assets
 
 | 
 
 | 
 
 | 
    170,850
 | 
 
 | 
 
 | 
 
 | 
    95,650
 | 
 
 | 
| 
 
    Property, plant and equipment, net
 
 | 
 
 | 
 
 | 
    13,918
 | 
 
 | 
 
 | 
 
 | 
    12,351
 | 
 
 | 
| 
 
    Long-term investments
 
 | 
 
 | 
 
 | 
    22,866
 | 
 
 | 
 
 | 
 
 | 
    66,249
 | 
 
 | 
| 
 
    Goodwill
 
 | 
 
 | 
 
 | 
    18,389
 | 
 
 | 
 
 | 
 
 | 
    7,905
 | 
 
 | 
| 
 
    Other intangible assets, net of amortization of $1,801 and
    $1,248 at December 31, 2010 and 2009, respectively
 
 | 
 
 | 
 
 | 
    6,984
 | 
 
 | 
 
 | 
 
 | 
    3,537
 | 
 
 | 
| 
 
    Deferred income taxes and other long-term assets
 
 | 
 
 | 
 
 | 
    18,764
 | 
 
 | 
 
 | 
 
 | 
    17,686
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total assets
 
 | 
 
 | 
    $
 | 
    251,771
 | 
 
 | 
 
 | 
    $
 | 
    203,378
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
| 
    LIABILITIES AND STOCKHOLDERS EQUITY
 | 
| 
 
    Current liabilities:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Accounts payable
 
 | 
 
 | 
    $
 | 
    5,562
 | 
 
 | 
 
 | 
    $
 | 
    4,701
 | 
 
 | 
| 
 
    Accrued payroll and related liabilities
 
 | 
 
 | 
 
 | 
    11,365
 | 
 
 | 
 
 | 
 
 | 
    2,784
 | 
 
 | 
| 
 
    Other accrued liabilities
 
 | 
 
 | 
 
 | 
    11,104
 | 
 
 | 
 
 | 
 
 | 
    11,104
 | 
 
 | 
| 
 
    Customer advances
 
 | 
 
 | 
 
 | 
    4,867
 | 
 
 | 
 
 | 
 
 | 
    13,180
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total current liabilities
 
 | 
 
 | 
 
 | 
    32,898
 | 
 
 | 
 
 | 
 
 | 
    31,769
 | 
 
 | 
| 
 
    Other long-term liabilities
 
 | 
 
 | 
 
 | 
    11,630
 | 
 
 | 
 
 | 
 
 | 
    252
 | 
 
 | 
| 
 
    Commitments and contingencies
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Stockholders equity:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Undesignated preferred stock, $0.001 par value,
    10,000 shares authorized, no shares issued and outstanding
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Common stock, $0.001 par value :
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Authorized shares  50,000 issued and outstanding
    shares  22,558 and 22,079 at December 31, 2010
    and 2009, respectively
 
 | 
 
 | 
 
 | 
    23
 | 
 
 | 
 
 | 
 
 | 
    22
 | 
 
 | 
| 
 
    Additional
    paid-in-capital
 
 | 
 
 | 
 
 | 
    139,824
 | 
 
 | 
 
 | 
 
 | 
    134,071
 | 
 
 | 
| 
 
    Accumulated other comprehensive income (loss)
 
 | 
 
 | 
 
 | 
    255
 | 
 
 | 
 
 | 
 
 | 
    (1,828
 | 
    )
 | 
| 
 
    Retained earnings
 
 | 
 
 | 
 
 | 
    67,141
 | 
 
 | 
 
 | 
 
 | 
    39,092
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total stockholders equity
 
 | 
 
 | 
 
 | 
    207,243
 | 
 
 | 
 
 | 
 
 | 
    171,357
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total liabilities and stockholders equity
 
 | 
 
 | 
    $
 | 
    251,771
 | 
 
 | 
 
 | 
    $
 | 
    203,378
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    See accompanying notes.
    
    40
 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except per share amounts)
 | 
 
 | 
|  
 | 
| 
 
    Net revenues:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Systems and components
 
 | 
 
 | 
    $
 | 
    184,217
 | 
 
 | 
 
 | 
    $
 | 
    61,893
 | 
 
 | 
 
 | 
    $
 | 
    95,962
 | 
 
 | 
| 
 
    Technology development
 
 | 
 
 | 
 
 | 
    18,309
 | 
 
 | 
 
 | 
 
 | 
    16,088
 | 
 
 | 
 
 | 
 
 | 
    14,345
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total net revenues
 
 | 
 
 | 
 
 | 
    202,526
 | 
 
 | 
 
 | 
 
 | 
    77,981
 | 
 
 | 
 
 | 
 
 | 
    110,307
 | 
 
 | 
| 
 
    Cost of net revenues:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Systems and components
 
 | 
 
 | 
 
 | 
    101,975
 | 
 
 | 
 
 | 
 
 | 
    36,172
 | 
 
 | 
 
 | 
 
 | 
    58,503
 | 
 
 | 
| 
 
    Technology development
 
 | 
 
 | 
 
 | 
    12,879
 | 
 
 | 
 
 | 
 
 | 
    9,089
 | 
 
 | 
 
 | 
 
 | 
    8,465
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total cost of net revenues
 
 | 
 
 | 
 
 | 
    114,854
 | 
 
 | 
 
 | 
 
 | 
    45,261
 | 
 
 | 
 
 | 
 
 | 
    66,968
 | 
 
 | 
| 
 
    Gross profit
 
 | 
 
 | 
 
 | 
    87,672
 | 
 
 | 
 
 | 
 
 | 
    32,720
 | 
 
 | 
 
 | 
 
 | 
    43,339
 | 
 
 | 
| 
 
    Operating expenses:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Research and development
 
 | 
 
 | 
 
 | 
    27,918
 | 
 
 | 
 
 | 
 
 | 
    28,064
 | 
 
 | 
 
 | 
 
 | 
    35,083
 | 
 
 | 
| 
 
    Selling, general and administrative
 
 | 
 
 | 
 
 | 
    28,516
 | 
 
 | 
 
 | 
 
 | 
    22,003
 | 
 
 | 
 
 | 
 
 | 
    28,229
 | 
 
 | 
| 
 
    Impairment of goodwill and intangible assets
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    10,498
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total operating expenses
 
 | 
 
 | 
 
 | 
    56,434
 | 
 
 | 
 
 | 
 
 | 
    50,067
 | 
 
 | 
 
 | 
 
 | 
    73,810
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Operating income (loss)
 
 | 
 
 | 
 
 | 
    31,238
 | 
 
 | 
 
 | 
 
 | 
    (17,347
 | 
    )
 | 
 
 | 
 
 | 
    (30,471
 | 
    )
 | 
| 
 
    Interest income
 
 | 
 
 | 
 
 | 
    899
 | 
 
 | 
 
 | 
 
 | 
    1,362
 | 
 
 | 
 
 | 
 
 | 
    3,968
 | 
 
 | 
| 
 
    Other income (expense), net
 
 | 
 
 | 
 
 | 
    (126
 | 
    )
 | 
 
 | 
 
 | 
    (108
 | 
    )
 | 
 
 | 
 
 | 
    (36
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Income (loss) before income taxes
 
 | 
 
 | 
 
 | 
    32,011
 | 
 
 | 
 
 | 
 
 | 
    (16,093
 | 
    )
 | 
 
 | 
 
 | 
    (26,539
 | 
    )
 | 
| 
 
    Provision (benefit) for income taxes
 
 | 
 
 | 
 
 | 
    3,962
 | 
 
 | 
 
 | 
 
 | 
    (6,016
 | 
    )
 | 
 
 | 
 
 | 
    (11,194
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net income (loss)
 
 | 
 
 | 
    $
 | 
    28,049
 | 
 
 | 
 
 | 
    $
 | 
    (10,077
 | 
    )
 | 
 
 | 
    $
 | 
    (15,345
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net income (loss) per share:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Basic
 
 | 
 
 | 
    $
 | 
    1.26
 | 
 
 | 
 
 | 
    $
 | 
    (0.46
 | 
    )
 | 
 
 | 
    $
 | 
    (0.71
 | 
    )
 | 
| 
 
    Diluted
 
 | 
 
 | 
    $
 | 
    1.22
 | 
 
 | 
 
 | 
    $
 | 
    (0.46
 | 
    )
 | 
 
 | 
    $
 | 
    (0.71
 | 
    )
 | 
| 
 
    Weighted average shares outstanding:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Basic
 
 | 
 
 | 
 
 | 
    22,340
 | 
 
 | 
 
 | 
 
 | 
    21,975
 | 
 
 | 
 
 | 
 
 | 
    21,724
 | 
 
 | 
| 
 
    Diluted
 
 | 
 
 | 
 
 | 
    22,977
 | 
 
 | 
 
 | 
 
 | 
    21,975
 | 
 
 | 
 
 | 
 
 | 
    21,724
 | 
 
 | 
 
    See accompanying notes.
    
    41
 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Accumulated 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Additional 
    
 | 
 
 | 
 
 | 
    Other 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Total 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Common Stock
 | 
 
 | 
 
 | 
    Paid-In 
    
 | 
 
 | 
 
 | 
    Comprehensive 
    
 | 
 
 | 
 
 | 
    Retained 
    
 | 
 
 | 
 
 | 
    Stockholders 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Shares
 | 
 
 | 
 
 | 
    Amount
 | 
 
 | 
 
 | 
    Capital
 | 
 
 | 
 
 | 
    Income (Loss)
 | 
 
 | 
 
 | 
    Earnings
 | 
 
 | 
 
 | 
    Equity
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
|  
 | 
| 
 
    Balance at December 31, 2007
 
 | 
 
 | 
 
 | 
    21,591
 | 
 
 | 
 
 | 
    $
 | 
    22
 | 
 
 | 
 
 | 
    $
 | 
    120,022
 | 
 
 | 
 
 | 
    $
 | 
    605
 | 
 
 | 
 
 | 
    $
 | 
    64,514
 | 
 
 | 
 
 | 
    $
 | 
    185,163
 | 
 
 | 
| 
 
    Shares issued in connection with:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Exercise of stock options
 
 | 
 
 | 
 
 | 
    48
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    322
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    322
 | 
 
 | 
| 
 
    Employee stock purchase plan
 
 | 
 
 | 
 
 | 
    166
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    1,516
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    1,516
 | 
 
 | 
| 
 
    Income tax benefits realized from activity in employee stock
    plans
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    327
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    327
 | 
 
 | 
| 
 
    Equity-based compensation expense
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    6,499
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    6,499
 | 
 
 | 
| 
 
    Net loss
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (15,345
 | 
    )
 | 
 
 | 
 
 | 
    (15,345
 | 
    )
 | 
| 
 
    Unrealized loss on securities held as
    available-for-sale
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (8,072
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (8,072
 | 
    )
 | 
| 
 
    Deferred taxes on unrealized loss on
    available-for-sale
    securities
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    2,825
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    2,825
 | 
 
 | 
| 
 
    Foreign currency translation adjustment
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (166
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (166
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Comprehensive loss
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    (20,758
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Balance at December 31, 2008
 
 | 
 
 | 
 
 | 
    21,805
 | 
 
 | 
 
 | 
    $
 | 
    22
 | 
 
 | 
 
 | 
    $
 | 
    128,686
 | 
 
 | 
 
 | 
    $
 | 
    (4,808
 | 
    )
 | 
 
 | 
    $
 | 
    49,169
 | 
 
 | 
 
 | 
    $
 | 
    173,069
 | 
 
 | 
| 
 
    Shares issued in connection with:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Exercise of stock options
 
 | 
 
 | 
 
 | 
    34
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    223
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    223
 | 
 
 | 
| 
 
    Employee stock purchase plan
 
 | 
 
 | 
 
 | 
    240
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    899
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    899
 | 
 
 | 
| 
 
    Income tax benefits realized from activity in employee stock
    plans
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    69
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    69
 | 
 
 | 
| 
 
    Equity-based compensation expense
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    4,194
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    4,194
 | 
 
 | 
| 
 
    Net loss
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (10,077
 | 
    )
 | 
 
 | 
 
 | 
    (10,077
 | 
    )
 | 
| 
 
    Unrealized gain on securities held as
    available-for-sale
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    4,371
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    4,371
 | 
 
 | 
| 
 
    Deferred taxes on unrealized gain on
    available-for-sale
    securities
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (1,529
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (1,529
 | 
    )
 | 
| 
 
    Foreign currency translation adjustment
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    138
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    138
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Comprehensive loss
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    (7,097
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Balance at December 31, 2009
 
 | 
 
 | 
 
 | 
    22,079
 | 
 
 | 
 
 | 
    $
 | 
    22
 | 
 
 | 
 
 | 
    $
 | 
    134,071
 | 
 
 | 
 
 | 
    $
 | 
    (1,828
 | 
    )
 | 
 
 | 
    $
 | 
    39,092
 | 
 
 | 
 
 | 
    $
 | 
    171,357
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Shares issued in connection with:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Exercise of stock options
 
 | 
 
 | 
 
 | 
    224
 | 
 
 | 
 
 | 
 
 | 
    1
 | 
 
 | 
 
 | 
 
 | 
    1,740
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    1,741
 | 
 
 | 
| 
 
    Employee stock purchase plan
 
 | 
 
 | 
 
 | 
    255
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    1,027
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    1,027
 | 
 
 | 
| 
 
    Income tax benefits realized from activity in employee stock
    plans
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (279
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (279
 | 
    )
 | 
| 
 
    Equity-based compensation expense
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    3,265
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    3,265
 | 
 
 | 
| 
 
    Net income
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    28,049
 | 
 
 | 
 
 | 
 
 | 
    28,049
 | 
 
 | 
| 
 
    Unrealized gain on securities held as
    available-for-sale
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    3,072
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    3,072
 | 
 
 | 
| 
 
    Deferred taxes on unrealized gain on
    available-for-sale
    securities
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (1,075
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (1,075
 | 
    )
 | 
| 
 
    Foreign currency translation adjustment
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    86
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    86
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Comprehensive income
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    30,132
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Balance at December 31, 2010
 
 | 
 
 | 
 
 | 
    22,558
 | 
 
 | 
 
 | 
    $
 | 
    23
 | 
 
 | 
 
 | 
    $
 | 
    139,824
 | 
 
 | 
 
 | 
    $
 | 
    255
 | 
 
 | 
 
 | 
    $
 | 
    67,141
 | 
 
 | 
 
 | 
    $
 | 
    207,243
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    See accompanying notes.
    
    42
 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Operating activities
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net income (loss)
 
 | 
 
 | 
    $
 | 
    28,049
 | 
 
 | 
 
 | 
    $
 | 
    (10,077
 | 
    )
 | 
 
 | 
    $
 | 
    (15,345
 | 
    )
 | 
| 
 
    Adjustments to reconcile net income (loss) to net cash and cash
    equivalents provided by (used in) operating activities:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Depreciation & amortization
 
 | 
 
 | 
 
 | 
    5,307
 | 
 
 | 
 
 | 
 
 | 
    5,031
 | 
 
 | 
 
 | 
 
 | 
    4,709
 | 
 
 | 
| 
 
    Net accretion of investment premiums and discounts
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (20
 | 
    )
 | 
 
 | 
 
 | 
    (256
 | 
    )
 | 
| 
 
    Gain on acquisition
 
 | 
 
 | 
 
 | 
    (481
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Impairment of goodwill and intangible assets
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    10,498
 | 
 
 | 
| 
 
    Amortization of intangible assets
 
 | 
 
 | 
 
 | 
    554
 | 
 
 | 
 
 | 
 
 | 
    554
 | 
 
 | 
 
 | 
 
 | 
    700
 | 
 
 | 
| 
 
    Equity-based compensation
 
 | 
 
 | 
 
 | 
    3,316
 | 
 
 | 
 
 | 
 
 | 
    4,255
 | 
 
 | 
 
 | 
 
 | 
    6,577
 | 
 
 | 
| 
 
    Deferred income taxes
 
 | 
 
 | 
 
 | 
    (2,142
 | 
    )
 | 
 
 | 
 
 | 
    (87
 | 
    )
 | 
 
 | 
 
 | 
    (8,002
 | 
    )
 | 
| 
 
    Excess tax benefits from equity-based compensation
 
 | 
 
 | 
 
 | 
    (299
 | 
    )
 | 
 
 | 
 
 | 
    (69
 | 
    )
 | 
 
 | 
 
 | 
    (327
 | 
    )
 | 
| 
 
    Loss on disposal of equipment
 
 | 
 
 | 
 
 | 
    153
 | 
 
 | 
 
 | 
 
 | 
    57
 | 
 
 | 
 
 | 
 
 | 
    7
 | 
 
 | 
| 
 
    Changes in assets and liabilities:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Accounts receivable
 
 | 
 
 | 
 
 | 
    18,845
 | 
 
 | 
 
 | 
 
 | 
    (28,935
 | 
    )
 | 
 
 | 
 
 | 
    765
 | 
 
 | 
| 
 
    Inventories
 
 | 
 
 | 
 
 | 
    (1,555
 | 
    )
 | 
 
 | 
 
 | 
    (1,411
 | 
    )
 | 
 
 | 
 
 | 
    4,434
 | 
 
 | 
| 
 
    Prepaid expenses and other assets
 
 | 
 
 | 
 
 | 
    (2,665
 | 
    )
 | 
 
 | 
 
 | 
    (3,177
 | 
    )
 | 
 
 | 
 
 | 
    (100
 | 
    )
 | 
| 
 
    Accounts payable
 
 | 
 
 | 
 
 | 
    450
 | 
 
 | 
 
 | 
 
 | 
    441
 | 
 
 | 
 
 | 
 
 | 
    (3,468
 | 
    )
 | 
| 
 
    Accrued payroll and other accrued liabilities
 
 | 
 
 | 
 
 | 
    10,095
 | 
 
 | 
 
 | 
 
 | 
    6,902
 | 
 
 | 
 
 | 
 
 | 
    (5,475
 | 
    )
 | 
| 
 
    Customer advances
 
 | 
 
 | 
 
 | 
    (8,313
 | 
    )
 | 
 
 | 
 
 | 
    9,967
 | 
 
 | 
 
 | 
 
 | 
    (2,911
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total adjustments
 
 | 
 
 | 
 
 | 
    23,265
 | 
 
 | 
 
 | 
 
 | 
    (6,492
 | 
    )
 | 
 
 | 
 
 | 
    7,151
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net cash and cash equivalents provided by (used in) operating
    activities
 
 | 
 
 | 
 
 | 
    51,314
 | 
 
 | 
 
 | 
 
 | 
    (16,569
 | 
    )
 | 
 
 | 
 
 | 
    (8,194
 | 
    )
 | 
| 
 
    Investing activities
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Purchase of investments
 
 | 
 
 | 
 
 | 
    (20,683
 | 
    )
 | 
 
 | 
 
 | 
    (26,979
 | 
    )
 | 
 
 | 
 
 | 
    (7,000
 | 
    )
 | 
| 
 
    Proceeds from sales and maturities of investments
 
 | 
 
 | 
 
 | 
    68,050
 | 
 
 | 
 
 | 
 
 | 
    25,450
 | 
 
 | 
 
 | 
 
 | 
    45,850
 | 
 
 | 
| 
 
    Acquisition of SIT, net of cash acquired
 
 | 
 
 | 
 
 | 
    (2,638
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Acquisition of Oerlikon assets, net of cash acquired
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (15,093
 | 
    )
 | 
| 
 
    Purchase of equipment
 
 | 
 
 | 
 
 | 
    (7,055
 | 
    )
 | 
 
 | 
 
 | 
    (2,615
 | 
    )
 | 
 
 | 
 
 | 
    (4,185
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net cash and cash equivalents provided by (used in) investing
    activities
 
 | 
 
 | 
 
 | 
    37,674
 | 
 
 | 
 
 | 
 
 | 
    (4,144
 | 
    )
 | 
 
 | 
 
 | 
    19,572
 | 
 
 | 
| 
 
    Financing activities
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Proceeds from issuance of common stock
 
 | 
 
 | 
 
 | 
    2,768
 | 
 
 | 
 
 | 
 
 | 
    1,122
 | 
 
 | 
 
 | 
 
 | 
    1,838
 | 
 
 | 
| 
 
    Payment of notes payable assumed upon SIT acquisition
 
 | 
 
 | 
 
 | 
    (177
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Repayment of note payable
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (2,000
 | 
    )
 | 
 
 | 
 
 | 
    (2,000
 | 
    )
 | 
| 
 
    Excess tax benefits from equity-based compensation
 
 | 
 
 | 
 
 | 
    299
 | 
 
 | 
 
 | 
 
 | 
    69
 | 
 
 | 
 
 | 
 
 | 
    327
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net cash and cash equivalents provided by (used in) financing
    activities
 
 | 
 
 | 
 
 | 
    2,890
 | 
 
 | 
 
 | 
 
 | 
    (809
 | 
    )
 | 
 
 | 
 
 | 
    165
 | 
 
 | 
| 
 
    Effect of exchange rate changes on cash
 
 | 
 
 | 
 
 | 
    50
 | 
 
 | 
 
 | 
 
 | 
    (87
 | 
    )
 | 
 
 | 
 
 | 
    (15
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net increase (decrease) in cash and cash equivalents
 
 | 
 
 | 
 
 | 
    91,928
 | 
 
 | 
 
 | 
 
 | 
    (21,609
 | 
    )
 | 
 
 | 
 
 | 
    11,528
 | 
 
 | 
| 
 
    Cash and cash equivalents at beginning of period
 
 | 
 
 | 
 
 | 
    17,592
 | 
 
 | 
 
 | 
 
 | 
    39,201
 | 
 
 | 
 
 | 
 
 | 
    27,673
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Cash and cash equivalents at end of period
 
 | 
 
 | 
    $
 | 
    109,520
 | 
 
 | 
 
 | 
    $
 | 
    17,592
 | 
 
 | 
 
 | 
    $
 | 
    39,201
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Cash paid (received) for:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Income taxes
 
 | 
 
 | 
    $
 | 
    1,829
 | 
 
 | 
 
 | 
    $
 | 
    713
 | 
 
 | 
 
 | 
    $
 | 
    410
 | 
 
 | 
| 
 
    Income tax refund
 
 | 
 
 | 
    $
 | 
    (481
 | 
    )
 | 
 
 | 
    $
 | 
    (2,821
 | 
    )
 | 
 
 | 
    $
 | 
    (3,717
 | 
    )
 | 
 
    See accompanying notes.
    
    43
 
    INTEVAC,
    INC.
    
 
 
     | 
     | 
    | 
    1.  
 | 
    
    Summary
    of Significant Accounting Policies
 | 
 
    Principles
    of Consolidation and Basis of Presentation
 
    The consolidated financial statements include the accounts of
    Intevac, Inc. and its subsidiaries (Intevac or the Company)
    after elimination of inter-company balances and transactions.
 
    The preparation of financial statements in conformity with
    accounting principles generally accepted in the United States of
    America requires management to make estimates and assumptions
    that affect the amounts reported in the consolidated financial
    statements and accompanying notes. Actual results could differ
    materially from those estimates.
 
    Cash,
    Cash Equivalents and Investments
 
    Intevac considers all highly liquid investments with original
    maturities of three months or less when purchased to be cash
    equivalents.
    Available-for-sale
    securities, comprised of commercial paper, obligations of the
    U.S. government and its agencies, corporate debt securities
    and Auction Rate Securities (ARS), are carried at
    fair value, with unrealized gains and losses recorded within
    other comprehensive income (loss) as a separate component of
    stockholders equity. Realized gains and losses and
    declines in value judged to be other than temporary, if any, on
    available-for-sale
    securities are included in earnings. The cost of investment
    securities sold is determined by the specific identification
    method.
 
    Fair
    Value Measurement  Definition and
    Hierarchy
 
    Intevac reports certain financial assets and liabilities at fair
    value. Intevac measures fair value in accordance with Accounting
    Standards Codification (ASC)
    820-10,
    Fair Value Measurements and Disclosures, which
    defines fair value as the price that would be received from
    selling an asset or paid to transfer a liability in an orderly
    transaction between market participants at the measurement date.
 
    Fair value measurements are classified and disclosed in one of
    the following three categories:
 
    Level 1  Valuations based on quoted
    prices in active markets for identical assets or liabilities.
 
    Level 2  Valuations based on other than
    quoted prices in active markets for identical assets and
    liabilities, quoted prices for identical or similar assets or
    liabilities in inactive markets, or other inputs that are
    observable or can be corroborated by observable market data for
    substantially the full term of the assets or liabilities.
 
    Level 3  Valuations based on inputs that
    are generally unobservable and typically reflect
    managements estimates of assumptions that market
    participants would use in pricing the asset or liability.
 
    Business
    Combinations
 
    On January 1, 2009, Intevac adopted a new accounting
    standard issued by the Financial Accounting Standards Board
    (FASB), related to accounting for business
    combinations using the acquisition method of accounting
    (previously referred to as the purchase method). Among the
    significant changes, this standard requires a redefined
    measurement date of a business combination, expensing direct
    transaction costs as incurred, capitalizing in-process research
    and development (IPR&D) costs as an intangible
    asset and recording a liability for contingent consideration at
    the measurement date with subsequent re-measurements recorded as
    general and administrative expense. This standard also requires
    costs for business restructuring and exit activities related to
    the acquired company to be included in the post-combination
    financial results of operations and also provides new guidance
    for the recognition and measurement of contingent assets and
    liabilities in a business combination. Acquisitions consummated
    prior to January 1, 2009 were accounted for in accordance
    with the previously applicable guidance. During 2010, Intevac
    incurred $255,000 of acquisition-related costs which have been
    included in selling, general and administrative expenses on the
    Consolidated Statement of Operations.
    
    44
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    Trade
    Accounts and Notes Receivables and Doubtful
    Accounts
 
    Intevac evaluates the collectibility of trade accounts
    receivables and notes receivable on an ongoing basis and
    provides reserves against potential losses when appropriate.
    Management analyzes historical bad debts, customer
    concentrations, customer creditworthiness, changes in customer
    payment tendencies and current economic trends when evaluating
    the adequacy of the allowance for doubtful accounts. Customer
    accounts are written off against the allowance when the amount
    is deemed uncollectible. Also, accounts determined to be
    uncollectible are put in nonaccrual status whereby interest is
    not accrued on those accounts. Credit losses, when realized,
    have been within the range of the Companys expectations.
 
    Included in trade receivables at December 31, 2010 is the
    current portion of a discounted promissory note from a customer
    of $1.1 million. The non-current portion of the note
    receivable of $3.3 million is included in other long-term
    assets.
 
    Included in trade receivables are unbilled receivables related
    to government contracts of $1.1 million and
    $2.1 million at December 31, 2010 and
    December 31, 2009, respectively which includes $474,000 and
    $371,000 of fee retention, respectively.
 
    Inventories
 
    Inventories are generally stated at the lower of cost or market,
    with cost determined on an average cost basis.
 
    Property,
    Plant and Equipment
 
    Equipment and leasehold improvements are stated at cost.
    Depreciation is computed using the straight-line method over the
    estimated useful lives of the assets as follows: computers and
    software, 3 years; machinery and equipment, 5 years;
    furniture, 7 years; vehicles, 4 years; and leasehold
    improvements, remaining lease term.
 
    Goodwill
    and Purchased Intangible Assets
 
    The purchase price of an acquired business is allocated, as
    applicable, between IPR&D, other identifiable intangible
    assets, net tangible assets and goodwill. IPR&D is defined
    as the value assigned to those projects for which the related
    products have no alternative future use. Determining the portion
    of the purchase price allocated to IPR&D and other
    intangible assets requires the Company to make significant
    estimates. The amount of the purchase price allocated to
    IPR&D and other intangible assets is determined by
    estimating the future cash flows of each project or technology
    and discounting the net cash flows back to their present values.
    The discount rate used is determined at the time of the
    acquisition in accordance with accepted valuation methods. For
    IPR&D, these valuation methodologies include consideration
    of the risk of the project not achieving commercial feasibility.
 
    Contingent consideration is recorded at the acquisition date at
    the estimated fair value of the contingent payments. The
    acquisition date fair value is measured based on the
    consideration expected to be transferred (probability-weighted),
    discounted back to present value. The discount rate used is
    determined at the time of the acquisition in accordance with
    accepted valuation methods. The fair value of the contingent
    consideration is remeasured at the estimated fair value at each
    reporting period with the change in fair value recognized as
    income or expense in the consolidated statements of operations.
 
    Goodwill represents the excess of the aggregate purchase price
    over the fair value of net assets, including IPR&D, of
    acquired businesses. Intevacs methodology for allocating
    the purchase price relating to purchase acquisitions is
    determined through established and generally accepted valuation
    techniques. Goodwill is measured as the excess of the cost of
    the acquisition over the sum of the amounts assigned to tangible
    and identifiable intangible assets acquired less liabilities
    assumed. Intevac assigns assets acquired (including goodwill)
    and liabilities assumed to a reporting unit as of the date of
    acquisition.
    
    45
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    Purchased intangible assets other than goodwill are amortized
    over their useful lives unless these lives are determined to be
    indefinite. Purchased intangible assets are carried at cost,
    less accumulated amortization. Amortization is computed over the
    estimated useful lives of the respective assets, generally one
    to thirteen years using the straight line method.
 
    Goodwill and purchased intangible assets with indefinite useful
    lives are not amortized, but are reviewed for impairment
    annually during the fourth quarter of each fiscal year and
    whenever events or changes in circumstances indicate that the
    carrying value of an asset may not be recoverable. For goodwill,
    Intevac performs a two-step impairment test. In the first step,
    Intevac compares the fair value of each reporting unit to its
    carrying value. Intevacs reporting units are consistent
    with the reportable segments identified in Note 12, based
    on the manner in which Intevac operates its business and the
    nature of those operations. Depending on the facts and
    circumstances Intevac determines the fair value of each of its
    reporting units based upon the most appropriate valuation
    technique using the income approach, the market approach or a
    combination thereof. The income and market approaches were
    selected as management believes these approaches generally
    provide the most reliable indications of fair value when the
    value of the operations is more dependent on the ability to
    generate earnings than on the value of the assets used in the
    production process. Under the income approach Intevac calculates
    the fair value of the reporting units based on the present value
    of estimated future cash flows. Under the market approach
    Intevac estimates the fair value based on market multiples of
    revenue or earnings for comparable companies. Each valuation
    technique has advantages and drawbacks, which must be considered
    when applying those techniques. The income approach closely
    correlates to managements expectations of future results
    but requires significant assumptions which can be highly
    sensitive. The market approach is relatively straightforward to
    measure, but it may be difficult to find directly comparable
    companies in the marketplace. If the fair value of the reporting
    unit exceeds the carrying value of the net assets assigned to
    that unit, goodwill is not impaired and no further testing is
    performed. If the carrying value of the net assets assigned to
    the reporting unit exceeds the fair value of the reporting unit,
    then Intevac would perform the second step of the impairment
    test in order to determine the implied fair value of the
    reporting units goodwill. If the carrying value of a
    reporting units goodwill exceeds its implied fair value,
    Intevac would record an impairment loss equal to the difference.
    Intevac conducted these impairment tests in the fourth quarter
    of fiscal 2010 and the results of these tests indicated that
    Intevacs goodwill and a purchased intangible asset with an
    indefinite useful live were not impaired. In the fourth quarter
    of 2008, Intevac recorded an impairment charge of
    $10.5 million for goodwill and purchased technology
    intangible assets due to a decline in market value and lower
    revenue expectations and future operating expectations.
 
    Impairment
    of Long-Lived Assets
 
    Long-lived assets and certain identifiable intangible assets to
    be held and used are reviewed for impairment whenever events or
    changes in circumstances indicate that the carrying amount of
    such assets may not be recoverable. Determination of
    recoverability of long-lived assets is based on an estimate of
    undiscounted future cash flows resulting from the use of the
    asset and its eventual disposition. Measurement of an impairment
    loss for long-lived assets and certain identifiable intangible
    assets that management expects to hold and use is based on the
    fair value of the asset. When an impairment loss is recognized,
    the carrying amount of the asset is reduced to its estimated
    fair value. As a result of Intevacs projected undiscounted
    future cash flows related to certain of its intangible assets
    being less than the carrying value of those assets, Intevac
    recorded an impairment charge of $808,000 in fiscal 2008. No
    impairment charges were recognized in fiscal 2010 and 2009.
 
    Income
    Taxes
 
    Deferred tax assets and liabilities are recognized using enacted
    tax rates for the effect of temporary differences between book
    and tax bases of recorded assets and liabilities. Deferred tax
    assets are reduced by a valuation allowance if it is more likely
    than not that a portion of the deferred tax asset will not be
    realized.
 
    On a quarterly basis, Intevac provides for income taxes based
    upon an annual effective income tax rate. The effective tax rate
    is highly dependent upon the level of Intevacs projected
    earnings, the geographic composition of
    
    46
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    worldwide earnings, tax regulations governing each region, net
    operating loss carryforwards, availability of tax credits and
    the effectiveness of Intevacs tax planning strategies.
    Intevac carefully monitors the changes in many factors and
    adjust its effective income tax rate on a timely basis. If
    actual results differ from the estimates, this could have a
    material effect on Intevacs business, financial condition
    and results of operations.
 
    The calculation of tax liabilities involves significant judgment
    in estimating the impact of uncertainties in the application of
    complex tax laws. Resolution of these uncertainties in a manner
    inconsistent with Intevacs expectations could have a
    material effect on Intevacs business, financial condition
    and results of operations.
 
    Intevac recognizes accrued interest and penalties related to
    unrecognized tax benefits in the provision for income taxes.
 
    Sales
    and Value Added Taxes
 
    Taxes collected from customers and remitted to governmental
    authorities are presented on a net basis in the accompanying
    Consolidated Statements of Operations.
 
    Revenue
    Recognition
 
    In 2009, the FASB issued amended revenue recognition guidance
    for arrangements with multiple deliverables and certain software
    sold with tangible products. This new guidance eliminates the
    residual method of revenue recognition and requires the use of
    managements best estimate of selling price
    (ESP) for individual elements of an arrangement when
    vendor specific objective evidence (VSOE) or third
    party evidence (TPE) is unavailable. Intevac
    implemented this guidance prospectively beginning in the first
    quarter of fiscal 2010 for transactions that were initiated or
    materially modified during fiscal 2010. The implementation of
    the new guidance had an insignificant impact on reported net
    revenues as compared to net revenues under the previous
    guidance, as the new guidance did not change the units of
    accounting within sales arrangements, and the elimination of the
    residual method for the allocation of arrangement consideration
    had an inconsequential impact on the amount and timing of
    reported net revenues.
 
    In 2010, the FASB issued guidance for the milestone method of
    revenue recognition. Under the milestone method, consideration
    earned from achievement of the milestone is viewed as being
    indicative of the value provided to the customer through either
    (1) the efforts performed or (2) a specific outcome
    resulting from the performance to achieve that specific
    milestone. Under the milestone method, contingent arrangement
    consideration earned from the achievement of a milestone is
    recognized in its entirety in the period in which the milestone
    is achieved. Under this new method of accounting, a milestone
    must be substantive before the method can be
    applied; that is, at the inception of the arrangement there is a
    substantial uncertainty about the achievement of the milestone,
    substantive effort is required to achieve the milestone, and
    none of the payment for the milestone is refundable. Intevac
    implemented this guidance prospectively beginning in the first
    quarter of fiscal 2010 for transactions that were initiated or
    materially modified during fiscal 2010. Implementation of this
    new guidance had an insignificant impact on reported net
    revenues as compared to net revenues under the previous guidance.
 
    Intevac recognizes revenue when persuasive evidence of an
    arrangement exists, delivery has occurred and title and risk of
    loss have passed to Intevacs customer or services have
    been rendered, the price is fixed or determinable, and
    collectibility is reasonably assured. Intevacs shipping
    terms are customarily FOB shipping point or equivalent terms.
    Intevacs revenue recognition policy generally results in
    revenue recognition at the following points: (1) for all
    transactions where legal title passes to the customer upon
    shipment, Intevac recognizes revenue upon shipment for all
    products that have been demonstrated to meet product
    specifications prior to shipment; the portion of revenue
    associated with certain installation-related tasks is deferred,
    and that revenue is recognized upon completion of the
    installation-related tasks; (2) for products that have not
    been demonstrated to meet product specifications prior to
    shipment, revenue is recognized at customer acceptance; and
    (3) for arrangements containing multiple elements, the
    revenue relating to the undelivered elements is deferred until
    delivery of the deferred elements. When a sales arrangement
    contains multiple elements, Intevac allocates revenue to each
    element based on a selling price
    
    47
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    hierarchy. The selling price for a deliverable is based on its
    vendor specific evidence (VSOE) if available, third
    party evidence (TPE) if VSOE is not available, or
    best estimate of selling price (ESP) if neither VSOE
    nor TPE is available. Intevac generally utilizes the ESP due to
    the nature of its products. In certain cases, technology upgrade
    sales are accounted for as multiple-element arrangements,
    usually split between delivery of the parts and installation on
    the customers systems. In these cases, Intevac recognizes
    revenue for the relative sales price of the parts upon shipment
    and transfer of title, and recognizes revenue for the relative
    sales price of installation services when those services are
    completed. Revenue related to sales of spare parts is generally
    recognized upon shipment. Revenue related to services is
    generally recognized upon completion of the services. In
    addition, Intevac uses the installment method to record revenue
    based on cash receipts in situations where the account
    receivable is collected over an extended period of time and in
    managements judgment the degree of collectibility is
    uncertain.
 
    Intevac performs research and development work under various
    government-sponsored research contracts. Revenue on
    cost-plus-fee contracts is recognized to the extent of costs
    actually incurred plus a proportionate amount of the fee earned.
    Intevac considers fixed fees under cost-plus-fee contracts to be
    earned in proportion to the allowable costs actually incurred in
    performance of the contract. Revenue on fixed-price contracts is
    recognized on a milestone method or
    percentage-of-completion
    method of contract accounting. For contracts structured as
    milestone agreements, revenue is recognized when a specified
    milestone is achieved, provided that (1) the milestone
    event is substantive in nature and there is substantial
    uncertainty about the achievement of the milestone at the
    inception of the agreement, (2) the milestone payment is
    non-refundable, and (3) there is no continuing performance
    obligations associated with the milestone payment. Any milestone
    payments received prior to satisfying these revenue recognition
    criteria are deferred. Intevac generally determines the
    percentage completed based on the percentage of costs incurred
    to date in relation to total estimated costs expected through
    completion of the contract. When estimates of total costs to be
    incurred on a contract exceed estimates of total revenue to be
    earned, a provision for the entire loss on the contract is
    recorded in the period the loss is determined.
 
    Advertising
    Costs
 
    Advertising costs are expensed as incurred. Advertising costs
    were not material for all periods presented.
 
    Foreign
    Currency Translation
 
    The functional currency of Intevacs foreign subsidiaries
    in Singapore and Hong Kong is the U.S. dollar. The
    functional currency of Intevacs foreign subsidiaries in
    China, Malaysia and Korea, is the local currency of the country
    in which the respective subsidiary operates. Assets and
    liabilities recorded in foreign currencies are translated at
    year-end exchange rates; revenues and expenses are translated at
    average exchange rates during the year. The effect of foreign
    currency translation adjustments are included in
    stockholders equity as a component of accumulated other
    comprehensive income in the accompanying consolidated balance
    sheets. The effects of foreign currency transactions are
    included in other income in the determination of net income. Net
    losses from foreign currency transactions were $520,000,
    $226,000 and $31,000 in 2010, 2009 and 2008, respectively.
 
    Comprehensive
    Income
 
    The components of accumulated other comprehensive income (loss),
    were as follows at December 31, 2010 and 2009:
 
    
    48
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Accumulated net unrealized holding loss on
    available-for-sale
    investments, net 
    of tax
 
 | 
 
 | 
    $
 | 
    (408
 | 
    )
 | 
 
 | 
    $
 | 
    (2,405
 | 
    )
 | 
| 
 
    Foreign currency translation gains and losses
 
 | 
 
 | 
 
 | 
    663
 | 
 
 | 
 
 | 
 
 | 
    577
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total accumulated other comprehensive income (loss)
 
 | 
 
 | 
    $
 | 
    255
 | 
 
 | 
 
 | 
    $
 | 
    (1,828
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Employee
    Stock Plans
 
    Intevac has equity-based compensation plans that provide for the
    grant to employees of equity-based awards, including incentive
    or non-statutory stock options, restricted stock, stock
    appreciation rights, performance units and performance shares.
    In addition, these plans provide for the grant of non-statutory
    stock options to non-employee directors and consultants. Intevac
    also has an employee stock purchase plan, which provides
    Intevacs employees with the opportunity to purchase
    Intevac common stock at a discount through payroll deductions.
    See Note 2 for a complete description of these plans and
    their accounting treatment.
 
    Recent
    Accounting Pronouncements
 
    In January 2009, the Securities and Exchange Commission
    (SEC) issued Release
    No. 33-9002,
    Interactive Data to Improve Financial Reporting. The
    final rule requires companies to provide their financial
    statements and financial statement schedules to the SEC and on
    their corporate websites in interactive data format using the
    eXtensible Business Reporting Language (XBRL). The
    rule was adopted by the SEC to improve the ability of financial
    statement users to access and analyze financial data. The SEC
    adopted a phase-in schedule indicating when registrants must
    furnish interactive data. Under this schedule, Intevac will be
    required to submit filings with financial statement information
    using XBRL commencing with its July 2, 2011 quarterly
    report on
    Form 10-Q.
    Intevac is currently evaluating the impact of XBRL reporting on
    its financial reporting process.
 
    In December 2010, the FASB issued Accounting Standards Update
    (ASU)
    2010-29,
    Business Combinations (Topic 805): Disclosure of
    Supplementary Pro Forma Information for Business
    Combinations. For business combinations that are material
    on an individual or aggregate basis the amendment requires that
    comparative financial statements be presented and revenue and
    earnings of the combined entity be disclosed as though the
    business combination(s) that occurred during the current year
    had occurred as of the beginning of the comparable prior annual
    reporting period. The amendment also expands the supplemental
    pro forma disclosures to include a description of the nature and
    amount of material, nonrecurring pro forma adjustments directly
    attributable to the business combination included in the
    reported pro forma revenue and earnings. The amendment is
    effective prospectively for business combinations for which the
    acquisition date is on or after the beginning of the first
    annual reporting period beginning on or after December 15,
    2010. The adoption of the ASU
    2010-29 will
    not have material impact to the financial statements of the
    Company.
 
     | 
     | 
    | 
    2.  
 | 
    
    Equity-Based
    Compensation
 | 
 
    Intevac accounts for share-based awards in accordance with the
    provisions of the revised accounting guidance which requires the
    measurement and recognition of compensation expense for all
    share-based payment awards made to employees, consultants and
    directors based upon the grant-date fair value of those awards.
    The estimated fair value of Intevacs equity-based awards,
    less expected forfeitures, is amortized over the awards
    service periods using the graded vesting attribution method.
    During the years ended December 31, 2010, 2009 and 2008
    Intevac recognized equity-based compensation expense related to
    stock options and shares issued pursuant to its employee stock
    purchase plan of $3.3 million, $4.3 million and
    $6.6 million, respectively.
    49
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    Descriptions
    of Plans
 
    2004
    Equity Incentive Plan
 
    In 2004, the Board of Directors and Intevac stockholders
    approved adoption of the 2004 Equity Incentive Plan (the
    2004 Plan). The 2004 Plan serves as the successor
    equity incentive program to the 1995 Stock Option/Stock Issuance
    Plan (the 1995 Plan). Upon adoption of the 2004
    Plan, all remaining shares available for issuance under the 1995
    Plan were transferred to the 2004 Plan.
 
    The 2004 Plan is a broad-based, long-term retention program
    intended to attract and retain qualified management and
    employees, and align stockholder and employee interests. The
    2004 Plan permits the grant of incentive or non-statutory stock
    options, restricted stock, stock appreciation rights,
    performance units and performance shares. To date only stock
    options have been issued pursuant to the 2004 Plan. Option
    price, vesting period, and other terms are determined by the
    administrator of the 2004 Plan, but the option price shall
    generally not be less than 100% of the fair market value per
    share on the date of grant. As of December 31, 2010,
    3.9 million shares of common stock were authorized for
    future issuance under the 2004 Plan. Options granted under the
    2004 Plan are exercisable upon vesting and vest over periods of
    up to five years. Options currently expire no later than ten
    years from the date of grant. The 2004 Plan expires no later
    than March 10, 2014.
 
    During the year ended December 31, 2010, Intevac granted
    763,000 stock options pursuant to the 2004 Plan with an
    estimated total grant-date fair value of $5.1 million
    including 2,000 shares granted to a consultant with a grant
    date fair value of $13,000. Of this amount, Intevac estimated
    that the equity-based compensation for option grants that will
    be forfeited, and are therefore not expected to vest, was
    $1.2 million. During the year ended December 31, 2009,
    Intevac granted 536,000 stock options pursuant to the 2004 Plan
    with an estimated total grant-date fair value of
    $1.4 million. Of this amount, Intevac estimated that the
    equity-based compensation for option grants that will be
    forfeited, and are therefore not expected to vest, was $319,000.
    During the year ended December 31, 2008, Intevac granted
    697,000 stock options pursuant to the 2004 Plan with an
    estimated total grant-date fair value of $4.3 million,
    including 7,500 shares granted to a consultant with a grant
    date fair value of $50,000. Of this amount, Intevac estimated
    that the equity-based compensation for option grants that will
    be forfeited, and are therefore not expected to vest, was
    $904,000.
 
    2003
    Employee Stock Purchase Plan
 
    In 2003, Intevacs stockholders approved adoption of the
    2003 Employee Stock Purchase Plan (the ESPP), which
    serves as the successor to the Employee Stock Purchase Plan
    originally adopted in 1995. Upon adoption of the ESPP, all
    shares available for issuance under the prior plan were
    transferred to the ESPP. The ESPP provides that eligible
    employees may purchase Intevac common stock through payroll
    deductions at a price equal to 85% of the lower of the fair
    market value at the beginning of the applicable offering period
    or at the end of each applicable purchase interval. Offering
    periods are generally two years in length, and consist of a
    series of six-month purchase intervals. Eligible employees may
    join the ESPP at the beginning of any six-month purchase
    interval. Under the terms of the ESPP, employees can choose to
    have up to 10% of their base earnings withheld to purchase
    Intevac common stock. Under the ESPP, Intevac sold 255,000,
    240,000 and 166,000 shares to employees in 2010, 2009 and
    2008, respectively. As of December 31, 2010,
    236,000 shares remained available for issuance under the
    ESPP. During the years ended December 31, 2010, 2009, and
    2008 Intevac granted purchase rights with an estimated total
    grant-date fair value of $53,000, $328,000 and
    $1.0 million, respectively.
    
    50
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    The effect of recording equity-based compensation for the years
    ended December 31, 2010, 2009 and 2008 was as follows (in
    thousands):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
|  
 | 
| 
 
    Equity-based compensation by type of award:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Stock options
 
 | 
 
 | 
    $
 | 
    2,965
 | 
 
 | 
 
 | 
    $
 | 
    3,468
 | 
 
 | 
 
 | 
    $
 | 
    5,315
 | 
 
 | 
| 
 
    Employee stock purchase plan
 
 | 
 
 | 
 
 | 
    351
 | 
 
 | 
 
 | 
 
 | 
    787
 | 
 
 | 
 
 | 
 
 | 
    1,262
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total equity-based compensation
 
 | 
 
 | 
 
 | 
    3,316
 | 
 
 | 
 
 | 
 
 | 
    4,255
 | 
 
 | 
 
 | 
 
 | 
    6,577
 | 
 
 | 
| 
 
    Tax effect on equity-based compensation
 
 | 
 
 | 
 
 | 
    (1,068
 | 
    )
 | 
 
 | 
 
 | 
    (1,224
 | 
    )
 | 
 
 | 
 
 | 
    (1,785
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net effect on net income
 
 | 
 
 | 
    $
 | 
    2,248
 | 
 
 | 
 
 | 
    $
 | 
    3,031
 | 
 
 | 
 
 | 
    $
 | 
    4,792
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Stock
    Options
 
    The exercise price of each stock option equals the market price
    of Intevacs stock on the date of grant. Most options are
    scheduled to vest over four years and expire no later than ten
    years after the grant date. The fair value of each option grant
    is estimated on the date of grant using the Black-Scholes option
    pricing model. This model was developed for use in estimating
    the value of publicly traded options that have no vesting
    restrictions and are fully transferable. Intevacs employee
    stock options have characteristics significantly different from
    those of publicly traded options. The weighted average
    assumptions used in the model are outlined in the following
    table:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
|  
 | 
| 
 
    Stock Options:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Expected volatility
 
 | 
 
 | 
 
 | 
    67.75
 | 
    %
 | 
 
 | 
 
 | 
    67.17
 | 
    %
 | 
 
 | 
 
 | 
    65.60
 | 
    %
 | 
| 
 
    Risk free interest rate
 
 | 
 
 | 
 
 | 
    1.69
 | 
    %
 | 
 
 | 
 
 | 
    2.01
 | 
    %
 | 
 
 | 
 
 | 
    2.87
 | 
    %
 | 
| 
 
    Expected term of options (in years)
 
 | 
 
 | 
 
 | 
    4.52
 | 
 
 | 
 
 | 
 
 | 
    4.47
 | 
 
 | 
 
 | 
 
 | 
    4.47
 | 
 
 | 
| 
 
    Dividend yield
 
 | 
 
 | 
 
 | 
    None
 | 
 
 | 
 
 | 
 
 | 
    None
 | 
 
 | 
 
 | 
 
 | 
    None
 | 
 
 | 
 
    The computation of the expected volatility assumption used in
    the Black-Scholes calculations for new grants is based on
    historical volatility of Intevacs stock price. The
    risk-free interest rate is based on the yield available on
    U.S. Treasury Strips with an equivalent remaining term. The
    expected life of employee stock options represents the
    weighted-average period that the stock options are expected to
    remain outstanding and was determined based on historical
    experience of similar awards, giving consideration to the
    contractual terms of the stock-based awards and vesting
    schedules. The dividend yield assumption is based on
    Intevacs history of not paying dividends and the
    assumption of not paying dividends in the future.
 
    The weighted-average estimated fair value of employee stock
    options granted during the years ended December 31, 2010,
    2009 and 2008 was $6.63, $2.57 and $6.12 per share, respectively.
 
    ESPP
 
    The fair value of the employee stock purchase right is estimated
    on the date of grant using the Black-Scholes option pricing
    model with the following weighted-average assumptions:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
|  
 | 
| 
 
    Stock Purchase Rights:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Expected volatility
 
 | 
 
 | 
 
 | 
    55.20
 | 
    %
 | 
 
 | 
 
 | 
    82.56
 | 
    %
 | 
 
 | 
 
 | 
    62.65
 | 
    %
 | 
| 
 
    Risk free interest rate
 
 | 
 
 | 
 
 | 
    0.41
 | 
    %
 | 
 
 | 
 
 | 
    0.85
 | 
    %
 | 
 
 | 
 
 | 
    1.68
 | 
    %
 | 
| 
 
    Expected term of purchase rights (in years)
 
 | 
 
 | 
 
 | 
    0.73
 | 
 
 | 
 
 | 
 
 | 
    1.85
 | 
 
 | 
 
 | 
 
 | 
    1.87
 | 
 
 | 
| 
 
    Dividend yield
 
 | 
 
 | 
 
 | 
    None
 | 
 
 | 
 
 | 
 
 | 
    None
 | 
 
 | 
 
 | 
 
 | 
    None
 | 
 
 | 
    
    51
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    The expected life of purchase rights is the period of time
    remaining in the current offering period. The weighted-average
    estimated fair value of employee stock purchase rights granted
    pursuant to the ESPP during the years ended December 31,
    2010, 2009 and 2008 was $4.63, $2.73 and $5.40 per share,
    respectively.
 
    Stock
    Plan Activity
 
    2004
    Equity Incentive Plan
 
    A summary of activity under the above captioned plan is as
    follows:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Weighted 
    
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Average Remaining 
    
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
    Weighted Average 
    
 | 
 
 | 
    Contractual Term 
    
 | 
 
 | 
    Aggregate Intrinsic 
    
 | 
| 
 
 | 
 
 | 
    Shares
 | 
 
 | 
    Exercise Price
 | 
 
 | 
    (years)
 | 
 
 | 
    Value
 | 
|  
 | 
| 
 
    Options outstanding at December 31, 2009
 
 | 
 
 | 
 
 | 
    3,111,214
 | 
 
 | 
 
 | 
    $
 | 
    11.50
 | 
 
 | 
 
 | 
 
 | 
    6.43
 | 
 
 | 
 
 | 
    $
 | 
    7,744,629
 | 
 
 | 
| 
 
    Options granted
 
 | 
 
 | 
 
 | 
    762,525
 | 
 
 | 
 
 | 
    $
 | 
    12.22
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Options forfeited
 
 | 
 
 | 
 
 | 
    (264,837
 | 
    )
 | 
 
 | 
    $
 | 
    15.40
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Options exercised
 
 | 
 
 | 
 
 | 
    (223,657
 | 
    )
 | 
 
 | 
    $
 | 
    7.79
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Options outstanding at December 31, 2010
 
 | 
 
 | 
 
 | 
    3,385,245
 | 
 
 | 
 
 | 
    $
 | 
    11.61
 | 
 
 | 
 
 | 
 
 | 
    5.93
 | 
 
 | 
 
 | 
    $
 | 
    12,104,861
 | 
 
 | 
| 
 
    Vested and expected to vest at December 31, 2010
 
 | 
 
 | 
 
 | 
    3,179,759
 | 
 
 | 
 
 | 
    $
 | 
    11.66
 | 
 
 | 
 
 | 
 
 | 
    5.86
 | 
 
 | 
 
 | 
    $
 | 
    11,405,013
 | 
 
 | 
| 
 
    Options exercisable at December 31, 2010
 
 | 
 
 | 
 
 | 
    2,007,901
 | 
 
 | 
 
 | 
    $
 | 
    12.19
 | 
 
 | 
 
 | 
 
 | 
    5.09
 | 
 
 | 
 
 | 
    $
 | 
    7,119,365
 | 
 
 | 
 
    The total intrinsic value of options exercised during fiscal
    years 2010, 2009 and 2008 was $1.3 million, $149,000 and
    $204,000, respectively. At December 31, 2010, Intevac had
    $3.4 million of total unrecognized compensation expense,
    net of estimated forfeitures, related to stock option plans that
    will be recognized over the weighted average period of
    1.46 years.
 
    The options outstanding and currently exercisable at
    December 31, 2010 were in the following exercise price
    ranges:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Options Outstanding
 | 
 
 | 
 
 | 
    Options Exercisable
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Weighted Average 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Remaining 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Number 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
    Number of Shares 
    
 | 
 
 | 
 
 | 
    Contractual Term 
    
 | 
 
 | 
 
 | 
    Weighted Average 
    
 | 
 
 | 
 
 | 
    Vested and 
    
 | 
 
 | 
 
 | 
    Weighted Average 
    
 | 
 
 | 
| 
 
    Range of Exercise Prices
 
 | 
 
 | 
    Outstanding
 | 
 
 | 
 
 | 
    (In Years)
 | 
 
 | 
 
 | 
    Exercise Price
 | 
 
 | 
 
 | 
    Exercisable
 | 
 
 | 
 
 | 
    Exercise Price
 | 
 
 | 
|  
 | 
| 
 
    $2.63 - $4.06
 
 | 
 
 | 
 
 | 
    610,506
 | 
 
 | 
 
 | 
 
 | 
    5.07
 | 
 
 | 
 
 | 
    $
 | 
    3.44
 | 
 
 | 
 
 | 
 
 | 
    346,868
 | 
 
 | 
 
 | 
    $
 | 
    3.08
 | 
 
 | 
| 
 
    $4.07 - $7.72
 
 | 
 
 | 
 
 | 
    285,650
 | 
 
 | 
 
 | 
 
 | 
    4.78
 | 
 
 | 
 
 | 
    $
 | 
    7.08
 | 
 
 | 
 
 | 
 
 | 
    275,713
 | 
 
 | 
 
 | 
    $
 | 
    7.13
 | 
 
 | 
| 
 
    $7.73 - $10.69
 
 | 
 
 | 
 
 | 
    276,640
 | 
 
 | 
 
 | 
 
 | 
    5.40
 | 
 
 | 
 
 | 
    $
 | 
    9.30
 | 
 
 | 
 
 | 
 
 | 
    147,015
 | 
 
 | 
 
 | 
    $
 | 
    9.20
 | 
 
 | 
| 
 
    $10.70 - $15.40
 
 | 
 
 | 
 
 | 
    1,291,174
 | 
 
 | 
 
 | 
 
 | 
    6.62
 | 
 
 | 
 
 | 
    $
 | 
    12.32
 | 
 
 | 
 
 | 
 
 | 
    463,550
 | 
 
 | 
 
 | 
    $
 | 
    12.75
 | 
 
 | 
| 
 
    $15.41 - $15.81
 
 | 
 
 | 
 
 | 
    13,875
 | 
 
 | 
 
 | 
 
 | 
    4.93
 | 
 
 | 
 
 | 
    $
 | 
    15.74
 | 
 
 | 
 
 | 
 
 | 
    13,875
 | 
 
 | 
 
 | 
    $
 | 
    15.74
 | 
 
 | 
| 
 
    $15.82 - $16.13
 
 | 
 
 | 
 
 | 
    501,150
 | 
 
 | 
 
 | 
 
 | 
    6.15
 | 
 
 | 
 
 | 
    $
 | 
    16.13
 | 
 
 | 
 
 | 
 
 | 
    435,880
 | 
 
 | 
 
 | 
    $
 | 
    16.13
 | 
 
 | 
| 
 
    $16.14 - $22.01
 
 | 
 
 | 
 
 | 
    282,250
 | 
 
 | 
 
 | 
 
 | 
    6.17
 | 
 
 | 
 
 | 
    $
 | 
    19.07
 | 
 
 | 
 
 | 
 
 | 
    208,625
 | 
 
 | 
 
 | 
    $
 | 
    19.75
 | 
 
 | 
| 
 
    $22.12 - $29.45
 
 | 
 
 | 
 
 | 
    124,000
 | 
 
 | 
 
 | 
 
 | 
    5.59
 | 
 
 | 
 
 | 
    $
 | 
    24.25
 | 
 
 | 
 
 | 
 
 | 
    116,375
 | 
 
 | 
 
 | 
    $
 | 
    24.04
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    $2.63 - $29.45
 
 | 
 
 | 
 
 | 
    3,385,245
 | 
 
 | 
 
 | 
 
 | 
    5.93
 | 
 
 | 
 
 | 
    $
 | 
    11.61
 | 
 
 | 
 
 | 
 
 | 
    2,007,901
 | 
 
 | 
 
 | 
    $
 | 
    12.19
 | 
 
 | 
 
    2003
    Employee Stock Purchase Plan
 
    During fiscal years 2010, 2009 and 2008 the aggregate intrinsic
    value of purchase rights exercised under the ESPP was
    $2.2 million, $1.0 million and $267,000, respectively,
    determined as of the date of purchase. During
    
    52
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    fiscal years 2010, 2009 and 2008, 255,000, 240,000 and
    166,000 shares were purchased at an average per share price
    of $4.02, $3.73 and $9.15. At December 31, 2010, there were
    236,000 shares available to be issued under the ESPP. As of
    December 31, 2010, Intevac had $15,000 of total
    unrecognized compensation expense, net of estimated forfeitures
    related to purchase rights that will be recognized over the
    weighted average period of 0.25 years.
 
 
    Intevac calculates basic earnings per share (EPS)
    using net income (loss) and the weighted-average number of
    shares outstanding during the reporting period. Diluted EPS
    includes the effect from potential issuance of common stock
    pursuant to the exercise of employee stock options.
 
    The following table sets forth the computation of basic and
    diluted income (loss) per share:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except per share amounts)
 | 
 
 | 
|  
 | 
| 
 
    Net income (loss)
 
 | 
 
 | 
    $
 | 
    28,049
 | 
 
 | 
 
 | 
    $
 | 
    (10,077
 | 
    )
 | 
 
 | 
    $
 | 
    (15,345
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Weighted-average shares  basic
 
 | 
 
 | 
 
 | 
    22,340
 | 
 
 | 
 
 | 
 
 | 
    21,975
 | 
 
 | 
 
 | 
 
 | 
    21,724
 | 
 
 | 
| 
 
    Effect of dilutive potential common shares
 
 | 
 
 | 
 
 | 
    637
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Weighted-average shares  diluted
 
 | 
 
 | 
 
 | 
    22,977
 | 
 
 | 
 
 | 
 
 | 
    21,975
 | 
 
 | 
 
 | 
 
 | 
    21,724
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net income (loss) per share  basic
 
 | 
 
 | 
    $
 | 
    1.26
 | 
 
 | 
 
 | 
    $
 | 
    (0.46
 | 
    )
 | 
 
 | 
    $
 | 
    (0.71
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net income (loss) per share  diluted
 
 | 
 
 | 
    $
 | 
    1.22
 | 
 
 | 
 
 | 
    $
 | 
    (0.46
 | 
    )
 | 
 
 | 
    $
 | 
    (0.71
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Antidilutive shares based on employee awards excluded
 
 | 
 
 | 
 
 | 
    1,896
 | 
 
 | 
 
 | 
 
 | 
    3,150
 | 
 
 | 
 
 | 
 
 | 
    2,761
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Potentially dilutive common shares consist of shares issuable
    upon exercise of employee stock options, and are excluded from
    the calculation of diluted EPS when their effect would be
    anti-dilutive.
 
 
    Credit
    Risk and Significant Customers
 
    Financial instruments that potentially subject the Company to
    significant concentrations of credit risk consist of cash
    equivalents, short- and long-term investments, and accounts and
    notes receivable. Intevac generally invests its excess cash in
    money market funds, commercial paper, obligations of the
    U.S. government and its agencies, corporate debt securities
    and ARS. By policy, investments in money market funds and ARS
    are rated AAA or better, and Intevac limits the amount of credit
    exposure to any one issuer.
 
    Intevacs accounts receivable tend to be concentrated in a
    limited number of customers. At December 31, 2010, three
    customers accounted for 29%, 24% and 10%, respectively, of
    Intevacs accounts receivable and in aggregate accounted
    for 63% of net accounts receivable. At December 31, 2009,
    two customers accounted for 47% and 35%, respectively, of
    Intevacs accounts receivable and in aggregate accounted
    for 82% of net accounts receivable.
 
    Intevacs largest customers tend to change from period to
    period. Historically, a significant portion of Intevacs
    revenues in any particular period have been attributable to
    sales to a limited number of customers. In 2010, three customers
    accounted for 40%, 26% and 12%, respectively, of consolidated
    net revenues and in aggregate accounted for 78% of net revenues.
    In 2009, two customers accounted for 38% and 17%, respectively,
    of consolidated net revenues and in aggregate accounted for 55%
    of net revenues. In 2008, two customers accounted for 35% and
    34%, respectively, of consolidated net revenues and in aggregate
    accounted for 69% of net revenues. Intevac performs credit
    evaluations of its customers financial condition and
    generally requires deposits on system orders but does not
    generally require collateral or other security to support
    customer receivables.
    
    53
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    Products
 
    Disk manufacturing products contributed a significant portion of
    Intevacs revenues in 2010, 2009, and 2008. Intevac expects
    that the ability to maintain or expand its current levels of
    revenues in the future will depend upon continuing market demand
    for its products; its success in enhancing its existing systems
    and developing and manufacturing competitive disk manufacturing
    equipment, such as the 200 Lean; Intevacs success in
    developing both military and commercial products based on its
    low-light technology; and its success in utilizing
    Intevacs expertise in complex manufacturing equipment to
    develop and sell new equipment products for photovoltaic
    (PV) and semiconductor wafer handling.
 
 
    Balance sheet details were as follows for the years ended
    December 31, 2010 and 2009:
 
    Inventories
 
    Inventories are stated at the lower of average cost or market
    and consist of the following:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Raw materials
 
 | 
 
 | 
    $
 | 
    13,370
 | 
 
 | 
 
 | 
    $
 | 
    10,147
 | 
 
 | 
| 
 
    Work-in-progress
 
 | 
 
 | 
 
 | 
    5,295
 | 
 
 | 
 
 | 
 
 | 
    4,421
 | 
 
 | 
| 
 
    Finished goods
 
 | 
 
 | 
 
 | 
    2,006
 | 
 
 | 
 
 | 
 
 | 
    4,532
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
    $
 | 
    20,671
 | 
 
 | 
 
 | 
    $
 | 
    19,100
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Finished goods inventory consists primarily of completed systems
    at customer sites that are undergoing installation and
    acceptance testing.
 
    Property,
    Plant and Equipment
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Leasehold improvements
 
 | 
 
 | 
    $
 | 
    14,043
 | 
 
 | 
 
 | 
    $
 | 
    13,964
 | 
 
 | 
| 
 
    Machinery and equipment
 
 | 
 
 | 
 
 | 
    36,936
 | 
 
 | 
 
 | 
 
 | 
    30,577
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
    50,979
 | 
 
 | 
 
 | 
 
 | 
    44,541
 | 
 
 | 
| 
 
    Less accumulated depreciation and amortization
 
 | 
 
 | 
 
 | 
    37,061
 | 
 
 | 
 
 | 
 
 | 
    32,190
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total property, plant and equipment, net
 
 | 
 
 | 
    $
 | 
    13,918
 | 
 
 | 
 
 | 
    $
 | 
    12,351
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Customer
    Advances
 
    Customer advances generally represent nonrefundable deposits
    invoiced by the Company in connection with receiving customer
    purchase orders and other events preceding acceptance of
    systems. Customer advances related to products that have not
    been shipped to customers and included in accounts receivable
    were $1.3 million at December 31, 2010 and
    $11.8 million at December 31, 2009.
    
    54
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    Other
    Accrued Liabilities
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Contingent consideration
 
 | 
 
 | 
    $
 | 
    4,234
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
| 
 
    Accrued product warranties
 
 | 
 
 | 
 
 | 
    2,612
 | 
 
 | 
 
 | 
 
 | 
    1,550
 | 
 
 | 
| 
 
    Deferred revenue
 
 | 
 
 | 
 
 | 
    1,714
 | 
 
 | 
 
 | 
 
 | 
    7,283
 | 
 
 | 
| 
 
    Other taxes payable
 
 | 
 
 | 
 
 | 
    991
 | 
 
 | 
 
 | 
 
 | 
    1,776
 | 
 
 | 
| 
 
    Accrued income taxes
 
 | 
 
 | 
 
 | 
    360
 | 
 
 | 
 
 | 
 
 | 
    53
 | 
 
 | 
| 
 
    Other
 
 | 
 
 | 
 
 | 
    1,193
 | 
 
 | 
 
 | 
 
 | 
    442
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total other accrued liabilities
 
 | 
 
 | 
    $
 | 
    11,104
 | 
 
 | 
 
 | 
    $
 | 
    11,104
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Other
    Long-Term Liabilities
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Contingent consideration
 
 | 
 
 | 
    $
 | 
    5,623
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
| 
 
    Accrued income taxes
 
 | 
 
 | 
 
 | 
    4,098
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Deferred profit
 
 | 
 
 | 
 
 | 
    1,106
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Accrued product warranties
 
 | 
 
 | 
 
 | 
    803
 | 
 
 | 
 
 | 
 
 | 
    52
 | 
 
 | 
| 
 
    Accrued compensation
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    200
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total other long-term liabilities
 
 | 
 
 | 
    $
 | 
    11,630
 | 
 
 | 
 
 | 
    $
 | 
    252
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
     | 
     | 
    | 
    6.  
 | 
    
    Goodwill
    and Purchased Intangible Assets, Net
 | 
 
    Information regarding goodwill by reportable segment is as
    follows:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Intevac 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
    Equipment
 | 
 
 | 
 
 | 
    Photonics
 | 
 
 | 
 
 | 
    Total
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Balance as of December 31, 2007
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    7,905
 | 
 
 | 
 
 | 
    $
 | 
    7,905
 | 
 
 | 
| 
 
    Goodwill acquired during the period
 
 | 
 
 | 
 
 | 
    9,768
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    9,768
 | 
 
 | 
| 
 
    Impairment charges
 
 | 
 
 | 
 
 | 
    (9,689
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (9,689
 | 
    )
 | 
| 
 
    Foreign exchange
 
 | 
 
 | 
 
 | 
    (79
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (79
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Balance as of December 31, 2008
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    7,905
 | 
 
 | 
 
 | 
    $
 | 
    7,905
 | 
 
 | 
| 
 
    Goodwill acquired during the period
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Impairment charges
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Balance as of December 31, 2009
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    7,905
 | 
 
 | 
 
 | 
    $
 | 
    7,905
 | 
 
 | 
| 
 
    Goodwill acquired during the period
 
 | 
 
 | 
 
 | 
    10,484
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    10,484
 | 
 
 | 
| 
 
    Impairment charges
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Balance as of December 31, 2010
 
 | 
 
 | 
    $
 | 
    10,484
 | 
 
 | 
 
 | 
    $
 | 
    7,905
 | 
 
 | 
 
 | 
    $
 | 
    18,389
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Goodwill and indefinite life intangible assets are tested for
    impairment on an annual basis or more frequently upon the
    occurrence of circumstances that indicate that goodwill and
    indefinite life intangible assets may be impaired. Intevac
    conducted these impairment tests in the fourth quarter of fiscal
    2010 and 2009 and the results of these tests indicated that
    Intevacs goodwill and purchased intangible assets with
    indefinite useful lives were not impaired.
    
    55
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    In the fourth quarter of fiscal 2008, the Company experienced a
    significant decline in its stock price. As a result of the
    decline in its stock price, the Companys market
    capitalization fell significantly below the recorded value of
    its consolidated net assets. Based on the results of its
    assessment of goodwill for impairment, Intevac determined that
    the fair value of its Equipment reporting unit was less than the
    carrying value and impairment existed. Therefore, Intevac
    performed the second step of the impairment test to determine
    the implied fair value of goodwill. The analysis indicated that
    there would be no remaining implied value attributable to
    goodwill in the Equipment reporting unit and accordingly,
    Intevac wrote off all $9.7 million of goodwill in its
    Equipment reporting unit. The goodwill associated with the
    Intevac Photonics reporting unit was not impaired.
 
    During the year ended December 31, 2010, goodwill increased
    by $10.5 million due to the acquisition of Solar Implant
    Technologies, Inc. (SIT).
 
    Information regarding other acquisition-related intangible
    assets is as follows:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31, 2010
 | 
 
 | 
 
 | 
    December 31, 2009
 | 
 
 | 
| 
 
 | 
 
 | 
    Gross 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Net 
    
 | 
 
 | 
 
 | 
    Gross 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Net 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Carrying 
    
 | 
 
 | 
 
 | 
    Accumulated 
    
 | 
 
 | 
 
 | 
    Carrying 
    
 | 
 
 | 
 
 | 
    Carrying 
    
 | 
 
 | 
 
 | 
    Accumulated 
    
 | 
 
 | 
 
 | 
    Carrying 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Amount
 | 
 
 | 
 
 | 
    Amortization
 | 
 
 | 
 
 | 
    Amount
 | 
 
 | 
 
 | 
    Amount
 | 
 
 | 
 
 | 
    Amortization
 | 
 
 | 
 
 | 
    Amount
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Customer relationships
 
 | 
 
 | 
    $
 | 
    3,181
 | 
 
 | 
 
 | 
    $
 | 
    1,074
 | 
 
 | 
 
 | 
    $
 | 
    2,107
 | 
 
 | 
 
 | 
    $
 | 
    3,181
 | 
 
 | 
 
 | 
    $
 | 
    677
 | 
 
 | 
 
 | 
    $
 | 
    2,504
 | 
 
 | 
| 
 
    Purchased technology
 
 | 
 
 | 
 
 | 
    1,145
 | 
 
 | 
 
 | 
 
 | 
    388
 | 
 
 | 
 
 | 
 
 | 
    757
 | 
 
 | 
 
 | 
 
 | 
    1,145
 | 
 
 | 
 
 | 
 
 | 
    243
 | 
 
 | 
 
 | 
 
 | 
    902
 | 
 
 | 
| 
 
    Covenants not to compete
 
 | 
 
 | 
 
 | 
    140
 | 
 
 | 
 
 | 
 
 | 
    140
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    140
 | 
 
 | 
 
 | 
 
 | 
    129
 | 
 
 | 
 
 | 
 
 | 
    11
 | 
 
 | 
| 
 
    Backlog
 
 | 
 
 | 
 
 | 
    199
 | 
 
 | 
 
 | 
 
 | 
    199
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    199
 | 
 
 | 
 
 | 
 
 | 
    199
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total amortizable intangible assets
 
 | 
 
 | 
 
 | 
    4,665
 | 
 
 | 
 
 | 
 
 | 
    1,801
 | 
 
 | 
 
 | 
 
 | 
    2,864
 | 
 
 | 
 
 | 
 
 | 
    4,665
 | 
 
 | 
 
 | 
 
 | 
    1,248
 | 
 
 | 
 
 | 
 
 | 
    3,417
 | 
 
 | 
| 
 
    IPR&D
 
 | 
 
 | 
 
 | 
    4,000
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    4,000
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Tradename
 
 | 
 
 | 
 
 | 
    120
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    120
 | 
 
 | 
 
 | 
 
 | 
    120
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    120
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total intangible assets
 
 | 
 
 | 
    $
 | 
    8,785
 | 
 
 | 
 
 | 
    $
 | 
    1,801
 | 
 
 | 
 
 | 
    $
 | 
    6,984
 | 
 
 | 
 
 | 
    $
 | 
    4,785
 | 
 
 | 
 
 | 
    $
 | 
    1,248
 | 
 
 | 
 
 | 
    $
 | 
    3,537
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    During the fourth quarter of fiscal year 2008 Intevac performed
    an impairment test on intangible assets and determined that
    certain purchased technology assets in the Equipment and Intevac
    Photonics segments were impaired due to lower revenue
    expectations and future operating expectations. The
    determination was based on reviewing estimated undiscounted cash
    flows for these intangible assets, which were less than their
    carrying values. As a result, Intevac recorded an impairment
    charge of $808,000 in fiscal 2008, which represented the
    difference between the estimated fair values of these intangible
    assets as compared to their carrying fair values which were
    determined based upon market conditions, the income approach
    which utilized cash flow projections, and other factors.
 
    Total amortization expense of purchased intangibles for the
    years ended December 31, 2010, 2009 and 2008 was $554,000,
    $554,000 and $700,000 respectively. Future amortization expense
    is expected to be $541,000 for 2011, $541,000 for 2012, $541,000
    for 2013, $363,000 for 2014, $284,000 for 2015 and $593,000
    thereafter. Intangible assets by segment as of December 31,
    2010 are as follows: Equipment; $6.0 million and Intevac
    Photonics; $972,000.
 
 
    On November 19, 2010, Intevac acquired the outstanding
    shares of Solar Implant Technologies, Inc. (SIT), a
    privately-owned, development stage company, creating an ion
    implant module to be used in the manufacturing of photovoltaic
    cells. Intevacs primary reasons for this acquisition were
    to complement its existing product offerings and to provide
    opportunities for future growth. The preliminary aggregate
    purchase price was $12.4 million, which consisted of an
    initial cash payment totaling $2.7 million and a contingent
    consideration obligation with a fair value of $9.7 million
    payable in cash. In connection with the acquisition, Intevac
    acquired $4.0 million of IPR&D, $43,000 of tangible
    assets, and $10.5 million of goodwill and assumed $703,000
    of tangible liabilities. Intevac also recorded an
    $827,000 net deferred tax liability to reflect the tax
    impact of the identified intangible assets that will
    
    56
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    not generate tax deductible amortization expense net of the
    future tax benefit of acquired net operating loss carryforwards.
    The value attributable to IPR&D has been capitalized as an
    indefinite-lived intangible asset. Goodwill is attributable to
    estimated synergies arising from the acquisition and other
    intangible assets that do not qualify for separate recognition.
    Goodwill is not deductible for tax purposes.
 
    In connection with the acquisition of SIT, Intevac agreed to pay
    up to an aggregate of $7.0 million in cash to the selling
    shareholders if certain milestones are achieved over a specified
    period. Intevac estimated the fair value of this contingent
    consideration to be in the amount of $5.6 million based on
    the probability that certain milestones would be met and the
    payments would be made on the targeted dates outlined in the
    acquisition agreement.
 
    In connection with the acquisition of SIT, Intevac also agreed
    to pay a revenue earnout on Intevacs net revenue from
    commercial sales of certain products over a specified period up
    to an aggregate of $9.0 million in cash to the selling
    shareholders. Intevac estimated the fair value of this
    contingent consideration to be in the amount of
    $4.1 million based on probability-based forecasted revenues
    reflecting Intevacs own assumptions concerning future
    revenue of SIT. A change in the estimated probabilities of
    revenue achievement could have a material effect on the
    statement of operations and balance sheets in the period of
    change.
 
    Any change in fair value of the contingent consideration
    subsequent to the acquisition date is recognized in operating
    income within the statement of operations. The fair value of the
    contingent consideration increased $108,000 during the fourth
    quarter of fiscal 2010.
 
    Prior to the acquisition, Intevac had an equity interest in SIT
    with a cost basis of $94,000 that was accounted for under the
    cost method. As a result of revaluing Intevacs equity
    interest in SIT on the acquisition date, the Company recognized
    a gain of $481,000, which was included in other income, net, in
    the consolidated statement of operations.
 
    Intevac has accounted for the acquisition of SIT as a business
    combination. Under business combination accounting, the assets
    and liabilities of SIT were recorded as of the acquisition date,
    at their respective fair values, and consolidated with the
    Company. The preliminary purchase price allocation is based on
    estimates of the fair value of assets acquired and liabilities
    assumed. Subsequent to the acquisition, Intevac paid in full
    $177,000 in notes payable to certain selling shareholders
    assumed upon the acquisition. The purchase price has been
    allocated as follows:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Current assets (including cash of $38)
 
 | 
 
 | 
    $
 | 
    40
 | 
 
 | 
| 
 
    Property, plant, and equipment
 
 | 
 
 | 
 
 | 
    3
 | 
 
 | 
| 
 
    IPR&D
 
 | 
 
 | 
 
 | 
    4,000
 | 
 
 | 
| 
 
    Goodwill
 
 | 
 
 | 
 
 | 
    10,484
 | 
 
 | 
| 
 
    Long-term deferred tax assets
 
 | 
 
 | 
 
 | 
    697
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total assets acquired
 
 | 
 
 | 
 
 | 
    15,224
 | 
 
 | 
| 
 
    Notes payable to sellers
 
 | 
 
 | 
 
 | 
    177
 | 
 
 | 
| 
 
    Current liabilities
 
 | 
 
 | 
 
 | 
    526
 | 
 
 | 
| 
 
    Long-term deferred tax liabilities
 
 | 
 
 | 
 
 | 
    1,524
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total liabilities assumed
 
 | 
 
 | 
 
 | 
    2,227
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net assets acquired
 
 | 
 
 | 
    $
 | 
    12,997
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Intevacs consolidated financial statements include
    SITs operating results from the date of acquisition,
    November 19, 2010. The pro forma impact of the above
    acquisition was not significant to Intevacs results for
    the year ended December 31, 2010.
    
    57
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    On July 14, 2008, Intevac acquired certain assets and
    liabilities of OC Oerlikon Balzers Ltd.
    (Oerlikon)s magnetic media equipment business
    for a purchase price of $15.1 million in cash, net of cash
    acquired. In addition Intevac agreed to pay contingent
    consideration to Oerlikon in the form of a royalty on
    Intevacs net revenue from commercial sales of certain
    products. This agreement terminates on July 13, 2011.
    Intevac has made no payments to Oerlikon under this agreement
    through December 31, 2010. As part of the acquisition,
    Intevac also entered into a settlement agreement with Oerlikon
    related to a patent infringement lawsuit filed by Intevac
    against Unaxis USA, Inc., a wholly owned subsidiary of Oerlikon,
    and all claims in the litigation were dismissed.
 
    In connection with this acquisition, Intevac recorded goodwill
    of $9.8 million and intangible assets of $3.8 million.
    Of the $3.8 million of acquired intangible assets,
    $2.6 million was assigned to customer relationships (to be
    amortized over 6 to 9 years), $1.2 million was
    assigned to purchased technology (to be amortized over 3 to
    7 years) and $80,000 was assigned to acquired backlog (to
    be amortized over 1 year). Future contingent payments will
    also be allocated to goodwill.
 
    The results of operations for the acquired businesses have been
    included in Intevacs consolidated statements of operations
    for the periods subsequent to their respective acquisition
    dates. Pro forma results of operations have not been presented
    because the effects of the acquisitions, individually and in
    aggregate, were not material.
 
 
    Cash and cash equivalents, short-term investments and long-term
    investments consist of:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31, 2010
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Unrealized 
    
 | 
 
 | 
 
 | 
    Unrealized 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
    Amortized 
    
 | 
 
 | 
 
 | 
    Holding 
    
 | 
 
 | 
 
 | 
    Holding 
    
 | 
 
 | 
 
 | 
    Fair 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Cost
 | 
 
 | 
 
 | 
    Gains
 | 
 
 | 
 
 | 
    Losses
 | 
 
 | 
 
 | 
    Value
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Cash and cash equivalents:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Cash
 
 | 
 
 | 
    $
 | 
    22,887
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    22,887
 | 
 
 | 
| 
 
    Commercial paper
 
 | 
 
 | 
 
 | 
    2,999
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    1
 | 
 
 | 
 
 | 
 
 | 
    2,998
 | 
 
 | 
| 
 
    Corporate bonds
 
 | 
 
 | 
 
 | 
    1,259
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    1,259
 | 
 
 | 
| 
 
    Money market funds
 
 | 
 
 | 
 
 | 
    82,376
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    82,376
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total cash and cash equivalents
 
 | 
 
 | 
    $
 | 
    109,521
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    1
 | 
 
 | 
 
 | 
    $
 | 
    109,520
 | 
 
 | 
| 
 
    Short-term investments:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Commercial paper
 
 | 
 
 | 
    $
 | 
    2,995
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    2,995
 | 
 
 | 
| 
 
    U.S. treasury and agency securities
 
 | 
 
 | 
 
 | 
    1,999
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    1,999
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total short-term investments
 
 | 
 
 | 
    $
 | 
    4,994
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    4,994
 | 
 
 | 
| 
 
    Long-term investments:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    U.S. treasury and agency securities
 
 | 
 
 | 
    $
 | 
    6,978
 | 
 
 | 
 
 | 
    $
 | 
    5
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    6,983
 | 
 
 | 
| 
 
    Corporate bonds and medium-term notes
 
 | 
 
 | 
 
 | 
    5,615
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    5
 | 
 
 | 
 
 | 
 
 | 
    5,610
 | 
 
 | 
| 
 
    ARS
 
 | 
 
 | 
 
 | 
    10,900
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    627
 | 
 
 | 
 
 | 
 
 | 
    10,273
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total long-term investments
 
 | 
 
 | 
    $
 | 
    23,493
 | 
 
 | 
 
 | 
    $
 | 
    5
 | 
 
 | 
 
 | 
    $
 | 
    632
 | 
 
 | 
 
 | 
    $
 | 
    22,866
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total cash, cash equivalents, and investments
 
 | 
 
 | 
    $
 | 
    138,008
 | 
 
 | 
 
 | 
    $
 | 
      5
 | 
 
 | 
 
 | 
    $
 | 
    633
 | 
 
 | 
 
 | 
    $
 | 
    137,380
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    
    58
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31, 2009
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Unrealized 
    
 | 
 
 | 
 
 | 
    Unrealized 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
    Amortized 
    
 | 
 
 | 
 
 | 
    Holding 
    
 | 
 
 | 
 
 | 
    Holding 
    
 | 
 
 | 
 
 | 
    Fair 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Cost
 | 
 
 | 
 
 | 
    Gains
 | 
 
 | 
 
 | 
    Losses
 | 
 
 | 
 
 | 
    Value
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Cash and cash equivalents:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Cash
 
 | 
 
 | 
    $
 | 
    8,337
 | 
 
 | 
 
 | 
    $
 | 
      
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    8,337
 | 
 
 | 
| 
 
    Money market funds
 
 | 
 
 | 
 
 | 
    9,255
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    9,255
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total cash and cash equivalents
 
 | 
 
 | 
    $
 | 
    17,592
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    17,592
 | 
 
 | 
| 
 
    Short-term investments:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    U.S. treasury and agency securities
 
 | 
 
 | 
    $
 | 
    6,000
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    6,000
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total short-term investments
 
 | 
 
 | 
    $
 | 
    6,000
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    6,000
 | 
 
 | 
| 
 
    Long-term investments
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    ARS
 
 | 
 
 | 
    $
 | 
    69,950
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    3,701
 | 
 
 | 
 
 | 
    $
 | 
    66,249
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total long-term investments
 
 | 
 
 | 
    $
 | 
    69,950
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    3,701
 | 
 
 | 
 
 | 
    $
 | 
    66,249
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total cash, cash equivalents, and investments
 
 | 
 
 | 
    $
 | 
    93,542
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    3,701
 | 
 
 | 
 
 | 
    $
 | 
    89,841
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    The contractual maturities of
    available-for-sale
    securities at December 31, 2010 are presented in the
    following table.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Amortized 
    
 | 
 
 | 
 
 | 
    Fair 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Cost
 | 
 
 | 
 
 | 
    Value
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Due in one year or less
 
 | 
 
 | 
    $
 | 
    91,628
 | 
 
 | 
 
 | 
    $
 | 
    91,627
 | 
 
 | 
| 
 
    Due between one and two years
 
 | 
 
 | 
 
 | 
    12,593
 | 
 
 | 
 
 | 
 
 | 
    12,593
 | 
 
 | 
| 
 
    Greater than two years (ARS, ranging from 20 years to
    35 years)
 
 | 
 
 | 
 
 | 
    10,900
 | 
 
 | 
 
 | 
 
 | 
    10,273
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
    $
 | 
    115,121
 | 
 
 | 
 
 | 
    $
 | 
    114,493
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    As of December 31, 2010, Intevacs investment
    portfolio included ARS with an aggregate par value of
    $10.9 million. All of the ARS are student loan structured
    issues, where the loans have been originated under the
    U.S. Department of Educations Federal Family
    Education Loan Program. The principal and interest are
    97-98%
    reinsured by the U.S. Department of Education and the
    collateral ratios range from 102% to 115%. Securities with a par
    value of $8.5 million are rated AAA/Aaa, and a security
    with a par value of $2.4 million is rated AAA/A3. These
    investments have experienced failed auctions beginning in
    February 2008. The investments in ARS will not be accessible
    until a successful auction occurs, they are restructured into a
    more liquid security, a buyer is found outside of the auction
    process, or the underlying securities have matured.
 
    As of December 31, 2010, there was insufficient observable
    market information for the ARS held by Intevac to determine the
    fair value. Therefore Level 3 fair values were estimated
    for these securities by incorporating assumptions that market
    participants would use in their estimates of fair value. At
    December 31, 2010, the fair value of the ARS was estimated
    at $10.3 million based on a valuation by Houlihan Capital
    Advisors, LLC using discounted cash flow models and management
    applying internal analysis to the valuation. The estimates of
    future cash flows are based on certain key assumptions, such as
    discount rates appropriate for the type of asset and risk, which
    are significant unobservable inputs. Some of these assumptions
    included credit quality, collateralization, final stated
    maturity, estimates of the probability of being called or
    becoming liquid prior to final maturity, redemptions of similar
    ARS, previous market activity for the same investment security,
    impact due to extended periods of maximum auction rates and
    valuation models. These securities are classified as long-term
    assets, as management believes that the ARS market will not
    become liquid within the next year. Potentially, it could take
    59
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    until the final maturity of the underlying notes (ranging from
    20 years to 35 years) to realize these
    investments recorded values.
 
    Management believes that the impairment of the ARS investments
    is temporary, primarily due to the government guarantee of the
    underlying securities and Intevacs ability to hold these
    securities for the foreseeable future. Management believes that
    it is more likely than not that it would not be required to sell
    these securities before the recovery of their par amounts. A
    temporary impairment charge results in an unrealized loss being
    recorded in the other comprehensive income component of
    stockholders equity. Such an unrealized loss does not
    reduce net income for the applicable accounting period, because
    the loss is not viewed as
    other-than-temporary.
    The factors evaluated to differentiate between temporary and
    other-than-temporary
    include the projected future cash flows, credit ratings actions,
    and assessment of the credit quality of the underlying
    collateral. Factors considered in determining whether a loss is
    temporary include length of time and the extent to which the
    investments fair value has been less than the cost basis,
    the financial condition and near-term prospects of the issuer,
    including any specific events which may influence the operations
    of the issuer, and Intevacs intent and ability to retain
    the investment for a period of time sufficient to allow for any
    anticipated recovery of fair value. As of December 31,
    2010, management has no reason to believe that any of the
    underlying issuers of Intevacs ARS or their insurers are
    presently at risk or that the underlying credit quality of the
    assets backing Intevacs ARS has been impacted by the
    reduced liquidity of these investments. As of December 31,
    2010, based on the Level 3 valuation performed, Intevac
    determined that there was a temporary decline in fair value of
    its ARS of $627,000.
 
    On March 19, 2009, Intevac filed a statement of claim under
    the Financial Industry Regulatory Authority dispute resolution
    process against Citigroup Inc. and Citigroup Global Markets,
    Inc. (collectively, Citigroup) with respect to
    alleged fraud and market manipulation by Citigroup related to
    ARS. The statement of claim requested that Citigroup accept
    Intevacs tender of its ARS at par value and that Intevac
    receive compensatory, consequential and punitive damages and
    costs and expenses. Citigroup responded denying Intevacs
    claims. The arbitration proceedings were completed on
    June 10, 2010. On June 29, 2010, Intevac received a
    favorable ruling from the arbitration panel whereby Citigroup
    was ordered to rescind the sale of the $54.8 million par
    value in outstanding ARS investments. On July 27, 2010,
    Intevac received $54.8 million from the repurchase of the
    securities by Citigroup at par including interest and recognized
    the reversal of a $3.3 million temporary impairment charge
    in other comprehensive loss in the third quarter of fiscal year
    2010.
 
    The following table represents the fair value hierarchy of
    Intevacs assets and liabilities measured at fair value on
    a recurring basis as of December 31, 2010.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Fair Value Measurements at December 31, 2010
 | 
 
 | 
| 
 
 | 
 
 | 
    Total
 | 
 
 | 
 
 | 
    Level 1
 | 
 
 | 
 
 | 
    Level 2
 | 
 
 | 
 
 | 
    Level 3
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Assets:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Money market funds
 
 | 
 
 | 
    $
 | 
    82,376
 | 
 
 | 
 
 | 
    $
 | 
    82,376
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
| 
 
    U.S. treasury and agency securities
 
 | 
 
 | 
 
 | 
    8,982
 | 
 
 | 
 
 | 
 
 | 
    3,995
 | 
 
 | 
 
 | 
 
 | 
    4,987
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Commercial paper
 
 | 
 
 | 
 
 | 
    5,994
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    5,994
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Corporate bonds and medium-term notes
 
 | 
 
 | 
 
 | 
    6,868
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    6,868
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    ARS
 
 | 
 
 | 
 
 | 
    10,273
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    10,273
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total assets
 
 | 
 
 | 
    $
 | 
    114,493
 | 
 
 | 
 
 | 
    $
 | 
    86,371
 | 
 
 | 
 
 | 
    $
 | 
    17,849
 | 
 
 | 
 
 | 
    $
 | 
    10,273
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Liabilities:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Contingent consideration
 
 | 
 
 | 
    $
 | 
    9,857
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    9,857
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    
    60
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    The following table presents the changes in Level 3
    instruments measured on a recurring basis for the years ended
    December 31, 2010 and 2009. The majority of Intevacs
    Level 3 balances consist of investment securities
    classified as
    available-for-sale
    with changes in fair value recorded in equity.
 
    Changes in Level 3 instruments (in thousands):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Investment securities at December 31, 2008
 
 | 
 
 | 
    $
 | 
    66,328
 | 
 
 | 
| 
 
    Net unrealized gains and losses included in earnings
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Net unrealized gains and losses included in other comprehensive
    income
 
 | 
 
 | 
 
 | 
    4,371
 | 
 
 | 
| 
 
    Redemptions at par
 
 | 
 
 | 
 
 | 
    (4,450
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Investment securities at December 31, 2009
 
 | 
 
 | 
 
 | 
    66,249
 | 
 
 | 
| 
 
    Net unrealized gains and losses included in earnings
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Net unrealized gains and losses included in other comprehensive
    income
 
 | 
 
 | 
 
 | 
    3,074
 | 
 
 | 
| 
 
    Redemptions at par
 
 | 
 
 | 
 
 | 
    (59,050
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Investment securities at December 31, 2010
 
 | 
 
 | 
    $
 | 
    10,273
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Included in accounts payable is $660,000 and $722,000 of book
    overdraft at December 31, 2010 and 2009, respectively.
 
 
    The provision for (benefit from) income taxes on income (loss)
    from continuing operations consists of the following (in
    thousands):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
|  
 | 
| 
 
    Federal:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Current
 
 | 
 
 | 
    $
 | 
    5,241
 | 
 
 | 
 
 | 
    $
 | 
    (3,927
 | 
    )
 | 
 
 | 
    $
 | 
    (3,498
 | 
    )
 | 
| 
 
    Deferred
 
 | 
 
 | 
 
 | 
    (1,706
 | 
    )
 | 
 
 | 
 
 | 
    (3,860
 | 
    )
 | 
 
 | 
 
 | 
    (7,442
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
    3,535
 | 
 
 | 
 
 | 
 
 | 
    (7,787
 | 
    )
 | 
 
 | 
 
 | 
    (10,940
 | 
    )
 | 
| 
 
    State:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Current
 
 | 
 
 | 
 
 | 
    8
 | 
 
 | 
 
 | 
 
 | 
    3
 | 
 
 | 
 
 | 
 
 | 
    3
 | 
 
 | 
| 
 
    Deferred
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    1,567
 | 
 
 | 
 
 | 
 
 | 
    (560
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
    8
 | 
 
 | 
 
 | 
 
 | 
    1,570
 | 
 
 | 
 
 | 
 
 | 
    (557
 | 
    )
 | 
| 
 
    Foreign:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Current
 
 | 
 
 | 
 
 | 
    419
 | 
 
 | 
 
 | 
 
 | 
    201
 | 
 
 | 
 
 | 
 
 | 
    303
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total
 
 | 
 
 | 
    $
 | 
    3,962
 | 
 
 | 
 
 | 
    $
 | 
    (6,016
 | 
    )
 | 
 
 | 
    $
 | 
    (11,194
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Income (loss) before income taxes (benefit) consisted of the
    following (in thousands):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
|  
 | 
| 
 
    U.S. 
 
 | 
 
 | 
    $
 | 
    384
 | 
 
 | 
 
 | 
    $
 | 
    (22,513
 | 
    )
 | 
 
 | 
    $
 | 
    (28,886
 | 
    )
 | 
| 
 
    Foreign
 
 | 
 
 | 
 
 | 
    31,627
 | 
 
 | 
 
 | 
 
 | 
    6,420
 | 
 
 | 
 
 | 
 
 | 
    2,347
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
    $
 | 
    32,011
 | 
 
 | 
 
 | 
    $
 | 
    (16,093
 | 
    )
 | 
 
 | 
    $
 | 
    (26,539
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Effective tax rate
 
 | 
 
 | 
 
 | 
    12.4
 | 
    %
 | 
 
 | 
 
 | 
    37.4
 | 
    %
 | 
 
 | 
 
 | 
    42.2
 | 
    %
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    
    61
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    The tax benefits associated with exercises of nonqualified stock
    options and disqualifying dispositions of stock acquired through
    incentive stock options and the employee stock purchase plan
    increased income taxes receivable by $299,000, $69,000 and
    $327,000 in 2010, 2009 and 2008 respectively. Such benefits were
    credited to additional paid-in capital.
 
    Deferred income taxes reflect the net tax effects of temporary
    differences between the carrying amounts of assets and
    liabilities for financial reporting purposes and the amounts for
    income tax purposes. Significant components of deferred tax
    assets are as follows (in thousands):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
|  
 | 
| 
 
    Deferred tax assets:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Vacation, rent, warranty and other accruals
 
 | 
 
 | 
    $
 | 
    1,073
 | 
 
 | 
 
 | 
    $
 | 
    932
 | 
 
 | 
| 
 
    Depreciation and amortization
 
 | 
 
 | 
 
 | 
    3,416
 | 
 
 | 
 
 | 
 
 | 
    3,280
 | 
 
 | 
| 
 
    Inventory valuation
 
 | 
 
 | 
 
 | 
    2,029
 | 
 
 | 
 
 | 
 
 | 
    2,044
 | 
 
 | 
| 
 
    Deferred income
 
 | 
 
 | 
 
 | 
    308
 | 
 
 | 
 
 | 
 
 | 
    (713
 | 
    )
 | 
| 
 
    Equity-based compensation
 
 | 
 
 | 
 
 | 
    6,156
 | 
 
 | 
 
 | 
 
 | 
    6,221
 | 
 
 | 
| 
 
    Research and other tax credit carryforwards
 
 | 
 
 | 
 
 | 
    16,949
 | 
 
 | 
 
 | 
 
 | 
    15,866
 | 
 
 | 
| 
 
    Impairment losses on
    available-for-sale
    securities
 
 | 
 
 | 
 
 | 
    221
 | 
 
 | 
 
 | 
 
 | 
    1,295
 | 
 
 | 
| 
 
    Other
 
 | 
 
 | 
 
 | 
    (211
 | 
    )
 | 
 
 | 
 
 | 
    (293
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
    29,941
 | 
 
 | 
 
 | 
 
 | 
    28,632
 | 
 
 | 
| 
 
    Valuation allowance for deferred tax assets
 
 | 
 
 | 
 
 | 
    (10,699
 | 
    )
 | 
 
 | 
 
 | 
    (10,576
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total deferred tax assets
 
 | 
 
 | 
 
 | 
    19,242
 | 
 
 | 
 
 | 
 
 | 
    18,056
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Deferred tax liabilities:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Purchased technology
 
 | 
 
 | 
 
 | 
    (1,524
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net deferred tax assets
 
 | 
 
 | 
    $
 | 
    17,718
 | 
 
 | 
 
 | 
    $
 | 
    18,056
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    As reported on the balance sheet:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Current assets
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Deferred tax assets
 
 | 
 
 | 
    $
 | 
    3,400
 | 
 
 | 
 
 | 
    $
 | 
    2,465
 | 
 
 | 
| 
 
    Valuation allowance for deferred tax assets
 
 | 
 
 | 
 
 | 
    (276
 | 
    )
 | 
 
 | 
 
 | 
    (950
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net current deferred tax assets
 
 | 
 
 | 
 
 | 
    3,124
 | 
 
 | 
 
 | 
 
 | 
    1,515
 | 
 
 | 
| 
 
    Other long-term assets
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Deferred tax assets
 
 | 
 
 | 
 
 | 
    25,017
 | 
 
 | 
 
 | 
 
 | 
    26,167
 | 
 
 | 
| 
 
    Valuation allowance for deferred tax assets
 
 | 
 
 | 
 
 | 
    (10,423
 | 
    )
 | 
 
 | 
 
 | 
    (9,626
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net non-current deferred tax assets
 
 | 
 
 | 
 
 | 
    14,594
 | 
 
 | 
 
 | 
 
 | 
    16,541
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net deferred tax assets
 
 | 
 
 | 
    $
 | 
    17,718
 | 
 
 | 
 
 | 
    $
 | 
    18,056
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    The valuation allowance of $10.7 million is attributable to
    state income tax temporary differences and deferred research and
    other tax credits that are not realizable in the foreseeable
    future. State research credit carry-forwards of
    $7.6 million, which are fully offset by a valuation
    allowance, do not expire.
    
    62
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    The difference between the tax provision (benefit) at the
    statutory federal income tax rate and the tax provision
    (benefit) was as follows (in thousands):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
|  
 | 
| 
 
    Income tax (benefit) at the federal statutory rate
 
 | 
 
 | 
    $
 | 
    11,204
 | 
 
 | 
 
 | 
    $
 | 
    (5,632
 | 
    )
 | 
 
 | 
    $
 | 
    (9,289
 | 
    )
 | 
| 
 
    State income taxes, net of federal benefit
 
 | 
 
 | 
 
 | 
    5
 | 
 
 | 
 
 | 
 
 | 
    1,020
 | 
 
 | 
 
 | 
 
 | 
    (312
 | 
    )
 | 
| 
 
    Effect of foreign operations taxes at various rates
 
 | 
 
 | 
 
 | 
    (10,650
 | 
    )
 | 
 
 | 
 
 | 
    (2,046
 | 
    )
 | 
 
 | 
 
 | 
    (518
 | 
    )
 | 
| 
 
    Research tax credits
 
 | 
 
 | 
 
 | 
    (500
 | 
    )
 | 
 
 | 
 
 | 
    (565
 | 
    )
 | 
 
 | 
 
 | 
    (1,100
 | 
    )
 | 
| 
 
    Effect of tax rate changes, permanent differences and
    adjustments of prior deferrals
 
 | 
 
 | 
 
 | 
    187
 | 
 
 | 
 
 | 
 
 | 
    965
 | 
 
 | 
 
 | 
 
 | 
    (36
 | 
    )
 | 
| 
 
    Unrecognized tax benefits
 
 | 
 
 | 
 
 | 
    3,716
 | 
 
 | 
 
 | 
 
 | 
    242
 | 
 
 | 
 
 | 
 
 | 
    140
 | 
 
 | 
| 
 
    Other
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (79
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total
 
 | 
 
 | 
    $
 | 
    3,962
 | 
 
 | 
 
 | 
    $
 | 
    (6,016
 | 
    )
 | 
 
 | 
    $
 | 
    (11,194
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Included in the above rate reconciliation for the year ended
    December 31, 2009 is $600,000 of net unfavorable federal
    adjustments related to prior estimates for research tax credits
    and the Domestic Production Activities Deduction (DPAD).
    Included in the above rate reconciliation for the year ended
    December 31, 2008 is $696,000 of net favorable federal and
    state adjustments related to prior estimates for research tax
    credits, DPAD, deduction limits on executive compensation, and a
    book and tax basis difference related to Intevacs interest
    in a real estate investment.
 
    Intevac has not provided for U.S. federal income and
    foreign withholding taxes on approximately $44.5 million of
    undistributed earnings from
    non-U.S. operations
    as of December 31, 2010 because Intevac intends to reinvest
    such earnings indefinitely outside of the United States. If
    Intevac were to distribute these earnings, foreign tax credits
    may become available under current law to reduce the resulting
    U.S. income tax liability. Determination of the amount of
    unrecognized deferred tax liability related to these earnings is
    not practicable. Intevac will remit the non-indefinitely
    reinvested earnings, if any, of Intevacs
    non-U.S. subsidiaries
    where excess cash has accumulated and Intevac determines that it
    is advantageous for business operations, tax or cash reasons.
 
    Intevac enjoys a tax holiday in Singapore through the tax years
    ending in 2015. The tax holiday provides a lower income tax rate
    on certain classes of income and the agreement requires that
    certain thresholds of business investment and employment levels
    be met in Singapore in order to maintain this holiday. As a
    result of this incentive, the impact of the tax holiday
    decreased income taxes by $5.1 million, $1.2 million
    and $250,000 in 2010, 2009 and 2008, respectively. The benefit
    of the tax holiday on net income (loss) per share (diluted) was
    approximately $0.22, $0.06, and $0.01 in 2010, 2009 and 2008,
    respectively.
 
    Included in prepaid expenses and other current assets at both
    December 31, 2010 and 2009 is $4.4 million of Federal
    income taxes receivable which represents amounts available as a
    result of carryback of losses. As of December 31, 2010, the
    Company had Federal NOL carryforwards available to offset future
    taxable income of approximately $568,000 that expire between
    2028 and 2030. As of December 31, 2010, the Company had
    state NOL carryforwards available to offset future state taxable
    income of approximately $28.9 million that expire between
    2011 and 2030. In addition, the Company had various federal and
    state tax credit carryforwards combined of approximately
    $14.4 million. Approximately $6.3 million of the
    credit carryforwards are available to offset future tax
    liabilities and expire between 2025 and 2030. The remaining
    amount is available indefinitely. Certain of these
    carryforwards, when realized, will be credited to additional
    paid-in capital.
    
    63
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    The total amount of gross unrecognized tax benefits was
    $4.5 million as of December 31, 2010, of which up to
    $4.1 million would affect Intevacs effective tax rate
    if realized. The aggregate changes in the balance of gross
    unrecognized tax benefits were as follows:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    (In thousands):
 | 
 
 | 
|  
 | 
| 
 
    Beginning balance as of December 31, 2008
 
 | 
 
 | 
    $
 | 
    540
 | 
 
 | 
| 
 
    Increases in balances related to tax positions taken during
    current period
 
 | 
 
 | 
 
 | 
    242
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Balance as of December 31, 2009
 
 | 
 
 | 
 
 | 
    782
 | 
 
 | 
| 
 
    Increases in balances related to tax positions taken during
    current period
 
 | 
 
 | 
 
 | 
    3,716
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Balance as of at December 31, 2010
 
 | 
 
 | 
    $
 | 
    4,498
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    The unrecognized tax benefits may decrease in the next twelve
    months due to examinations by tax authorities. Intevac did not
    accrue any interest or penalties related to these unrecognized
    tax benefits because Intevac has other tax attributes which
    would offset any potential taxes due.
 
    Intevac is subject to income taxes in the U.S. federal
    jurisdiction, and various states and foreign jurisdictions. Tax
    regulations within each jurisdiction are subject to the
    interpretation of the related tax laws and regulations and
    require significant judgment to apply. With few exceptions,
    Intevac is not subject to U.S. federal, state and local, or
    international jurisdictions income tax examinations by tax
    authorities for the years before 2004. The Company currently has
    a California income tax examination for fiscal years ended 2005,
    2006 and 2007. Presently, there are no other active income tax
    examinations in the jurisdictions where Intevac operates.
 
     | 
     | 
    | 
    10.  
 | 
    
    Employee
    Benefit Plans
 | 
 
    Employee
    Savings and Retirement Plan
 
    In 1991, Intevac established a defined contribution retirement
    plan with 401(k) plan features. The plan covers all United
    States employees eighteen years and older. Employees may make
    contributions by a percentage reduction in their salaries, not
    to exceed the statutorily prescribed annual limit. Intevac made
    cash contributions of $438,000, $109,000 and $541,000 for the
    years ended December 31, 2010, 2009, and 2008,
    respectively. Employees may choose among several investment
    options for their contributions and their share of
    Intevacs contributions, and they are able to move funds
    between investment options at any time. Intevacs common
    stock is not one of the investment options. Administrative
    expenses relating to the plan are insignificant.
 
    Employee
    Bonus Plans
 
    Intevac has various employee bonus plans. A profit-sharing plan
    provides for the distribution of a percentage of pre-tax profits
    to substantially all of Intevacs employees not eligible
    for other performance-based incentive plans, up to a maximum
    percentage of compensation. Other plans award annual or
    quarterly bonuses to Intevacs executives and key
    contributors based on the achievement of profitability and other
    specific performance criteria. Charges to expense under these
    plans were $7.6 million for the year ended
    December 31, 2010. There were no charges to expense under
    these plans for the years ended December 31, 2009 and 2008.
 
     | 
     | 
    | 
    11.  
 | 
    
    Commitments
    and Contingencies
 | 
 
    Leases
 
    Intevac leases certain facilities under non-cancelable operating
    leases that expire at various times up to March 2017 and
    has options to renew most leases, with rentals to be negotiated.
    Certain of Intevacs leases contain provisions for rental
    adjustments. Included in other long-term assets on the
    Consolidated Balance Sheets is $576,000 of prepaid rent related
    to the effective rent on Intevacs long-term lease for
    Intevacs Santa Clara facility. The facility leases
    require Intevac to pay for all normal maintenance costs. Gross
    rental expense was approximately
    
    64
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    $3.3 million, $3.4 million and $3.2 million for
    the years ended December 31, 2010, 2009, and 2008,
    respectively. Future minimum lease payments at December 31,
    2010 totaled $11.7 million and were: $2.6 million for
    fiscal 2011; $2.2 million for fiscal 2012;
    $1.9 million for fiscal 2013; $1.5 million for fiscal
    2014; $1.5 million for fiscal 2015 and $2.0 million
    for thereafter.
 
    Guarantees
 
    Officer
    and Director Indemnifications
 
    As permitted or required under Delaware law and to the maximum
    extent allowable under that law, Intevac has certain obligations
    to indemnify its current and former officers and directors for
    certain events or occurrences while the officer or director is,
    or was serving, at Intevacs request in such capacity.
    These indemnification obligations are valid as long as the
    director or officer acted in good faith and in a manner the
    person reasonably believed to be in or not opposed to the best
    interests of the corporation and, with respect to any criminal
    action or proceeding, had no reasonable cause to believe his or
    her conduct was unlawful. The maximum potential amount of future
    payments Intevac could be required to make under these
    indemnification obligations is unlimited; however, Intevac has a
    director and officer insurance policy that mitigates
    Intevacs exposure and enables Intevac to recover a portion
    of any future amounts paid. As a result of Intevacs
    insurance policy coverage, Intevac believes the estimated fair
    value of these indemnification obligations is not material.
 
    Other
    Indemnifications
 
    As is customary in Intevacs industry, many of
    Intevacs contracts provide remedies to certain third
    parties such as defense, settlement, or payment of judgment for
    intellectual property claims related to the use of its products.
    Such indemnification obligations may not be subject to maximum
    loss clauses. Historically, payments made related to these
    indemnifications have been immaterial.
 
    Warranty
 
    Intevac provides for the estimated cost of warranty when revenue
    is recognized. Intevacs warranty is per contract terms and
    for its disk manufacturing systems the warranty typically ranges
    between 12 and 24 months from customer acceptance. For
    systems sold through a distributor, Intevac offers a
    3 month warranty. The remainder of any warranty period is
    the responsibility of the distributor. During this warranty
    period any defective non-consumable parts are replaced and
    installed at no charge to the customer. The warranty period on
    consumable parts is limited to their reasonable usable lives.
    Intevac uses estimated repair or replacement costs along with
    its historical warranty experience to determine its warranty
    obligation. Intevac generally provides a twelve month warranty
    on its Intevac Photonics products. The provision for the
    estimated future costs of warranty is based upon historical cost
    and product performance experience. Intevac exercises judgment
    in determining the underlying estimates.
 
    On the Consolidated Balance Sheet, the short-term portion of the
    warranty provision is included in other accrued liabilities,
    while the long-term portion is included in other long-term
    liabilities. The expense associated with product warranties
    issued or adjusted is included in cost of net revenues on the
    Consolidated Statements of Operations.
    
    65
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    The following table displays the activity in the warranty
    provision account for 2010 and 2009:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Beginning balance
 
 | 
 
 | 
    $
 | 
    1,602
 | 
 
 | 
 
 | 
    $
 | 
    1,695
 | 
 
 | 
| 
 
    Expenditures incurred under warranties
 
 | 
 
 | 
 
 | 
    (2,938
 | 
    )
 | 
 
 | 
 
 | 
    (1,645
 | 
    )
 | 
| 
 
    Accruals for product warranties
 
 | 
 
 | 
 
 | 
    4,292
 | 
 
 | 
 
 | 
 
 | 
    1,740
 | 
 
 | 
| 
 
    Adjustments to previously existing warranty accruals
 
 | 
 
 | 
 
 | 
    459
 | 
 
 | 
 
 | 
 
 | 
    (188
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Ending balance
 
 | 
 
 | 
    $
 | 
    3,415
 | 
 
 | 
 
 | 
    $
 | 
    1,602
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    The following table displays the balance sheet classification of
    the warranty provision account at December 31, 2010 and
    2009:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Other accrued liabilities
 
 | 
 
 | 
    $
 | 
    2,612
 | 
 
 | 
 
 | 
    $
 | 
    1,550
 | 
 
 | 
| 
 
    Other long-term liabilities
 
 | 
 
 | 
 
 | 
    803
 | 
 
 | 
 
 | 
 
 | 
    52
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total warranty provision
 
 | 
 
 | 
    $
 | 
    3,415
 | 
 
 | 
 
 | 
    $
 | 
    1,602
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Legal
    Matters
 
    From time to time, Intevac receives notification from third
    parties, including customers and suppliers, seeking
    indemnification, litigation support, payment of money or other
    actions in connection with claims made against them. In
    addition, from time to time, Intevac receives notification from
    third parties claiming that Intevac may be or is infringing
    their intellectual property or other rights. Intevac also is
    subject to various other legal proceedings and claims, both
    asserted and unasserted, that arise in the ordinary course of
    business. Although the outcome of these claims and proceedings
    cannot be predicted with certainty, Intevac does not believe
    that any of these other existing proceedings or claims will have
    a material adverse effect on its consolidated financial
    condition or results of operations.
 
     | 
     | 
    | 
    12.  
 | 
    
    Segment
    and Geographic Information
 | 
 
    Intevacs two reportable segments are: Equipment and
    Intevac Photonics. Effective in the second quarter of 2008,
    Intevac renamed the Imaging Instrumentation segment Intevac
    Photonics. Intevacs chief operating decision-maker has
    been identified as the President and CEO, who reviews operating
    results to make decisions about allocating resources and
    assessing performance for the entire Company. Segment
    information is presented based upon Intevacs management
    organization structure as of December 31, 2010 and the
    distinctive nature of each segment. Future changes to this
    internal financial structure may result in changes to the
    reportable segments disclosed.
 
    Each reportable segment is separately managed and has separate
    financial results that are reviewed by Intevacs chief
    operating decision-maker. Each reportable segment contains
    closely related products that are unique to the particular
    segment. Segment operating profit is determined based upon
    internal performance measures used by the chief operating
    decision-maker.
 
    Intevac derives the segment results from its internal management
    reporting system. The accounting policies Intevac uses to derive
    reportable segment results are substantially the same as those
    used for external reporting purposes. Management measures the
    performance of each reportable segment based upon several
    metrics, including orders, net revenues and operating income.
    Management uses these results to evaluate the performance of,
    and to assign resources to, each of the reportable segments.
    Intevac manages certain operating expenses separately at the
    
    66
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    corporate level. Intevac allocates certain of these corporate
    expenses to the segments in an amount equal to 3% of net
    revenues. Segment operating income excludes interest
    income/expense and other financial charges and income taxes
    according to how a particular reportable segments
    management is measured. Management does not consider impairment
    charges and unallocated costs in measuring the performance of
    the reportable segments.
 
    The Equipment segment designs, develops and markets
    manufacturing equipment and solutions to the hard disk drive
    industry and offers high-productivity technology solutions to
    the PV and semiconductor industries. The Equipment segment began
    offering solar cell processing systems for thin film
    applications in 2009 and for wafer-based crystalline silicon
    (c-Si) applications in 2010 to PV cell
    manufacturers. In 2010 the Equipment segment also began offering
    inspection equipment to PV cell manufacturers. In 2010, the
    Equipment segment began offering wafer handling systems to the
    semiconductor market. Historically, the majority of
    Intevacs revenue has been derived from the Equipment
    segment and Intevac expects that the majority of its revenues
    for the next several years will continue to be derived from the
    Equipment segment.
 
    The Intevac Photonics segment develops compact, cost-effective,
    high-sensitivity digital-optical products for the capture and
    display of low-light images and the optical analysis of
    materials. Intevac provides sensors, cameras and systems for
    government applications such as night vision and long-range
    target identification and for commercial applications in the
    inspection, law enforcement, scientific and medical industries.
 
    Information for each reportable segment for the years ended
    December 31, 2010, 2009 and 2008 is as follows:
 
    Net
    Revenues
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Equipment
 
 | 
 
 | 
    $
 | 
    168,252
 | 
 
 | 
 
 | 
    $
 | 
    51,389
 | 
 
 | 
 
 | 
    $
 | 
    87,469
 | 
 
 | 
| 
 
    Intevac Photonics
 
 | 
 
 | 
 
 | 
    34,274
 | 
 
 | 
 
 | 
 
 | 
    26,592
 | 
 
 | 
 
 | 
 
 | 
    22,838
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total segment net revenues
 
 | 
 
 | 
    $
 | 
    202,526
 | 
 
 | 
 
 | 
    $
 | 
    77,981
 | 
 
 | 
 
 | 
    $
 | 
    110,307
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Operating
    Profit (Loss)
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Equipment
 
 | 
 
 | 
    $
 | 
    40,286
 | 
 
 | 
 
 | 
    $
 | 
    (8,826
 | 
    )
 | 
 
 | 
    $
 | 
    (9,924
 | 
    )
 | 
| 
 
    Intevac Photonics
 
 | 
 
 | 
 
 | 
    (4,901
 | 
    )
 | 
 
 | 
 
 | 
    (4,133
 | 
    )
 | 
 
 | 
 
 | 
    (6,674
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total segment operating profit (loss)
 
 | 
 
 | 
 
 | 
    35,385
 | 
 
 | 
 
 | 
 
 | 
    (12,959
 | 
    )
 | 
 
 | 
 
 | 
    (16,598
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Unallocated costs
 
 | 
 
 | 
 
 | 
    (4,147
 | 
    )
 | 
 
 | 
 
 | 
    (4,388
 | 
    )
 | 
 
 | 
 
 | 
    (3,375
 | 
    )
 | 
| 
 
    Impairment of goodwill and intangible assets
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (10,498
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Operating income (loss)
 
 | 
 
 | 
 
 | 
    31,238
 | 
 
 | 
 
 | 
 
 | 
    (17,347
 | 
    )
 | 
 
 | 
 
 | 
    (30,471
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Interest income
 
 | 
 
 | 
 
 | 
    899
 | 
 
 | 
 
 | 
 
 | 
    1,362
 | 
 
 | 
 
 | 
 
 | 
    3,968
 | 
 
 | 
| 
 
    Other income and expense, net
 
 | 
 
 | 
 
 | 
    (126
 | 
    )
 | 
 
 | 
 
 | 
    (108
 | 
    )
 | 
 
 | 
 
 | 
    (36
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Income (loss) before income taxes
 
 | 
 
 | 
    $
 | 
    32,011
 | 
 
 | 
 
 | 
    $
 | 
    (16,093
 | 
    )
 | 
 
 | 
    $
 | 
    (26,539
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    
    67
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    Depreciation
    and amortization
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Equipment
 
 | 
 
 | 
    $
 | 
    3,129
 | 
 
 | 
 
 | 
    $
 | 
    2,916
 | 
 
 | 
 
 | 
    $
 | 
    2,851
 | 
 
 | 
| 
 
    Intevac Photonics
 
 | 
 
 | 
 
 | 
    1,354
 | 
 
 | 
 
 | 
 
 | 
    1,326
 | 
 
 | 
 
 | 
 
 | 
    1,384
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total segment depreciation and amortization
 
 | 
 
 | 
 
 | 
    4,483
 | 
 
 | 
 
 | 
 
 | 
    4,242
 | 
 
 | 
 
 | 
 
 | 
    4,235
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Unallocated costs
 
 | 
 
 | 
 
 | 
    1,378
 | 
 
 | 
 
 | 
 
 | 
    1,343
 | 
 
 | 
 
 | 
 
 | 
    1,174
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total consolidated depreciation and amortization
 
 | 
 
 | 
    $
 | 
    5,861
 | 
 
 | 
 
 | 
    $
 | 
    5,585
 | 
 
 | 
 
 | 
    $
 | 
    5,409
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Capital
    Additions
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
    2009
 | 
 
 | 
    2008
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
|  
 | 
| 
 
    Equipment
 
 | 
 
 | 
    $
 | 
    1,540
 | 
 
 | 
 
 | 
    $
 | 
    1,176
 | 
 
 | 
 
 | 
    $
 | 
    1,588
 | 
 
 | 
| 
 
    Intevac Photonics
 
 | 
 
 | 
 
 | 
    5,167
 | 
 
 | 
 
 | 
 
 | 
    938
 | 
 
 | 
 
 | 
 
 | 
    1,743
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total segment capital additions
 
 | 
 
 | 
 
 | 
    6,707
 | 
 
 | 
 
 | 
 
 | 
    2,114
 | 
 
 | 
 
 | 
 
 | 
    3,331
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Unallocated
 
 | 
 
 | 
 
 | 
    348
 | 
 
 | 
 
 | 
 
 | 
    501
 | 
 
 | 
 
 | 
 
 | 
    854
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total consolidated capital additions
 
 | 
 
 | 
    $
 | 
    7,055
 | 
 
 | 
 
 | 
    $
 | 
    2,615
 | 
 
 | 
 
 | 
    $
 | 
    4,185
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Segment
    Assets
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
    2009
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
|  
 | 
| 
 
    Equipment
 
 | 
 
 | 
    $
 | 
    57,130
 | 
 
 | 
 
 | 
    $
 | 
    61,136
 | 
 
 | 
| 
 
    Intevac Photonics
 
 | 
 
 | 
 
 | 
    31,275
 | 
 
 | 
 
 | 
 
 | 
    25,529
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total segment assets
 
 | 
 
 | 
 
 | 
    88,405
 | 
 
 | 
 
 | 
 
 | 
    86,665
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Cash and investments
 
 | 
 
 | 
 
 | 
    137,380
 | 
 
 | 
 
 | 
 
 | 
    89,841
 | 
 
 | 
| 
 
    Deferred income taxes
 
 | 
 
 | 
 
 | 
    17,718
 | 
 
 | 
 
 | 
 
 | 
    18,056
 | 
 
 | 
| 
 
    Other current assets
 
 | 
 
 | 
 
 | 
    5,889
 | 
 
 | 
 
 | 
 
 | 
    5,171
 | 
 
 | 
| 
 
    Common property, plant and equipment
 
 | 
 
 | 
 
 | 
    1,803
 | 
 
 | 
 
 | 
 
 | 
    2,802
 | 
 
 | 
| 
 
    Other assets
 
 | 
 
 | 
 
 | 
    576
 | 
 
 | 
 
 | 
 
 | 
    843
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Consolidated total assets
 
 | 
 
 | 
    $
 | 
    251,771
 | 
 
 | 
 
 | 
    $
 | 
    203,378
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Geographic revenue information for the three years ended
    December 31, 2010 is based on the location of the customer.
    Revenue from unaffiliated customers by geographic region/country
    was as follows:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2008
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    United States
 
 | 
 
 | 
    $
 | 
    47,554
 | 
 
 | 
 
 | 
    $
 | 
    38,768
 | 
 
 | 
 
 | 
    $
 | 
    33,806
 | 
 
 | 
| 
 
    Asia(*)
 
 | 
 
 | 
 
 | 
    149,456
 | 
 
 | 
 
 | 
 
 | 
    38,144
 | 
 
 | 
 
 | 
 
 | 
    75,102
 | 
 
 | 
| 
 
    Europe
 
 | 
 
 | 
 
 | 
    5,000
 | 
 
 | 
 
 | 
 
 | 
    1,069
 | 
 
 | 
 
 | 
 
 | 
    1,321
 | 
 
 | 
| 
 
    Rest of world
 
 | 
 
 | 
 
 | 
    516
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    78
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total net revenues
 
 | 
 
 | 
    $
 | 
    202,526
 | 
 
 | 
 
 | 
    $
 | 
    77,981
 | 
 
 | 
 
 | 
    $
 | 
    110,307
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 
     | 
     | 
     | 
    | 
    (*)  | 
     | 
    
    Revenues are attributable to the geographic area in which
    Intevacs customers are located. Net trade revenues in Asia
    include shipments to Singapore, China, Japan and Malaysia. | 
    
    68
 
    INTEVAC,
    INC.
    
 
    NOTES TO
    CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
 
    Net property, plant and equipment by geographic region at
    December 31 was as follows:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    United States
 
 | 
 
 | 
    $
 | 
    13,268
 | 
 
 | 
 
 | 
    $
 | 
    11,431
 | 
 
 | 
| 
 
    Asia
 
 | 
 
 | 
 
 | 
    650
 | 
 
 | 
 
 | 
 
 | 
    920
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net property, plant & equipment
 
 | 
 
 | 
    $
 | 
    13,918
 | 
 
 | 
 
 | 
    $
 | 
    12,351
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
     | 
     | 
    | 
    13.  
 | 
    
    Selected
    Quarterly Consolidated Financial Data (Unaudited)
 | 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Three Months Ended
 | 
 
 | 
| 
 
 | 
 
 | 
    April 3, 
    
 | 
 
 | 
 
 | 
    July 3, 
    
 | 
 
 | 
 
 | 
    Oct. 2, 
    
 | 
 
 | 
 
 | 
    Dec. 31, 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    2010
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except per share data)
 | 
 
 | 
|  
 | 
| 
 
    Net sales
 
 | 
 
 | 
    $
 | 
    33,142
 | 
 
 | 
 
 | 
    $
 | 
    68,598
 | 
 
 | 
 
 | 
    $
 | 
    64,627
 | 
 
 | 
 
 | 
    $
 | 
    36,159
 | 
 
 | 
| 
 
    Gross profit
 
 | 
 
 | 
 
 | 
    14,478
 | 
 
 | 
 
 | 
 
 | 
    29,034
 | 
 
 | 
 
 | 
 
 | 
    29,584
 | 
 
 | 
 
 | 
 
 | 
    14,576
 | 
 
 | 
| 
 
    Net income
 
 | 
 
 | 
 
 | 
    1,430
 | 
 
 | 
 
 | 
 
 | 
    12,337
 | 
 
 | 
 
 | 
 
 | 
    13,179
 | 
 
 | 
 
 | 
 
 | 
    1,103
 | 
 
 | 
| 
 
    Basic income per share
 
 | 
 
 | 
    $
 | 
    0.06
 | 
 
 | 
 
 | 
    $
 | 
    0.55
 | 
 
 | 
 
 | 
    $
 | 
    0.59
 | 
 
 | 
 
 | 
    $
 | 
    0.05
 | 
 
 | 
| 
 
    Diluted income per share
 
 | 
 
 | 
    $
 | 
    0.06
 | 
 
 | 
 
 | 
    $
 | 
    0.54
 | 
 
 | 
 
 | 
    $
 | 
    0.58
 | 
 
 | 
 
 | 
    $
 | 
    0.05
 | 
 
 | 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Three Months Ended
 | 
 
 | 
| 
 
 | 
 
 | 
    March 28, 
    
 | 
 
 | 
 
 | 
    June 27, 
    
 | 
 
 | 
 
 | 
    Sept. 26, 
    
 | 
 
 | 
 
 | 
    Dec. 31, 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except per share data)
 | 
 
 | 
|  
 | 
| 
 
    Net sales
 
 | 
 
 | 
    $
 | 
    12,308
 | 
 
 | 
 
 | 
    $
 | 
    12,318
 | 
 
 | 
 
 | 
    $
 | 
    19,155
 | 
 
 | 
 
 | 
    $
 | 
    34,200
 | 
 
 | 
| 
 
    Gross profit
 
 | 
 
 | 
 
 | 
    4,265
 | 
 
 | 
 
 | 
 
 | 
    4,513
 | 
 
 | 
 
 | 
 
 | 
    8,678
 | 
 
 | 
 
 | 
 
 | 
    15,264
 | 
 
 | 
| 
 
    Net income (loss)
 
 | 
 
 | 
 
 | 
    (5,773
 | 
    )
 | 
 
 | 
 
 | 
    (4,487
 | 
    )
 | 
 
 | 
 
 | 
    (1,792
 | 
    )
 | 
 
 | 
 
 | 
    1,975
 | 
 
 | 
| 
 
    Basic income (loss) per share
 
 | 
 
 | 
    $
 | 
    (0.26
 | 
    )
 | 
 
 | 
    $
 | 
    (0.20
 | 
    )
 | 
 
 | 
    $
 | 
    (0.08
 | 
    )
 | 
 
 | 
    $
 | 
    0.09
 | 
 
 | 
| 
 
    Diluted income (loss) per share
 
 | 
 
 | 
    $
 | 
    (0.26
 | 
    )
 | 
 
 | 
    $
 | 
    (0.20
 | 
    )
 | 
 
 | 
    $
 | 
    (0.08
 | 
    )
 | 
 
 | 
    $
 | 
    0.09
 | 
 
 | 
    
    69
 
 
     | 
     | 
    | 
    Item 9.  
 | 
    
    Changes
    In and Disagreements With Accountants on Accounting and
    Financial Disclosure
 | 
 
    None.
 
     | 
     | 
    | 
    Item 9A.  
 | 
    
    Controls
    and Procedures
 | 
 
    Managements
    Report on Assessment of Internal Controls Over Financial
    Reporting
 
    Evaluation
    of Disclosure Controls and Procedures
 
    Based on Intevacs managements evaluation (with the
    participation of Intevacs chief executive officer and
    chief financial officer), as of the end of the period covered by
    this report, Intevacs chief executive officer and chief
    financial officer have concluded that Intevacs disclosure
    controls and procedures (as defined in
    Rules 13a-15(e)
    and
    15d-15(e)
    under the Securities Exchange Act of 1934, as amended, (the
    Exchange Act)) are effective to ensure that
    information required to be disclosed by Intevac in reports that
    Intevac files or submits under the Exchange Act is recorded,
    processed, summarized and reported within the time periods
    specified in Securities and Exchange Commission rules and forms
    and is accumulated and communicated to Intevacs
    management, including Intevacs chief executive officer and
    chief financial officer, as appropriate to allow timely
    decisions regarding required disclosure.
 
    Managements
    Report on Internal Control over Financial
    Reporting
 
    Management is responsible for establishing and maintaining
    adequate internal control over financial reporting for Intevac.
    Internal control over financial reporting is a process designed
    to provide reasonable assurance regarding the reliability of
    financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted
    accounting principles. Internal control over financial reporting
    includes those policies and procedures that: (i) pertain to
    the maintenance of records that in reasonable detail accurately
    and fairly reflect the transactions and dispositions of the
    assets of the Company; (ii) provide reasonable assurance
    that transactions are recorded as necessary to permit
    preparation of financial statements in accordance with generally
    accepted accounting principles, and that receipts and
    expenditures of the Company are being made only in accordance
    with authorizations of management and directors of the Company;
    and (iii) provide reasonable assurance regarding prevention
    or timely detection of unauthorized acquisition, use, or
    disposition of the Companys assets that could have a
    material effect on the financial statements.
 
    Because of its inherent limitations, internal control over
    financial reporting may not prevent or detect misstatements.
    Also, projections of any evaluation of effectiveness to future
    periods are subject to the risk that controls may become
    inadequate because of changes in conditions, or that the degree
    of compliance with the policies or procedures may deteriorate.
 
    Management (with the participation of the chief executive
    officer and chief financial officer) conducted an evaluation of
    the effectiveness of Intevacs internal control over
    financial reporting based on the framework in Internal
    Control  Integrated Framework issued by the
    Committee of Sponsoring Organizations of the Treadway
    Commission. Based on this evaluation, management concluded that
    Intevacs internal control over financial reporting was
    effective as of December 31, 2010. Grant Thornton LLP, an
    independent registered public accounting firm, has audited the
    effectiveness of Intevacs internal control over financial
    reporting and has issued a report on Intevacs internal
    control over financial reporting, which is included in their
    report on the following page.
 
    Changes
    in Internal Control over Financial Reporting
 
    There was no change in our internal control over financial
    reporting during our fourth quarter of fiscal 2010 that has
    materially affected, or is reasonably likely to materially
    affect, Intevacs internal control over financial reporting.
    
    70
 
 
    REPORT OF
    INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
    Board of Directors and Stockholders
    Intevac, Inc.
 
    We have audited Intevac, Inc. (a Delaware corporation) and
    subsidiaries (collectively, the Company)
    internal control over financial reporting as of
    December 31, 2010, based on criteria established in
    Internal Control  Integrated Framework issued
    by the Committee of Sponsoring Organizations of the Treadway
    Commission (COSO). The Companys management is
    responsible for maintaining effective internal control over
    financial reporting and for its assessment of the effectiveness
    of internal control over financial reporting, included in the
    accompanying Managements Report on Internal Control Over
    Financial Reporting. Our responsibility is to express an opinion
    on the Companys internal control over financial reporting
    based on our audit.
 
    We conducted our audit in accordance with the standards of the
    Public Company Accounting Oversight Board (United States). Those
    standards require that we plan and perform the audit to obtain
    reasonable assurance about whether effective internal control
    over financial reporting was maintained in all material
    respects. Our audit included obtaining an understanding of
    internal control over financial reporting, assessing the risk
    that a material weakness exists, testing and evaluating the
    design and operating effectiveness of internal control based on
    the assessed risk, and performing such other procedures as we
    considered necessary in the circumstances. We believe that our
    audit provides a reasonable basis for our opinion.
 
    A companys internal control over financial reporting is a
    process designed to provide reasonable assurance regarding the
    reliability of financial reporting and the preparation of
    financial statements for external purposes in accordance with
    generally accepted accounting principles. A companys
    internal control over financial reporting includes those
    policies and procedures that (1) pertain to the maintenance
    of records that, in reasonable detail, accurately and fairly
    reflect the transactions and dispositions of the assets of the
    company; (2) provide reasonable assurance that transactions
    are recorded as necessary to permit preparation of financial
    statements in accordance with generally accepted accounting
    principles, and that receipts and expenditures of the company
    are being made only in accordance with authorizations of
    management and directors of the company; and (3) provide
    reasonable assurance regarding prevention or timely detection of
    unauthorized acquisition, use, or disposition of the
    companys assets that could have a material effect on the
    financial statements.
 
    Because of its inherent limitations, internal control over
    financial reporting may not prevent or detect misstatements.
    Also, projections of any evaluation of effectiveness to future
    periods are subject to the risk that controls may become
    inadequate because of changes in conditions, or that the degree
    of compliance with the policies or procedures may deteriorate.
 
    In our opinion, Intevac, Inc. and subsidiaries maintained, in
    all material respects, effective internal control over financial
    reporting as of December 31, 2010, based on criteria
    established in Internal Control  Integrated
    Framework issued by COSO.
 
    We also have audited, in accordance with the standards of the
    Public Company Accounting Oversight Board (United States), the
    consolidated balance sheets of the Company as of
    December 31, 2010 and 2009, and the related consolidated
    statements of operations, stockholders equity and
    comprehensive income (loss), and cash flows for each of the
    three years in the period ended December 31, 2010. Our
    audits of the basic financial statements included the financial
    statement schedule listed in the index appearing under
    Item 15(a)(2). Our report dated February 25, 2011
    expressed an unqualified opinion on those consolidated financial
    statements and schedule.
 
    /s/ GRANT THORNTON LLP
 
    San Jose, California
    February 25, 2011
    
    71
 
 
     | 
     | 
    | 
    Item 9B.  
 | 
    
    Other
    Information
 | 
 
    None.
 
    PART III
 
     | 
     | 
    | 
    Item 10.  
 | 
    
    Directors,
    Executive Officers and Corporate Governance
 | 
 
    The information required by this item relating to the
    Companys directors and nominees, disclosure relating to
    compliance with Section 16(a) of the Securities Exchange
    Act of 1934, and information regarding Intevacs code of
    ethics, audit committee and stockholder recommendations for
    director nominees is included under the captions Election
    of Directors, Nominees, Business
    Experience of Nominees for Election as Directors,
    Board Meetings and Committees, Corporate
    Governance Matters, Section 16(a) Beneficial
    Ownership Reporting Compliance and Code of Business
    Conduct and Ethics in the Companys Proxy Statement
    for the 2011 Annual Meeting of Stockholders and is incorporated
    herein by reference. The information required by this item
    relating to the Companys executive officers and key
    employees is included under the caption Executive Officers
    of the Registrant under Item 1 in Part I of this
    Annual Report on
    Form 10-K.
 
     | 
     | 
    | 
    Item 11.  
 | 
    
    Executive
    Compensation
 | 
 
    The information required by this item is included under the
    caption Executive Compensation and Related
    Information in the Companys Proxy Statement for the
    2011 Annual Meeting of Stockholders and is incorporated herein
    by reference.
 
     | 
     | 
    | 
    Item 12.  
 | 
    
    Security
    Ownership of Certain Beneficial Owners and Management and
    Related Stockholder Matters
 | 
 
    Securities authorized for issuance under equity compensation
    plans.  The following table summarizes the number
    of outstanding options granted to employees and directors, as
    well as the number of securities remaining available for future
    issuance, under Intevacs equity compensation plans at
    December 31, 2010.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    (a)
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    (c)
 | 
 
 | 
| 
 
 | 
 
 | 
    Number of Securities 
    
 | 
 
 | 
 
 | 
    (b)
 | 
 
 | 
 
 | 
    Number of Securities 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    to be Issued upon 
    
 | 
 
 | 
 
 | 
    Weighted-Average 
    
 | 
 
 | 
 
 | 
    Remaining Available 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Exercise of 
    
 | 
 
 | 
 
 | 
    Exercise Price of 
    
 | 
 
 | 
 
 | 
    for Future Issuance 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Outstanding Options, 
    
 | 
 
 | 
 
 | 
    Outstanding Options, 
    
 | 
 
 | 
 
 | 
    under Equity 
    
 | 
 
 | 
| 
 
    Plan Category
 
 | 
 
 | 
    Warrants and Rights
 | 
 
 | 
 
 | 
    Warrants and Rights
 | 
 
 | 
 
 | 
    Compensation Plans
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    (1)
 | 
 
 | 
|  
 | 
| 
 
    Equity compensation plans approved by security holders(2)
 
 | 
 
 | 
 
 | 
    3,385,245
 | 
 
 | 
 
 | 
    $
 | 
    11.61
 | 
 
 | 
 
 | 
 
 | 
    772,814
 | 
 
 | 
| 
 
    Equity compensation plans not approved by security holders
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total
 
 | 
 
 | 
 
 | 
    3,385,245
 | 
 
 | 
 
 | 
    $
 | 
    11.61
 | 
 
 | 
 
 | 
 
 | 
    772,814
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 
     | 
     | 
     | 
    | 
    (1)  | 
     | 
    
    Excludes securities reflected in column (a). | 
|   | 
    | 
    (2)  | 
     | 
    
    Included in the column (c) amount are 235,571 shares
    available for future issuance under Intevacs 2003 Employee
    Stock Purchase Plan. | 
 
    The other information required by this item is included under
    the caption Ownership of Securities in the
    Companys Proxy Statement for the 2011 Annual Meeting of
    Stockholders and is incorporated herein by reference.
 
     | 
     | 
    | 
    Item 13.  
 | 
    
    Certain
    Relationships and Related Transactions, and Director
    Independence
 | 
 
    The information required by this item is included under the
    captions Certain Transactions and Corporate
    Governance Matters in the Companys Proxy Statement
    for the 2011 Annual Meeting of Stockholders and is incorporated
    herein by reference.
    
    72
 
 
     | 
     | 
    | 
    Item 14.  
 | 
    
    Principal
    Accountant Fees and Services
 | 
 
    The information required by this item is included under the
    caption Fees Paid To Accountants For Services Rendered
    During 2010 in the Companys Proxy Statement for the
    2011 Annual Meeting of Stockholders and is incorporated herein
    by reference.
 
    PART IV
 
     | 
     | 
    | 
    Item 15.  
 | 
    
    Exhibits
    and Financial Statement Schedules
 | 
 
    a) The following documents are filed as part of this Annual
    Report on
    Form 10-K:
 
    1. Financial Statements:
 
    See Index to Consolidated Financial Statements in
    Part II, Item 8 of this
    Form 10-K.
 
    2. Financial Statement Schedule:
 
    Schedule II  Valuation and Qualifying Accounts
 
    All other schedules have been omitted since the required
    information is not present in amounts sufficient to require
    submission of the schedule or because the information required
    is included in the consolidated financial statements or notes
    thereto.
 
    3. Exhibits
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
    Exhibit 
    
 | 
 
 | 
 
 | 
| 
 
    Number
 
 | 
 
 | 
 
    Description
 
 | 
|  
 | 
| 
 
 | 
    3
 | 
    .1(1)
 | 
 
 | 
    Certificate of Incorporation of the Registrant
 | 
| 
 
 | 
    3
 | 
    .2(2)
 | 
 
 | 
    Bylaws of the Registrant, as amended
 | 
| 
 
 | 
    10
 | 
    .1+(3)
 | 
 
 | 
    The Registrants 1995 Stock Option/Stock Issuance Plan, as
    amended
 | 
| 
 
 | 
    10
 | 
    .2+(4)
 | 
 
 | 
    The Registrants 2003 Employee Stock Purchase Plan, as
    amended
 | 
| 
 
 | 
    10
 | 
    .3+(4)
 | 
 
 | 
    The Registrants 2004 Equity Incentive Plan, as amended
 | 
| 
 
 | 
    10
 | 
    .4
 | 
 
 | 
    Lease, dated February 5, 2001 regarding the space located
    at 3510, 3544, 3560, 3570 and 3580 Bassett Street,
    Santa Clara, California, including the First through
    Seventh Amendments
 | 
| 
 
 | 
    10
 | 
    .6+(3)
 | 
 
 | 
    The Registrants 401(k) Profit Sharing Plan
 | 
| 
 
 | 
    10
 | 
    .9(5)
 | 
 
 | 
    Director and Officer Indemnification Agreement
 | 
| 
 
 | 
    10
 | 
    .11+(6)
 | 
 
 | 
    The Registrants Executive Incentive Plan
 | 
| 
 
 | 
    10
 | 
    .12+(6)
 | 
 
 | 
    Employment Agreement of Kevin Fairbairn dated January 24,
    2002, as amended
 | 
| 
 
 | 
    21
 | 
    .1
 | 
 
 | 
    Subsidiaries of the Registrant
 | 
| 
 
 | 
    23
 | 
    .1
 | 
 
 | 
    Consent of Independent Registered Public Accounting Firm
 | 
| 
 
 | 
    23
 | 
    .2
 | 
 
 | 
    Consent of Independent Valuation Firm
 | 
| 
 
 | 
    24
 | 
    .1
 | 
 
 | 
    Power of Attorney (see page 75)
 | 
| 
 
 | 
    31
 | 
    .1
 | 
 
 | 
    Certification of President and Chief Executive Officer Pursuant
    to Section 302 of the Sarbanes-Oxley Act of 2002
 | 
| 
 
 | 
    31
 | 
    .2
 | 
 
 | 
    Certification of Vice-President, Finance and Administration,
    Chief Financial Officer, Treasurer and Secretary Pursuant to
    Section 302 of the Sarbanes-Oxley Act of 2002
 | 
| 
 
 | 
    32
 | 
    .1
 | 
 
 | 
    Certifications Pursuant to U.S.C. 1350, adopted Pursuant to
    Section 906 of the Sarbanes-Oxley Act of 2002
 | 
 
 
     | 
     | 
     | 
    | 
    (1)  | 
     | 
    
    Previously filed as an exhibit to the Companys Report on
    Form 8-K
    filed July 23, 2007 | 
|   | 
    | 
    (2)  | 
     | 
    
    Previously filed as an exhibit to the Companys Report on
    Form 8-K
    filed November 19, 2008 | 
|   | 
    | 
    (3)  | 
     | 
    
    Previously filed as an exhibit to the Registration Statement on
    Form S-1
    (No.
    33-97806) | 
    
    73
 
 
     | 
     | 
     | 
    | 
    (4)  | 
     | 
    
    Previously filed as an exhibit to the Companys
    Form 10-Q
    filed May 4, 2010 | 
|   | 
    | 
    (5)  | 
     | 
    
    Previously filed as an exhibit to the Companys
    Form 10-K
    filed March 14, 2008 | 
|   | 
    | 
    (6)  | 
     | 
    
    Previously filed as an exhibit to the Companys
    Form 10-K
    filed March 4, 2009 | 
|   | 
    | 
    +  | 
     | 
    
    Management compensatory plan or arrangement required to be filed
    as an exhibit pursuant to Item 15(c) of
    Form 10-K | 
    
    74
 
 
    SIGNATURES
 
    Pursuant to the requirements of Section 13 or 15(d) of the
    Securities Exchange Act of 1934, the registrant has duly caused
    this report to be signed on its behalf by the undersigned,
    thereunto duly authorized, on February 25, 2011.
 
    INTEVAC, INC.
 
    Jeffrey Andreson
    Executive Vice President, Finance and Administration,
    Chief Financial Officer, Treasurer and Secretary
 
    POWER OF
    ATTORNEY
 
    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose
    signature appears below constitutes and appoints Kevin Fairbairn
    and Jeffrey Andreson and each of them, as his true and lawful
    attorneys-in-fact and agents, with full power of substitution
    and resubstitution, for him and in his name, place and stead, in
    any and all capacities, to sign any and all amendments
    (including post-effective amendments) to this Report on
    Form 10-K,
    and to file the same, with all exhibits thereto, and other
    documents in connection therewith, with the Securities and
    Exchange Commission, granting unto said attorneys-in-fact and
    agents, and each of them, full power and authority to do and
    perform each and every act and thing requisite and necessary to
    be done in connection therewith, as fully to all intents and
    purposes as he might or could do in person, hereby ratifying and
    confirming all that said attorneys-in-fact and agents, or any of
    them, or their or his substitute or substitutes, may lawfully do
    or cause to be done by virtue hereof.
 
    Pursuant to the requirements of the Securities Exchange Act of
    1934, this report has been signed below by the following persons
    on behalf of the registrant and in the capacities and on the
    dates indicated.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Signature
 
 | 
 
 | 
 
    Title
 
 | 
 
 | 
 
    Date
 
 | 
|  
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  KEVIN
    FAIRBAIRN  
    (Kevin
    Fairbairn)
 | 
 
 | 
    President, Chief Executive Officer and Director (Principal
    Executive Officer)
 | 
 
 | 
    February 25, 2011
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  NORMAN
    H. POND  
    (Norman
    H. Pond)
 | 
 
 | 
    Chairman of the Board
 | 
 
 | 
    February 25, 2011
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  JEFFREY
    ANDRESON  
    (Jeffrey
    Andreson)
 | 
 
 | 
    Executive Vice President, Finance and Administration, Chief
    Financial Officer Treasurer and Secretary (Principal Financial
    and Accounting Officer)
 | 
 
 | 
    February 25, 2011
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  DAVID
    S. DURY  
    (David
    S. Dury)
 | 
 
 | 
    Director
 | 
 
 | 
    February 25, 2011
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  STANLEY
    J. HILL  
    (Stanley
    J. Hill)
 | 
 
 | 
    Director
 | 
 
 | 
    February 25, 2011
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  THOMAS
    M. ROHRS  
    (Thomas
    M. Rohrs)
 | 
 
 | 
    Director
 | 
 
 | 
    February 25, 2011
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  JOHN
    F. SCHAEFER  
    (John
    F. Schaefer)
 | 
 
 | 
    Director
 | 
 
 | 
    February 25, 2011
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  PING
    YANG  
    (Ping
    Yang)
 | 
 
 | 
    Director
 | 
 
 | 
    February 25, 2011
 | 
    
    75
 
 
    SCHEDULE II 
    VALUATION AND QUALIFYING ACCOUNTS
    
 
    INTEVAC,
    INC.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
 
 | 
 
 | 
    Additions (Reductions)
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
    Charged 
    
 | 
 
 | 
    Charged 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
    Balance at 
    
 | 
 
 | 
    (Credited) 
    
 | 
 
 | 
    (Credited) 
    
 | 
 
 | 
 
 | 
 
 | 
    Balance at 
    
 | 
| 
 
 | 
 
 | 
    Beginning 
    
 | 
 
 | 
    to Costs and 
    
 | 
 
 | 
    to Other 
    
 | 
 
 | 
 
 | 
 
 | 
    End 
    
 | 
| 
 
    Description
 
 | 
 
 | 
    of Period
 | 
 
 | 
    Expenses
 | 
 
 | 
    Accounts
 | 
 
 | 
    Deductions - Describe
 | 
 
 | 
    of Period
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
|  
 | 
| 
 
    Year ended December 31, 2008:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Deducted from asset accounts:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Allowance for doubtful accounts
 
 | 
 
 | 
    $
 | 
    57
 | 
 
 | 
 
 | 
    $
 | 
    93
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    5
 | 
    (1)
 | 
 
 | 
    $
 | 
    145
 | 
 
 | 
| 
 
    Year ended December 31, 2009:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Deducted from asset accounts:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Allowance for doubtful accounts
 
 | 
 
 | 
    $
 | 
    145
 | 
 
 | 
 
 | 
    $
 | 
    133
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    145
 | 
    (1)
 | 
 
 | 
    $
 | 
    133
 | 
 
 | 
| 
 
    Year ended December 31, 2010:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Deducted from asset accounts:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Allowance for doubtful accounts
 
 | 
 
 | 
    $
 | 
    133
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    78
 | 
    (1)
 | 
 
 | 
    $
 | 
    55
 | 
 
 | 
 
 
     | 
     | 
     | 
    | 
    (1)  | 
     | 
    
    Write-offs of amounts deemed uncollectible. | 
    
    76